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A general synthetic method has been developed for the synthesis of post-
transition metal, triple-decker cations.  The addition of positively charged half-
sandwich cations to neutral metallocenes affords triple-decker cations of the 
formula, [η5-(C5Me5)3E2]+.  Examples of both group 13 and group 14 complexes 
have been prepared and structurally characterized.  These triple-decker cations 
provide a platform, which shows promise for the development of nanomaterials, 
such as molecular wires.  Group 14 metallocene complexes containing the 1,3-
bis(trimethylsilyl)indenide ligand have also been synthesized and structurally 
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characterized.  Rational syntheses for complexes of the formulas [1,3-
(Me3Si)2(η5-C9H5)]2E and [1,3-(Me3Si)2(η5-C9H5)](η5-C5Me5)E have been 
developed.  The lability of the indenide ligand renders these complexes promising 
potential precursors for group 14 nanoparticle formation.   
The merger of organometallic chemistry with molecular biology to 
provide creative solutions to difficult problems opened an opportunity to apply 
the background I have acquired in structure chemistry to the study of three 
metalloenzymes, 3-dehydroquinate synthase, 5-enolpyruvylshikimate 3-phosphate 
synthase, and Mycobacterium tuberculosis catalase-peroxidase (M. tuberculosis 
CP).  Computational analsysis of the crystal structure of each system provided 
valuable insight into residues that play a key role in the activity of the enzymes.  
This knowledge can in turn be applied to the development of the small-molecule 
inhibitors of the enzymes.  In addition to computational analysis of M. 
tuberculosis CP, an X-ray crystal structure of this enzyme was determined to a 
resolution of 2.4 Å.     
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CHAPTER 1:  GROUP 13 AND 14 MULTI-DECKER CATIONS 
INTRODUCTION 
The pentamethylcyclopentadienide ligand, [C5Me5]¯, is one of the most 
widely used bulky substituents for the stabilization of low valent and electron-
deficient species.  By accommodating a wide range of bonding modes, the 
[C5Me5]¯ ligand can effectively adjust to its electronic environment.[1]  This 
flexibility in bonding modes congruently with the bulky nature of the σ- or π- 
bound C5Me5 moiety permits the kinetic and thermodynamic stabilization of 
otherwise highly reactive species.[1]  Transition and lanthanide metal complexes 
featuring the [C5Me5]¯ ligand have been investigated extensively; however, it was 
not until recently that analogous complexes of the main group elements have been 
studied.[2, 3] 
    Since coinage of the term in 1952, metallocenes have typically been 
associated with (bis-cyclopentadienyl)metal derivatives; however the scope of the 
definition has expanded subsequently to include half-sandwich, multi-decker, and 
polymeric cyclopentadiene complexes.  The [C5Me5]¯ ligand exhibits fluxionality 
and a tendency for ring slippage.  There are six plausible bonding modes for the 
C5Me5 ligand, which are shown in Figure 1.1.  Due to the hapticity changes, the 
2 
C5Me5 ligand is able to adjust its effective electron contribution to the element 
center. 
E E E E E E
η1(π) η3 η5 η4 η2η1(σ)  
Figure 1.1  The six possible bonding modes for C5Me5. 
 
 In addition to their tendency toward ring slippage, the cyclopentadienyl 
family of ligands displays a facile migratory behavior.  NMR spectroscopic 
studies have evidenced the equivalence of all proton and all carbon and methyl 
carbon resonances for many C5Me5 species.  The migratory process is 














Figure 1.2  Sigmatropic rearrangements in C5Me5—E compounds where C 
designates a C-atom in the C5Me5 ring. 
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 The π-bonding mode of the [C5Me5]¯ ligand can be utilized to create 
metallocenes that are similar in structure to ferrocene, Fe(η5-C5H5)2.[4-7]  Several 
pentamethylcyclopentadienide complexes of the p-block elements have been 
structurally characterized including those of Sn(η5-C5Me5)2[8] and Pb(η5-
C5Me5)2.[9]  In each case, the [C5Me5]¯ rings of these +II oxidation state group 14 
metallocenes are not coplanar due to the presence of a lone pair on the 
heteroatom.  The presence of the lone pair causes a rather large bend in the ring 
centroid—metal—ring centroid bond angles: (154.9º in Sn (η5-C5Me5)2[8] and 
151º in Pb(η5-C5Me5)2[9]).     
Since the discovery of the first simple sandwich complex, ferrocene[4-7] in 
1952, an intense interest has been generated in the syntheses, structures, and 
properties of multi-decker sandwich compounds.  The first genuine triple-decker 
complex, [(η5-C5H5)3Ni2]+, was synthesized by Werner and Salzer in 1972.[10]  
Several transition metal multi-decker complexes have since been synthesized 
since that time including [(η5-C5Me5)3Co2]+,[11] [(η5-C5Me5)3Ru2]+,[12] and [(η5-
C5H5)Mo(CO)3(µ-η5-C5H5)Fe(CO)2(η5-C5H5)Mn(CO)3]+.[13]  Until recently only 
two main group multi-decker species had been characterized, namely [(η5-
C5H5)3Tl2]¯ [14] and [(η5-C5H5)3Cs2]¯.[15]  Both anions have a trans-geometry with 




Figure 1.3  The [(η5-C5H5)3Tl2]¯[14] and [(η5-C5H5)3Cs2]¯[15] anions have a 
trans-geometry with respect to the terminal cyclopentadienide groups. 
 
An upsurge of interest in the chemistry of main group metallocenes has 
occurred over the past decade.[3]  Apart from the fact that much less is known 
about s- and p-block metallocenes than their d- and f-block counterparts, interest 
in the main group metallocenes has been stimulated by structure and bonding 
considerations,[3] their utility as reagents and chemical vapor desposition 
sources,[16] and the possibility of serving as useful catalysts for alkene 
polyerizations.[17, 18]  Additionally, the use of post transition metal compounds as 
precursors for novel materials has driven the growth of synthesis and 
characterization of new classes of main group compounds. 
 Cation-π interactions provide a powerful tool for constructing novel 
molecular architectures and hold promise for the development of potentially new 
electronic materials.  The main group multi-decker, sandwich-type complexes 
have not received a similar level of attention in comparison with transition metal 
analogues.  The main group multidecker anions of thallium[14] and cesium[15] were 
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identified in 1995 and 1996, respectively.  An important step in the assembly of 
multidecker anions of the heavier main group elements consists of the addition of 
cyclopentadienide anions to neutral metallocenes in the presence of weakly 
coordinating cations.[14, 15, 19, 20]  However, the inverse of this approach, viz. the 
synthesis of homonuclear multidecker p-block cations by the addition of 
positively charged fragments to neutral metallocenes in the presence of 
appropriate anions, had not been reported until Cowley et al.[21] reported the 
synthesis of [(η5-C5Me5)3Sn2)][Ga(C6F5)4] in 2001.   In an attempt to create a 
Ga→Sn donor-acceptor bond, it was found that the reaction of Sn(η5-C5Me5)2 
with the Lewis acid Ga(C6F5)3 seredipidously afforded the triple-decker cation 
[(η5-C5Me5)3Sn2)]+ (Figure 1.4).  It was hypothesized that the formation of the 
triple-decker cation took place by the in situ formation of [Sn(η5-C5Me5)]+ via 
abstraction of a [C5Me5]¯ moiety by Ga(C6F5)3, followed by addition of the 








Figure 1.4  Reaction of [Sn(η5-C5Me5) 2] with Ga(C6F5)4.  Methyl groups have 
been omitted for clarity. 
 
 In order to extend the triple-decker cation chemistry to the group 13 
elements, it was necessary to recognize the isolobal relationship between [Sn(η5-
C5Me5)]+ and [In(η6-C6H6)]+ (Figure 1.5).  As summarized in Figure 1.5, the 
protolytic cleavage of In(η5-C5Me5) by the Brønsted acid, H2O·B(C6F5)3 in the 
presence of an arene solvent provides a potential source of [In(arene)]+ cations for 
addition to neutral In(η5-C5Me5).  Addition of an equimolar quantity of the Lewis 
acid, B(C6F5)3,[22, 23] was used for complexation to the conjugate base of 
H2O·B(C6F5)3.  Thus, treatment of In(η5-C5Me5) with equimolar quantities of 
B(C6F5)3,[22, 23] and H2O·B(C6F5)3[24] in toluene solution at 0ºC, afforded colorless 
crystals that were identified by X-ray diffraction as [(η6-toluene)In(η5-













Figure 1.6  Protolytic cleavage of In(η5-C5Me5) with H2O·B(C6F5)3 to give 
[(η6-toluene)In(η5-C5Me5)In(η6-toluene)]+.  Methyl groups of the η5-C5Me5 
have been omitted for clarity.  
  
  The bonding in [(η6-toluene)In(η5-C5Me5)In(η6-toluene)]+ can be 
interpreted in two different ways, namely (i) as a triple-decker sandwich cation or 
(ii) a base-stabilized inverse sandwich cation.  Density functional theory (DFT) 
calculations indicate that η6-coordination of the two toluene molecules to the 
[In(µ-C5H5)In]+ moiety causes only a slight perturbation of the core and the arene.  
Moreover, the arene—In bond dissociation energy (6.6 kcal/mol) suggests a very 
weak interaction, thus lending credence to identification of the complex as the 
first example of a main group inverse sandwich structure.  
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The present work focuses on validating and generalizing the concept of 
the synthesis of triple-decker, main group metallocene cations by the addition of 
positively charged fragments to neutral main group metallocenes.  The scope of 
the general method is tested further by attempting to assemble heterogeneous 
metal multi-decker sandwich compounds.  Additionally, investigations into the 
significance of the role of the gegenion will also be discussed.   
9 
RESULTS AND DISCUSSION 
Synthesis and Characterization of [(η5-Me5C5)Ge][B(C6F5)4], [1][B(C6F5)4] 
The pentamethylcyclopentadienylgermanium(II) cation, 1+, was 
synthesized in low yield via the metathetical reaction of 
pentamethylcyclopentadienylgermanium(II) chloride with one equivalent of 
LiB(C6F5)4.  The observed equivalence of the 1H and 13C NMR spectral peaks of 
[1][B(C6F5)4]  supported the proposed C5v symmetry structure for the cation.  
Insight into the proposed structure of the anion was provided by the detection of 
the ortho, meta, and para phenyl ring carbons in the 13C NMR spectrum, and the 
presence of a singlet at δ -20.23 in the 11B NMR spectrum.  The three peaks 
representing the ortho, meta, and para fluorine atoms on the phenyl rings were 
evidenced in the 19F NMR spectrum. 
Recrystallization of [1][B(C6F5)4] by the slow diffusion of hexane and 
dichloromethane yielded crystals suitable for X-ray diffraction experiments.  An 
X-ray diffraction study identified the crystals as the title compound shown in 
Figure 1.7.  Details of the data collection, structure solution, and refinement are 
compiled in Table 1.3 and selected metrical parameters are listed in Table 1.4 and 
Table 1.5.   
10 
 
Figure 1.7  Molecular structure of [(η5-C5Me5)Ge][B(C6F5)4], [1][B(C6F5)4]), 
showing the close contacts of the germanium cation with some of the fluorine 
atoms of the anion.  Carbon, boron, fluorine, and germanium atoms are 
shown in black, orange, green, and red, respectively.  Hydrogen atoms have 
been omitted for clarity. 
 
As illustrated in Figure 1.7, the germanium atom is centered above the 
C5Me5 ring and shows close contact interactions with three of the fluorine atoms 
of the tetrakis(pentafluorophenyl)borate anion.  The Ge—Cring bond distances 
range from 2.234(3)—2.250(3) Å with an average bond length of 2.241(3) Å, 
which is slightly shorter that that reported by Winters et al.,[25] for [(η5-
C5Me5)Ge][BF4] (av. 2.255(2) Å).  The ring-centroid to metal bond distance is 
1.883(4) Å.  The [η5-C5Me5] ring exhibits delocalized π-bonding as evidenced by 
the Cring—Cring bond distances of 1.368(4), 1.371(4), 1.382(4), 1.378(3), and 
1.396(3) Å.  Based on the pattern of bond distances, germanium is considered to 
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be pentahapto bonded to the pentametylcyclopentadienide ring.  The ring itself is 
planar and the methyl groups extend out of the plane and away from the 
germanium center.  Evidence for this is provided by the angles between the ring 
plane and the least-squares planes defined by the two adjacent ring-carbon atoms 
and the attached methyl carbon atoms, which have an average value of 2.9°.  
Three of the fluorine atoms (F44, F12, and F11) of the 
tetrakis(pentafluorophenyl)borate anion are located at distances which are less 
than the sum of the van der Waals radii of germanium and fluorine (van der 
Waals radii of Ge = 1.97 Å and F = 1.47 Å).[26]  The close contacts between the 
fluorine atoms and the germanium atom range in distance from 3.089—3.312 Å.  
Although the cation is very similar to [Cp*Ge][BF4] reported by Winters et al., 
[25] there is no discussion of coordination of the germanium to the fluorine atoms 
of the anion in that publication.  
Synthesis and Characterization of [(η5-Me5C5)Sn][B(C6F5)4], [2][B(C6F5)4] 
The pentamethylcyclopentadienyltin(II) cation, 2+, was synthesized via the 
metathetical reaction of pentamethylcyclopentadienyltin(II) chloride with one 
equivalent of LiB(C6F5)4 as described by Rhodes, et al.[27]  As reported by these 
authors, the 1H and 13C NMR spectra of [2][B(C6F5)4]  evidence the C5v symmetry 
of the cation.  Insight into the structure of the anion was provided by the detection 
of the ortho, meta, and para phenyl ring carbon resonances in the 13C NMR 
12 
spectrum.  For further characterization of the proposed structure of the cation and 
anion, 119Sn, 11B, and 19F NMR spectra were recorded.  As expected, examination 
of the 119Sn NMR spectrum revealed the presence of only one peak located at δ -
2219.  A singlet at δ -20.23 in the 11B NMR spectrum and three peaks 
representing the ortho, meta, and para fluorine atoms on the phenyl rings in the 
19F NMR spectrum were consistent with the tetrahedral geometry of the 
[B(C6F5)4]¯ anion. 
Although the synthesis of [2][B(C6F5)4] had been reported previously,[27] 
no structural data was available for this compound.  Recrystallization of 
[2][B(C6F5)4] by the slow diffusion of hexane and dichloromethane yielded 
crystals suitable for X-ray diffraction experiments.  An X-ray diffraction study 
identified the crystals as the title compound shown in Figure 1.8.  Details of the 
data collection, structure solution, and refinement are compiled in Table 1.6 and 




Figure 1.8  Molecular structure of [(η5-C5Me5)Sn][B(C6F5)4], [2][B(C6F5)4], 
showing the close contacts of the tin cation with some of the fluorine atoms 
on the anion.  Carbon, boron, fluorine, and tin atoms are shown in black, 
orange, green, and red, respectively.  Hydrogen atoms have been omitted for 
clarity. 
 
As illustrated in Figure 1.8, the C5v symmetry of the [(η5-C5Me5)Sn]+ 
cation, which was initially indicated by NMR spectroscopy, was confirmed by the 
X-ray diffraction experiment.  The tin atom is centered above the C5Me5 ring and 
exhibits close contact interactions with four fluorine atoms of the neighboring 
tetrakis(pentafluorophenyl)borate anion (F51, F52, F54, and F55).  The Sn—Cring 
bond distances range from 2.428(2)—2.446(3) Å with an average bond length of 
2.438(2) Å.  The ring-centroid to metal bond distance is 2.114(3) Å.  The [η5-
C5Me5)] ring exhibits delocalized π-bonding as evidenced by the Cring—Cring bond 
14 
distances of 1.426(4), 1.427(4), 1.428(4), 1.432(4), and 1.432(4) Å.  Based on the 
pattern of bond distances, the tin atom is pentahapto bonded to the 
pentametylcyclopentadienide ring.  The ring itself is planar and the methyl groups 
extend out of the plane and away from the tin center.  Evidence for this is 
provided by the angles between the ring plane and the least-squares planes 
defined by the two adjacent ring-carbon atoms and the attached methyl carbon 
atoms, which have an average value of 5.7°. 
Four of the fluorine atoms (F51, F52, F54, and F55) of the 
tetrakis(pentafluorophenyl)borate anion are located at distances which are less 
than the sum of the van der Waals radii of germanium and fluorine (van der 
Waals radii of Sn = 2.26 Å and F = 1.47 Å).[26]  The close contacts between the 
fluorine atoms and the tin atom range in distance from 3.172(2)—3.294(1) Å.  
Overall, the structure of 2+ closely compares with that of [(η5-C5Me5)Sn][BF4] 
reported by Jutzi et al., [8] in which the average Sn—Cring bond distance is 2.462 
Å.  However, there was no discussion of tin interactions between the cation and 
the anion in this publication.   
Synthesis and Characterization of [(η5-Me5C5)3Sn2][B(C6F5)4], [3][B(C6F5)4] 
Tris(pentamethylcyclopentadienyl)bis(tin) cation, 3+, was synthesized via 
the addition reaction of [3][B(C6F5)4] to one equivalent of 
bis(pentamethylcyclopentadienyl)tin.  The 1H NMR spectrum of [3][B(C6F5)4]  
15 
exhibits only a single proton signal thus indicating the equivalence of all forty-
five methyl protons on the three C5Me5 rings.  Likewise, the 13C NMR spectrum 
of 3+ showed only two signals for the carbon atoms of the C5Me5 rings, namely 
one for the methyl carbons and one for the ring carbons.  Three 13C NMR signals 
were detected for the [B(C6F5)4]¯ anion and correspond to the ortho, meta, and 
para ring carbon atoms.  Examination of the 119Sn NMR indicated the presence of 
only one peak located at δ -2223.  Analysis of the 11B and 19F NMR spectra 
confirmed the presence of the [B(C6F5)4]¯ anion.  Overall, however, it was not 
possible to assign the structure of the cation unambiguously hence an X-ray 
diffraction study was undertaken.     
Recrystallization of [3][B(C6F5)4] by the slow diffusion of hexane and 
dichloromethane yielded crystals suitable for X-ray diffraction experiments.  An 
X-ray diffraction study identified the crystals as the title compound shown in 
Figure 1.9 and clarified the structure of the cation in the solid state.  Details of the 
data collection, structure solution, and refinement are compiled in Table 1.9 and 
selected metrical parameters are listed in Table 1.10 and Table 1.11.  
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Figure 1.9  Molecular structure of [(η5-C5Me5)3Sn2]+, [3]+, showing cis-
geometry of the cation.  Carbon and tin atoms are shown in black and red, 
respectively.  Hydrogen atoms have been omitted for clarity. 
 
In the solid state, 3+, exists as a cationic, triple-decker, sandwich-type 
structure (Figure 1.9).  A pentahapto C5Me5 ring serves as a bridging group for 
two Sn(η5-C5Me5) units.  Within experimental error, the two tin atoms are located 
equidistantly from the bridging C5Me5 ring-centroid (X1B), and are located in a 
nearly linear fashion on either side of the bridging C5Me5 group (Sn(1)—X(1B)—
Sn(1A) = 175.5º).  The terminal C5Me5 rings are positioned in a mutually cis-
arrangement with a Sn—ring-centroid (X1A/X1C) distance of 2.233 Å, which is 
shorter than those to the bridging η5-C5Me5 moiety (2.614 Å).  The values lie 
between the value reported for Sn(η5-C5Me5)2 (2.396 Å)[8] and that determined for 
[Sn(η5-C5Me5)]+ (2.114(3) Å).  The X(1A)—Sn—X(1C) angle of 154.7º is similar 
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to the values reported for Sn(η5-C5Me5)2 (av. 154.9º).[8]  The cis-type geometry of 
the overall structure is intriguing because, as noted earlier, the triple-decker, main 
group anions, [(η5-C5H5)3Tl2]¯[14] and [(η5-C5H5)3Cs2]¯[15], possess transoid 
conformations. 
Overall, the solution state NMR data were not in accord with the solid 
state structure as determined by X-ray diffraction.  Thus the 1H, 13C, and 119Sn 
NMR spectra evidenced only one type of C5Me5 group and a unique tin center 
suggesting rapid, reversible dissociation of 3+ into Sn(η5-C5Me5)2 and [Sn(η5-
C5Me5)]+ (Figure 1.10).  In an attempt to identify the triple-decker cation in 
solution, low temperature 1H and 119Sn were attempted; however, the low-
temperature spectra were identical to those obtained at room temperature. 
Sn Sn Sn Sn Sn Sn
 
Figure 1.10  The proposed model for the facile exchange processes of [Sn(η5-
C5Me5)]+ based on the analysis of NMR spectra.  Methyl groups have been 
omitted for clarity. 
 
Synthesis and Characterization of [(η5-Me5C5)Pb][B(C6F5)4], [4][B(C6F5)4] 
The pentamethylcyclopentadienyllead(II) cation, 4+, was synthesized in 
good yield via the metathetical reaction of pentamethylcyclopentadienyllead(II) 
chloride with one equivalent of LiB(C6F5)4.  As in the cases of the analogous 
18 
germanium and tin cations, the 1H and 13C NMR spectra of [4][B(C6F5)4] were 
indicative of the C5v symmetry of the cation.  Insight into the structure of the 
anion was provided by the detection of the ortho, meta, and para phenyl ring 
carbons in the 13C NMR spectrum, a singlet at δ -20.23 in the 11B NMR spectrum, 
and three peaks representing the ortho, meta, and para fluorine atoms on the 
phenyl rings in the 19F NMR spectrum. 
Recrystallization of [4][B(C6F5)4] by the slow diffusion of hexane and 
dichloromethane yielded crystals suitable for X-ray diffraction experiments.  An 
X-ray diffraction study identified the crystals as the title compound shown in 
Figure 1.11.  Details of the data collection, structure solution, and refinement are 
compiled in Table 1.12 and selected metrical parameters are listed in Table 1.13 
and Table 1.14.  
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Figure 1.11  Molecular structure of [(η5-C5Me5)Pb][B(C6F5)4], [4][B(C6F5)4], 
showing the close contacts of the tin cation with some of the fluorine atoms of 
the anion.  Carbon, boron, fluorine, and lead atoms are shown in black, 
orange, green, and red, respectively.  Hydrogen atoms have been omitted for 
clarity. 
 
As illustrated in Figure 1.11, the lead atom in the [(η5-C5Me5)Pb]+ cation 
is centered above the C5Me5 ring.  The C5v symmetry of 4+, previously indicated 
on the basis of NMR data, was verified by X-ray diffraction analysis.  The Pb—
Cring bond distances range from 2.538(4)—2.559(4) Å with an average bond 
length of 2.548 Å.  The ring-centroid to metal bond distance is 2.240 Å.  The [η5-
C5Me5)] ring exhibits a delocalized π-bonding as evidenced by the Cring—Cring 
bond distances of 1.424(6), 1.428(6), 1.429(6), 1.435(6) and 1.503(6) Å.  Based 
on the pattern of bond distances, the lead atom is pentahapto bonded to the 
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pentametylcyclopentadienide ring.  The ring itself is planar and the methyl groups 
extend out of the plane and away from the tin center.  Evidence for this 
arrangement is provided by the values of the angles between the ring plane and 
the least-squares planes defined by the two adjacent ring-carbon atoms and the 
attached methyl carbon atoms, which have an average value of 6.5°. 
Three of the fluorine atoms (F23, F24, and F45) of the neighboring 
tetrakis(pentafluorophenyl)borate anions are located at distances which are less 
than the sum of the van der Waals radii of germanium and fluorine (van der 
Waals radii of Pb = 2.34 Å and F = 1.47 Å).[26]  The close contacts between the 
fluorine atoms and the lead atom range in distance from 2.944—3.327 Å. 
Overall, the structure of 4+ is similar to that of [(η5-C5Me5)Pb][BF4] 
reported by Jutzi et al., [28] which has an average Pb—Cring bond distance of 
2.565(10) Å.  In this case, there is a distinct interaction of the lead atom with one 
fluorine atom on each of the two adjacent tetrafluoroborate anions. 
Synthesis and Characterization of [(η5-Me5C5)3Pb2][B(C6F5)4], [5][B(C6F5)4] 
The tris(pentamethylcyclopentadienyl)bis(lead) cation, 5+, was 
synthesized via the reaction of [5][B(C6F5)4] with one equivalent of 
bis(pentamethylcyclopentadienyl)lead.  The 1H NMR spectrum of [5][B(C6F5)4]  
exhibited only a single proton signal, indicating the equivalence of all forty-five 
methyl protons on the three C5Me5 rings.  The 13C NMR spectrum of 5+ showed 
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two signals for the carbon atoms on the C5Me5 rings, namely one for the methyl 
carbons and one for the ring carbons.  13C NMR signals were detected for the 
ortho, meta, and para phenyl ring carbons of the anion.  Analysis of the 11B and 
19F NMR confirmed the presence of the expected [B(C6F5)4]¯ anion. 
Recrystallization of [5][B(C6F5)4]  by the slow diffusion of hexane and 
dichloromethane yielded crystals suitable for X-ray diffraction experiments. An 
X-ray diffraction study identified the crystals as the title compound shown in 
Figure 1.12.  Details of the data collection, structure solution, and refinement are 
compiled in Table 1.15 and selected metrical parameters are listed in Table 1.16 
and Table 1.17. 
 
 
Figure 1.12  Molecular structure of [(η5-C5Me5)3Pb2][B(C6F5)4], 
[5][B(C6F5)4], depicting the cis-geometry of the cation.  Carbon and lead 
atoms are shown in black and red, respectively.  Hydrogen atoms have been 
omitted for clarity. 
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In the solid state, 5+ possesses a triple-decker, sandwich-type structure 
(Figure 1.12).  A pentahapto bonded C5Me5 ring serves as the bridging group 
between two Pb(η5-C5Me5) units.  Within experimental error, the two lead atoms 
are located equidistantly from the bridging C5Me5 ring-centroid (X1B), and are 
located in a nearly linear fashion on wither side of the bridging C5Me5 groups, 
Pb(1)—X(1B)—Pb(1A) = 177.2º. The terminal C5Me5 rings are positioned in a 
mutually cis-arrangement with a Pb—ring-centroid (X1A/X1C) distance of 2.339 
Å, which is shorter than that to the bridging η5-C5Me5 moeity (2.672 Å) and lies 
between the value reported for Pb(η5-C5Me5)2 (av. 2.501(3) Å)[8] and that 
determined for [Pb(η5-C5Me5)]+ (2.240(3) Å).  The X(1A)—Pb—X(1C) angle of 
152.6º is similar to the value reported for Pb(η5-C5Me5)2 (151.3º).[9]  The cis-type 
geometry of the overall structure is similar to that obtained for 5+, but contrasts 
the transoid conformations of the triple-decker, main group anions, [(η5-
C5H5)3Tl2]¯[14] and [(η5-C5H5)3Cs2]¯.[15] 
Overall, the solution state NMR data were not in accord with the solid 
state structure as determined by X-ray diffraction.  Thus the 1H, 13C, and 207Pb 
NMR spectra evidenced only one type of C5Me5 group and a unique lead center 
thus suggesting rapid, reversible dissociation of 5+ into Pb(η5-C5Me5)2 and 
[Pb(η5-C5Me5)]+ (refer to Figure 1.10).  In an attempt to identify the triple-decker 
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cation in solution, low temperature 1H and 207Pb were attempted; however, the 
low temperature spectra were identical to those obtained at room temperature. 
Reactions of half-sandwich cations and neutral metallocenes 
 In an attempt to synthesize mixed metal, triple-decker metallocenes, a 
series of addition reactions between the half-sandwich cations and the neutral 
metallocenes were conducted.  Initially, the group 14 half-sandwich cations were 
treated with transition metal metallocenes as summarized in Table 1.1 and Figure 
1.13.  However, each attempt afforded an oxidation/reduction product, which was 
identified by X-ray crystallography, rather than the desired mixed metal, triple-
decker metallocene. 
Half-sandwich cation Neutral metallocene Reaction product 
[Sn(η5-C5Me5)]+ Fe2(η5-C5Me5) [(η5-C5Me5)2Fe]+ 
[Sn(η5-C5Me5)]+ Co2(η5-C5Me5) [(η5-C5Me5)2Co]+ 
[Sn(η5-C5H5)]+ Ni2(η5-C5H5) [(η5-C5H5)2Ni]+ 











Figure 1.13  Potential reaction scheme for the synthesis of mixed metal, 
triple-decker metallocenes, where E = group 14 metal and TM = transition 
metal.  All methyl groups have been omitted for clarity. 
 
 To avoid the oxidation/reduction problems that were encountered using 
group 14 elements and transition metals, reactions involving only group 14 metals 
were attempted (Figure 1.14) and the products identified via X-ray 
crystallography.  The results (Table 1.2) provided important information 
regarding the reactivity and stability of the metal cations.  The stability of the 
cations of general formula, [E(η5-C5Me5)]+, appears to increase moving up the 
group 14 elements from Pb<Sn<Ge.  The abstraction of a [C5Me5]¯ anion from 
germanocene by [Sn(η5-C5Me5)]+ to yield decamethylstannocene and the [Ge(η5-
C5Me5)]+ cation evidences the electrophilic nature of the [Sn(η5-C5Me5)]+ cation.  
25 
The mechanism for the formation of [(η5-C5Me5)3Pb2]+ in the reaction of [Sn(η5-
C5Me5)]+ with decamethylplumbocene, is hypothesized to proceed by the 
abstraction of a [C5Me5]¯ anion from Pb2(η5-C5Me5) to form the less stable cation, 
[Pb(η5-C5Me5)]+.  In turn, this electrophilic cation adds to any 
decamethylplumbocene that remains in the solution to form the non-
stoichiometric product [(η5-C5Me5)3Pb2]+. 
Half-sandwich cation Neutral metallocene Reaction product 
[Sn(η5-C5Me5)]+ Ge(η5-C5Me5)2 [Ge(η5-C5Me5)]+ 
[Sn(η5-C5Me5)]+ Pb(η5-C5Me5)2 [(η5-C5Me5)3Pb2]+ 







Figure 1.14  Potential reaction scheme for the synthesis of mixed metal, 
group 14, triple-decker metallocenes, where E1 and E2 are group 14 elements.  
Methyl groups are omitted for clarity. 
 
 In the reaction of [Sn(η5-C5Me5)]+ with Ge(η5-C5Me5)2 , the [Sn(η5-
C5Me5)]+ cation abstracted a [C5Me5]¯ anion from decamethylgermanocene to 
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yield the [Ge(η5-C5Me5)]+ cation and stannocene.  A similar reaction between 
[Sn(η5-C5Me5)]+ and plumbocene yielded slightly different results, namely the 
formation of the triple-decker cation, [(η5-C5Me5)3Pb2]+. 
Synthesis and Characterization of [(η5-µ-Me5C5)In2][B(C6F5)4], [6][B(C6F5)4] 
In order to extend the triple-decker cation chemistry to group 13 elements, 
the isolobal relationship between [Sn(η5-C5Me5)]+ and [In(η5-C6H6)]+ was 
utilized.  Previous work had structurally characterized (η6-toluene)In(µ-η5-
C5Me5)In(η6-toluene), which as pointed out earlier (p. 7) can be construed as a 
triple-decker system or it can equally well be thought of as an “inverse sandwich” 
cation.  The distinction between these possibilities depends on whether the 
capping η6-interacting toluene molecules are bonded or not.  In order to gain 
further insight into this question, it was decided to replace the voluminous 
[(C6F5)3BO(H)B(C6F5)3]¯ anion by a counter anion of more modest size.  Utilizing 
the acidity of [(toluene)H]+ to protonate a C5Me5 group, a second approach to the 
synthesis of multi-decker group 13 sandwich compounds was designed.  The 
reaction of pentamethylcyclopentadienylindium with one equivalent of 
[(toluene)H][B(C6F5)4] at -78 °C resulted in the inverse sandwich cation, [(η5-µ-
Me5C5)In2], 6+.  The 1H NMR spectrum of [6][B(C6F5)4]  evidenced the C5v 
symmetry of the C5Me5 ring.  Unfortunately, the impurity of the sample prevented 
the acquisition of a useful 13C NMR spectrum. 
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Crystallization of [6][B(C6F5)4] occurred during the initial work up of the 
sample and afforded crystals suitable for X-ray diffraction experiments.  An X-ray 
diffraction study identified the colorless crystals as the title compound shown in 
Figure 1.15.  Details of the data collection, structure solution, and refinement are 
compiled in Table 1.18 and selected metrical parameters are listed in Table 1.19 
and Table 1.20.   
 
Figure 1.15  Molecular structure of [(η5-µ-C5Me5)In2][B(C6F5)4], 
[6][B(C6F5)4], showing the close anion contacts of an indium atom with a 
neighboring fluorine atom and possible In—C6F5 π-interaction with the 
second indium atom.  Carbon, boron, fluorine, and indium atoms are shown 
in black, orange, green, and red, respectively.  Hydrogen atoms have been 
omitted for clarity. 
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As illustrated in Figure 1.15, the indium atoms are centered above and 
below the bridging C5Me5 ring.  The In—C5Me5 bond distances range from 
2.698(8)—2.708(8) Å with an average bond length of 2.701 Å.  The ring-centroid 
(X1A) to metal bond distances of 2.4350(7) and 2.4603(7) Å are longer than those 
reported[29] for monomeric (2.288(4) Å) and hexameric (2.302(4) Å) In(C5Me5).  
The In(1)—X(1A)—In(2) for the bridging C5Me5 ring is close to linear (177.2º).  
The η5- C5Me5 ring exhibits delocalized π-bonding as evidenced by the Cring—
Cring bond distances of 1.379(13), 1.404(11), 1.416(10), 1.417(13) and 1.490(13) 
Å.  The foregoing bond distances indicate both indium atoms are pentahapto 
bonded to the pentamethylcyclopentadienide ring.  The ring itself is planar with a 
mean deviation from the plane of 0.004 Å while the methyl groups have a mean 
deviation from the plane of 0.0189 Å.  Essentially, the methyl carbon atoms are 
located in the same plane as the ring carbon atoms.  Evidence for this conclusion 
stems from the angles between the ring plane and the least-squares planes defined 
by two adjacent ring-carbon atoms and the attached methyl carbon atoms, which 
have an average value of 1.3°. 
Close cation-anion interactions are a consequence of the electrophilic 
condition of the indium atoms in the inverse sandwich cation.  A meta-fluorine 
atom (F32) of a neighboring tetrakis(pentafluorophenyl)borate anion is located 
3.150(3) Å from In(1).  Although this distance is less than the sum of van der 
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Waals radii for In and F (3.90 Å) (van der Waals radius of In = 2.43 Å and F = 
1.47 Å) [26], shorter In· · ·F contacts have, in fact, been reported for In(2,4,6-
(CF3)3C6H2)3 (av. 2.762(7) Å) and In2(2,4,6-(CF3)3C6H2)4 (range 2.801(10)-
2.957(13) Å). [30]  Interestingly, the other indium atom of 6+ undergoes a weak η6-
interaction with one of the C6F5 moieties of a second [B(C6F5)4]¯ anion.  The In(2) 
to ring-centroid distance is 3.588(4) Å.  This represents an unprecedented mode of 
interaction for the [B(C6F5)4]¯.  To determine whether the close contacts between 
the indium atoms and the anion were due to coordination or crystal packing 
forces, density functional theory calculations were undertaken.  All calculations 
were performed with the Gaussian 94 package of programs.  Each molecule/ion 
was fully optimized in the indicated symmetry.  Density functional theory (DFT) 
optimization of the model system [(C6F6)—In—(η5-µ-C5H5)—In]+ predicts a D5h 
symmetric structure with a computed In—C6F6 bond distance of 3.218 Å, which 
is much shorter than the value observed experimentally for 6+.  The In—C6F6 
bond dissociation energy (~ 7 kcal/mol) suggest an extremely weak interaction, 
which could easily be overcome by crystal packing forces.  
Synthesis and Characterization of [(η5-µ-H5C5)Tl2][B(C6F5)4], [7][B(C6F5)4] 
The inverse sandwich cation [(µ-H5C5)Tl2], 7+, was synthesized via the 
reaction of cyclopentadienylthallium(I) with one equivalent of 
[(toluene)H][B(C6F5)4] at -78 °C.  A pure crystalline sample was never obtained; 
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however, high resolution, chemical ionization mass spectrometry indicated the 
presence of 7+. 
Synthesis and Characterization of [(Me5C5)H2][B(C6F5)4], [8][B(C6F5)4] 
An attempt to prepare a gallium inverse sandwich cation by treatment of 
[(η5-C5Me5)Ga]6 with [(η6-toluene)H][B(C6F5)4] resulted unexpectedly in 
formation of the pentamethylcyclopentenyl cation, 8+, as its [B(C6F5)4] salt, 
[8][B(C6F5)4].  The identity of 8+ was confirmed by X-ray diffraction studies.  
Following the identification of [8][B(C6F5)4], a rational synthesis of this 
compound was developed by protonation of pentamethylcyclopentadiene with an 
equimolar quantity of [(toluene)H][B(C6F5)4].  The 1H NMR and 13C NMR 
spectrum of [8][B(C6F5)4]  matched those reported previously by Campbell et al. 
[31] 
Recrystallization of [8][B(C6F5)4] by the slow diffusion of toluene and 
dichloromethane yielded crystals suitable for X-ray diffraction experiments.  X-
ray diffraction studies identified the crystals as the title compound shown in 
Figure 1.16.  Details of the data collection, structure solution, and refinement are 
compiled in Table 1.21 and selected metrical parameters are listed in Table 1.22 
and Table 1.23.   
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Figure 1.16  Side-on view of [(Me5C5)H2]+, 8+, showing the hydrogen atoms 
attached to C(4) and C(5) and the trans arrangement of the methyl groups 
attached to these carbon atoms.  Carbon and hydrogen atoms are shown in 
black and cyan, respectively.   
 
The structure of the pentamethylcyclopentenyl cation, 8+, is illustrated in 
Figure 1.16.  The Cring—Cring bond distances in 8+ are 1.396(3), 1.385(3), 
1.473(4), 1.478(3), and 1.517(4) Å indicating a localized cyclopentadiene-type 
structure for the ring.  The C(4)—C(5) bond length is close to the value of 1.54 Å 
anticipated for a single bond between sp3 hybridized carbon atoms.  Moreover, 
tetrahedral geometries are evident at carbon atoms C(4) and C(5) and the methyl 
groups attached to these carbon atoms are arranged above and below the five-
carbon ring in a trans fashion. The CH3—C(4)—C(5)—H dihedral angle is 
135.0(2)°.  The cyclopentenyl ring is somewhat non-planar, the internal ring 
dihedral angles being -2.1(3), 0.9(3), 2.7(3), -2.1(3), and 0.7(3)°. 
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The serendipitous synthesis and characterization of 8+ occurred at the ideal 
moment; Lambert et al.[32] reported the crystal structure of what was thought be to 
be the pentamethylcyclopentadienyl cation, [Me5C5]+.  However, after meticulous 
inspection of the data presented in the Lambert et al. communication, the strong 
similarities to 8+ were noted.  The intra-ring C—C bond lengths of 8+ and the 
structure of Lambert et al.[32] were determined to be nearly identical (Figure 1.17).  
A retraction letter[33] and a communication from our laboratory[34] were soon 
published identifying the ‘pentamethylcyclopentadienyl cation’ as the 
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Figure 1.17  Comparison of intra-ring C—C bond lengths (Å) for A) 
Lambert et al.[32] and B) 8+. 
 
CONCLUSIONS AND FUTURE WORK 
A rational synthesis of triple-decker main group metallocene cations has 
been developed.  The addition of positively charged half-sandwich cations to 
neutral metallocenes affords triple-decker cations of the formula, [η5-
(C5Me5)3E2]+.  The size of the gegenion plays a critical role in terms of 
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maximizing the lattice energies of the resulting salts, thus facilitating 
crystallization.  Interestingly, the solid state and solution phase structures of the 
triple-decker cations are not identical.  In the solid state, the cations have the 
structure shown in Figure 1.9; however, in solution phase, the triple-decker 
cations undergo facile exchange via reversible dissociation of [η5-(C5Me5)3E2]+ 
moieties.  The exchange process is rapid with respect to the NMR spectroscopy 
time scale; the triple-decker species can not be identified by NMR spectroscopy at 
low temperature. 
Unfortunately, attempts to produce mixed metal triple-decker metallocene 
cations were unsuccessful; however, valuable information regarding the reactivity 
of the [η5-(C5Me5)3E2]+ cations emerged from the studies.  Based on the reactions 
of [η5-(C5Me5)Sn]+ with group 14 metallocenes, the stability of the half-sandwich 
cations is [η5-(C5Me5)Ge]+ > [η5-(C5Me5)Sn]+ > [η5-(C5Me5)Pb]+.  Although the 
[η5-(C5Me5)3Ge2]+ cation has yet to be synthesized, the predicted stability of the 
triple-decker group 14 cations is [η5-(C5Me5)3Ge2]+ > [η5-(C5Me5)3Sn2]+ > [η5-
(C5Me5)3Pb2]+. 
One potential method to overcome the difficulties encountered in 
synthesizing mixed metal, triple-decker cations is by the use of the ansa-type 
ligands (Figure 1.18).  The use of a ligand system where the aromatic moieties are 
conjoined will prevent the abstraction of a ligand by the cationic species.  
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However, to date, no such main group metallocene complexes have been 










Figure 1.18  Potential reaction scheme to for the synthesis of mixed metal 
group 14 triple-decker cations using ansa-type metallocenes. 
 
The synthesis of the first inverse sandwich main group cation has been 
accomplished by the reaction of [η5-(C5Me5)In] and [(toluene)H][B(C6F5)4].  The 
strong Brønsted acid, [(toluene)H][B(C6F5)4], was also used for the synthesis of 
[(C5Me5)H2][B(C6F5)4].  The ability of the acid to remove a [C5Me5]¯ anion by 
protolysis in the presence of a large, weakly coordinating anion, such as 




All solvents were distilled over sodium benzophenone ketyl, except 
dichloromethane, which was distilled over CaH2, and degassed prior to use.  An 
M-Braun or VAC Vacuum Atmosphere argon-filled drybox was used for the 
manipulation of all solid reagents.  All reactions were performed under dry, 
oxygen-free conditions using standard Schlenk or drybox techniques.  To ensure 
the absence of water, all glassware was dried overnight in a 140° C oven before 
use. 
The group 14 dihalides were purchased from a commercial source and 
used without further purification.  The compounds (Me5C5)Li[35], LiB(C6F5)4[22], 
(η-Me5C5)2Ge[36], (η-Me5C5)2Sn,[36] and (η-Me5C5)2Pb[9] were prepared according 
to literature procedures. 
Physical Measurements 
Low-resolution CI mass spectra were collected on a Finnigan MAT TSQ-
700 machine; high resolution mass spectra were measured on a VG Analytical 
ZAB-VE sector instrument.  Mass spectral samples were flame sealed in glass 
capillaries to prevent exposure to oxygen.  Unless otherwise noted, solution phase 
13C and 1H NMR spectra were recorded at 295 K on a GE EQ-300 instrument (1H, 
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300 MHz; 13C, 75 MHz).  Some 13C and 1H NMR spectra and all 11B, 19F, 119Sn, 
and 207Pb solution-phase NMR spectra were recorded at 295 K, unless otherwise 
noted, on a Varian Inova-500 spectrometer (1H, 500 MHz; 11B, 160 MHz; 13C, 
125 MHz; 19F, 470 MHz; 27Al, 130 MHz) instrument.  NMR samples were flame-
sealed or recorded immediately following their removal from the drybox.  
Deuterodichloromethane was obtained in sealed vials from a commercial source 
and used without further purification.  1H, 11B, 13C, and 19F spectra are reported 
relative to tetramethylsilane (0.00 ppm) and referenced to the solvent.  119Sn 
chemical shifts are reported relative to Me4Sn (0.00 ppm), while 207Pb spectra are 
reported relative to Me4Pb (0.00 ppm).  Unless otherwise noted, 13C spectra were 
obtained under conditions of broadband proton decoupling.  Melting points were 
obtained on a Fisher-Johns apparatus after flame-sealing the samples in glass 
capillaries under argon; the reported values are uncorrected. 
X-Ray Crystallography 
Suitable single crystals were covered with a perfluorinated polyether oil to 
minimize exposure to oxygen.  The X-ray data were collected on a Nonius Kappa 
CCD diffractometer equipped with an Oxford Cryostream liquid nitrogen cooling 
stream.  Structure determination and refinements were performed by the author at 
the University of Texas at Austin.  All structures were solved by direct methods 
and refined by full-matrix least squares on F2 using the Siemens SHELX PLUS 
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5.0 (PC) software package.[37]  All non-hydrogen atoms were allowed anisotropic 
thermal motion.  When possible, all hydrogen atoms were located via the model; 
however, it was occasionally necessary to place the hydrogen atoms in calculated 
positions (C—H 0.96 Å).  The hydrogen atoms were refined using a riding model 
and a general isotropic thermal parameter.  The total number of reflections, 
collection ranges, and final R-values for each molecule are listed in the 
appropriate crystallographic data tables. 
Samples were mounted on a fine glass fiber using commercial silicon 
grease as an adhesive.  All data collections were performed at 153(2) K using a 
graphite monochromated Mo Kα radiation (λ = 0.71073 Å).  A correction was 
applied for Lorentz-polarization. 
Synthesis of [(η5-Me5C5)Ge][B(C6F5)4], [1][B(C6F5)4] 
A yellow solution of [(η5-Me5C5)Sn][B(C6F5)4] (0.636 g, 0.682 mmol) in 
methylene chloride (40 mL) was treated with a methylene chloride solution (40 
mL) of decamethylgermanocene (0.234 g, 0.682 mmol) at 0° C.  The pale yellow 
solution was allowed to warm to room temperature and stirred overnight.  Lithium 
chloride was removed by filtration through Celite®.  The solvent and volatiles 
were removed under low pressure until the volume of the solution was 
approximately 10 mL, at which point it was transferred to a narrow layering 
vessel and layered with hexane (15 mL).  A crop of pale yellow crystals (~20% 
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yield) formed at the solvent interface.  Spectroscopic Data:  HRMS (CI, CH4): 
calcd for C10H15Ge, 1H NMR (CD2Cl2): δ 2.231[s, η5-C5(CH3)5]; 11B NMR 
(CD2Cl2):  δ -12.941 [s,B(C6F5)4]; 13C{1H} NMR (CD2Cl2):  δ 9.265 [s, η5-
C5(CH3)5], 123.660 [s, η5-C5(CH3)5]; 19F NMR (CD2Cl2):  δ -132.936 [s,m-C6F5], 
-165.314 [t, p-C6F5], -167.888 [s, o–C6F5]. 
Synthesis of [(η5-Me5C5)Sn][B(C6F5)4], [2][B(C6F5)4] 
A pale yellow solution of (η5-Me5C5)SnCl (0.551 g, 1.46 mmol) in 
methylene chloride (40 mL) was treated with a methylene chloride solution (40 
mL) of LiB(C6F5)4 (1.000 g, 1.46 mmol) at 0° C.  The resulting orange solution 
was allowed to warm to room temperature and stirred overnight.  Lithium 
chloride was removed by filtration through Celite®.  The solvent and volatiles 
were removed under low pressure until the volume of the solution was 
approximately 10 mL, at which point it was transferred to a narrow layering 
vessel and layered with hexane (15 mL).  A crop of orange crystals (0.597 g, 
40.1% yield) formed at the solvent interface.  Spectroscopic data:  matched that 
reported by.[27] 
Synthesis of [(η5-Me5C5)3Sn2][B(C6F5)4], [3][B(C6F5)4] 
A pale yellow solution of [(η5-Me5C5)Sn][B(C6F5)4] (0.183 g, 0.196 
mmol) in methylene chloride (30 mL) was added to a stirred orange solution of 
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(η-Me5C5)2Sn (0.076g, 0.195 mmol) at 0° C.  The bright yellow solution was 
warmed slowly to room temperature and stirred overnight.  Lithium chloride was 
removed by filtration through Celite®.  The solvent and volatiles were reduced 
under low pressure until the volume of the solution was approximately 10 mL, at 
which point it was transferred to a narrow layering vessel and layered with hexane 
(15 mL).  A crop of bright yellow crystals (0.193g, 74.8% yield) formed at the 
solvent interface.  Spectroscopic Data:  HRMS (CI, CH4): calcd for C30H45Sn2, 
m/z 645.1565; found, 645.1575; 1H NMR (CD2Cl2): δ2.123[s, η5-C5(CH3)5]; 11B 
NMR (CD2Cl2):  δ-20.23 [s,B(C6F5)4]; 13C{1H} NMR (CD2Cl2):  δ 10.08 [s, η5-
C5(CH3)5] 121.50 [s, η5-C5(CH3)5]; 19F NMR (CD2Cl2):  δ-133.33 [s,m-C6F5], -
163.98 [t, p-C6F5], -167.80 [s, o–C6F5];  119Sn NMR (CD2Cl2):  δ -2223.451. 
Synthesis of [(η5-Me5C5)Pb][B(C6F5)4], [4][B(C6F5)4] 
An solution of (η5-Me5C5)PbCl (0.551 g, 1.46 mmol) in methylene 
chloride (40 mL) was treated with a methylene chloride solution (40 mL) of 
LiB(C6F5)4 (1.000 g, 1.46 mmol) at 0° C.  The resulting orange solution was 
warmed to room temperature and stirred overnight.  Lithium chloride was 
removed by filtration through Celite®.  The solvent and volatiles were reduced 
under low pressure until the volume of the solution was approximately 10 mL, at 
which point it was transferred to a narrow layering vessel and layered with hexane 
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(15 mL).  A crop of orange crystals (0.597 g, 40.1% yield) formed at the solvent 
interface. 
Spectroscopic Data:  HRMS (CI, CH4): calcd for C34H15BF20Pb 343.0940 found 
343.0936; 1H NMR (CD2Cl2): δ 2.67 [s, η5-C5(CH3)5]; 11B NMR (CD2Cl2):  δ       
-20.23 [s, B(C6F5)4]; 13C{1H} NMR (CD2Cl2):  δ 8.989 [s, η5-C5(CH3)5], 125.943  
[s, η5-C5(CH3)5]; 19F NMR (CD2Cl2):  δ -133.43 [s,m-C6F5], -163.94 [t, p-C6F5], -
167.79 [s, o–C6F5]. 
Synthesis of [(η5-Me5C5)3Pb2][B(C6F5)4], [5][B(C6F5)4] 
An orange solution of [(η5-Me5C5)Pb][B(C6F5)4] (0.535 g, 0.524 mmol) in 
methylene chloride (30 mL) was added to a stirred orange solution of (η5-
C5Me5)2Pb (0.250g, 0.523 mmol) at 0° C.  The resulting deep red-orange solution 
was allowed to reach room temperature and stirred overnight.  Lithium chloride 
was removed by filtration through Celite®.  The solvent and volatiles were 
reduced under low pressure until the volume of the solution was approximately 10 
mL, at which point it was transferred to a narrow layering vessel and layered with 
hexane (15 mL).  A crop of ruby red crystals (~65% yield) formed at the solvent 
interface. 
Spectroscopic Data:  HRMS (CI, CH4): calcd for C30H45Pb2 821.305 found 
821.306; 1H NMR (CD2Cl2): δ 2.286 [s, η5-C5(CH3)5]; 11B NMR (CD2Cl2):  δ-
20.23; 13C{1H} NMR (CD2Cl2):  δ 9.0887 [s, η5-C5(CH3)5], 125.7410 [s, η5-
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C5(CH3)5]; 19F NMR (CD2Cl2):  δ-133.37 [s,m-C6F5], -163.91 [t, p-C6F5], -167.76 
[‘t’, o–C6F5];   
Synthesis of [(η5-µ-Me5C5)In2][B(C6F5)4], [6][B(C6F5)4] 
[(Toluene)H][B(C6F5)4] was prepared by first treating a frozen toluene 
solution (150 mL) with a large excess of condensed HCl (g) (3 mL, 82.1 mmol), 
followed by the slow addition of a solution of LiB(C6F5)4 (5.00 g, 7.29 mmol) in 
toluene (60 mL).  The reaction mixture was allowed to equilibrate slowly to room 
temperature and stirred overnight.  By means of a double solvent trap, the volume 
of the solution was reduced to 25 mL and stored at -20° C, thereby affording a 
crop of colorless crystals (1.609 g, 28.6%).  The crystals were harvested and used 
without further purification.  A solution of (η5-Me5C5)In (0.648 g, 2.59 mmol) in 
toluene (40 mL) was added slowly to a stirred solution of [(toluene)H][B(C6F5)4] 
(1.00 g, 1.30 mmol) at -78 °C.  The volatiles were immediately removed under 
reduced pressure from the resulting brown solution to yield a thick brown oily 
solid.  Upon close observation, colorless needle-shaped crystals could be 
identified in the oily solid.  Unfortunately, however, completely pure crystalline 
samples were never obtained.  Spectroscopic Data:  HRMS (CI, CH4): calcd for 
C10H15In2 364.925 found 364.926; 1H NMR (C6D6): δ 1.49 [s, η5-C5(CH3)5]. 
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Synthesis of [(η5-µ-C5H5)Tl2][B(C6F5)4], [7][B(C6F5)4] 
A solution of (η5-C5H5)Tl (0.159 g, 0.589 mmol) in toluene (30 mL) was 
added slowly to a stirred solution of [(toluene)H][B(C6F5)4] (0.227 g, 0.294 
mmol) at -78 °C.  The volatiles were removed immediately under reduced 
pressure from the resulting brown solution to yield a brown oily solid.  
Unfortunately, completely pure crystalline samples were never obtained.  
Spectroscopic Data:  HRMS (CI, CH4): calc. for C10H15Tl2 474.988 found 
474.988. 
Synthesis of [(Me5C5)H2][B(C6F5)4], [8][B(C6F5)4] 
Approach A: 
Addition of a toluene solution of [(toluene)H][B(C6F5)4] (0.273 g, 0.344 
mmol) to a solution of [Ga(η5-Me5C5)]6 (0.145 g, 0.118 mmol) in the same 
solvent at -78 °C resulted in a red-violet colored reaction mixture.  The volatiles 
were removed immediately from the cool solution under reduced pressure to yield 
a red solid.  The red product was extracted into toluene (10 mL) and transferred to 
a narrow layering tube where it was layered with dichloromethane (15 mL).  A 
crop of colorless crystals (~ 5% yield) formed at the solvent interface. 
Approach B: 
[(Toluene)H][B(C6F5)4] (0.141 g, 0.183 mmol) in toluene (40 mL) was 
added to a toluene solution of (Me5C5)H (0.025 g, 0.184 mmol) at -78 °C.  The 
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volatiles were removed immediately from the cool solution under reduced 
pressure.  The pale yellow product was recrystallized from the slow diffusion of 
toluene and dichloromethane at room temperature to afford a crop of colorless 
crystals (0.034 g, 24% yield).  Spectroscopic Data:  HRMS (CI, CH4): calc. for 
C34H17 137.1330 found 137.1334; 1H and 13C NMR data matched those published 
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45 
 
Figure 1.19  Molecular structure of [(η5-C5Me5)Ge][B(C6F5)4], [1][B(C6F5)4], 
showing the atom number scheme.  The thermal ellipsoids are shown at the 
30% probability level.  All hydrogen atoms have been omitted for clarity. 
 
Figure 1.20  Molecular structure of [(η5-C5Me5)Ge]+, [1]+, showing the atom 
number scheme for the cation.  The thermal ellipsoids are shown at the 30% 
probability level.  All hydrogen atoms have been omitted for clarity. 
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Table 1.3  Crystal data and structure refinement for [(η5-
C5Me5)Ge][B(C6F5)4], [1][B(C6F5)4]. 
Identification code     [Cp*Ge][B(C6F5)4] 
Empirical formula  C34 H15 B F20 Ge 
Formula weight  886.86 
Temperature  153(2) K 
Wavelength  0.71069 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 13.456(5) Å        α= 90° 
 b = 14.052(5) Å        β= 90.940(5)°. 
 c = 17.494(5) Å         γ = 90° 
Volume 3307.4(19) Å3 
Z 4 
Density (calculated) 1.781 Mg/m3 
Absorption coefficient 1.066 mm-1 
F(000) 1744 
Crystal size 0.20 x 0.20 x 0.20 mm3 
Theta range for data collection 3.03 to 30.51°. 
Index ranges                                            -19≤h≤19, -19≤k≤18, -24≤l≤24 
Reflections collected 16719 
Independent reflections 10006 [R(int) = 0.0307] 
Completeness to theta = 30.51° 99.0 % 
Max. and min. transmission 0.8150 and 0.8150 
Refinement method Full-matrix least-squares on F2 
Goodness-of-fit on F2 1.015 
Final R indices [I>2sigma(I)] R1 = 0.0519, wR2 = 0.0970 
R indices (all data) R1 = 0.1026, wR2 = 0.1134 




Table 1.4  Selected bond lengths (Å) for [(η5-C5Me5)Ge][B(C6F5)4], 
[1][B(C6F5)4]). 
 
C(1)-C(5) 1.427(4)  C(3)-C(8) 1.504(4) 
C(1)-C(2) 1.433(4)  C(3)-Ge 2.250(3) 
C(1)-C(6) 1.497(4)  C(4)-C(5) 1.436(4) 
C(1)-Ge 2.237(3)  C(4)-C(9) 1.504(4) 
C(2)-C(3) 1.430(4)  C(4)-Ge 2.246(3) 
C(2)-C(7) 1.490(4)  C(5)-C(10) 1.497(5) 
C(2)-Ge 2.233(3)  C(5)-Ge 2.240(3) 
C(3)-C(4) 1.418(4)    
 
Table 1.5  Selected bond angles (°) for [(η5-C5Me5)Ge][B(C6F5)4], [1][ 
B(C6F5)4]. 
 
C(5)-C(1)-C(2) 107.7(2)  C(5)-C(4)-C(9) 125.3(3) 
C(5)-C(1)-C(6) 127.1(3)  C(3)-C(4)-Ge 71.78(15) 
C(2)-C(1)-C(6) 125.2(3)  C(5)-C(4)-Ge 71.07(16) 
C(5)-C(1)-Ge 71.51(15)  C(9)-C(4)-Ge 126.0(2) 
C(2)-C(1)-Ge 71.17(14)  C(1)-C(5)-C(4) 107.8(3) 
C(6)-C(1)-Ge 124.4(2)  C(1)-C(5)-C(10) 126.6(3) 
C(3)-C(2)-C(1) 108.2(2)  C(4)-C(5)-C(10) 125.6(3) 
C(3)-C(2)-C(7) 126.4(3)  C(1)-C(5)-Ge 71.30(15) 
C(1)-C(2)-C(7) 125.3(3)  C(4)-C(5)-Ge 71.59(15) 
C(3)-C(2)-Ge 72.05(15)  C(10)-C(5)-Ge 125.2(3) 
C(1)-C(2)-Ge 71.43(15)  C(2)-Ge-C(1) 37.40(10) 
C(7)-C(2)-Ge 124.31(19)  C(2)-Ge-C(5) 62.19(10) 
C(4)-C(3)-C(2) 107.9(2)  C(1)-Ge-C(5) 37.19(10) 
C(4)-C(3)-C(8) 125.8(3)  C(2)-Ge-C(4) 61.84(10) 
C(2)-C(3)-C(8) 126.3(3)  C(1)-Ge-C(4) 62.12(10) 
C(4)-C(3)-Ge 71.47(16)  C(5)-Ge-C(4) 37.34(11) 
C(2)-C(3)-Ge 70.75(14)  C(2)-Ge-C(3) 37.20(10) 
C(8)-C(3)-Ge 125.3(2)  C(1)-Ge-C(3) 62.26(10) 
C(3)-C(4)-C(5) 108.4(2)  C(5)-Ge-C(3) 62.07(11) 
C(3)-C(4)-C(9) 126.2(3)  C(4)-Ge-C(3) 36.75(11) 
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Figure 1.21  Molecular structure of [(η5-C5Me5)Sn][B(C6F5)4], [2][B(C6F5)4], 
showing the atom number scheme.  The thermal ellipsoids are shown at the 
30% probability level.  All hydrogen atoms have been omitted for clarity. 
 
 
Figure 1.22  Molecular structure of [(η5-C5Me5)Sn]+, 2+, showing the atom 
numbering scheme for the cation.  The thermal ellipsoids are shown at the 
30% probability level.  All hydrogen atoms have been omitted for clarity. 
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Table 1.6  Crystal data and structure refinement for [(η5-
C5Me5)Sn][B(C6F5)4], [2][B(C6F5)4].  
Identification code  p21overc 
Empirical formula C34 H15 B F20 Sn 
Formula weight  932.96 
Temperature  153(2) K 
Wavelength  0.71069 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 13.442(5) Å         α= 90° 
 b = 14.160(5) Å         β= 91.929(5)° 
 c = 17.551(5) Å          γ = 90° 
Volume 3339(2) Å3 
Z 4 
Density (calculated) 1.856 Mg/m3 
Absorption coefficient 0.904 mm-1 
F(000) 1816 
Crystal size 0.20 x 0.20 x 0.20 mm3 
Theta range for data collection 3.09 to 27.47°. 
Index ranges -17≤h≤17, -18≤k≤18, -22≤l≤22 
Reflections collected 13883 
Independent reflections 7559 [R(int) = 0.0226] 
Completeness to theta = 27.47° 98.7 % 
Absorption correction None 
Max. and min. transmission 0.8399 and 0.8399 
Refinement method Full-matrix least-squares on F2 
Goodness-of-fit on F2 1.057 
Final R indices [I>2sigma(I)] R1 = 0.0317, wR2 = 0.0622 
R indices (all data) R1 = 0.0447, wR2 = 0.0661 
Extinction coefficient 0.0040(3) 
Largest diff. peak and hole 0.491 and -0.258 e.Å-3 
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Table 1.7  Selected Bond Lengths (Å) for [(η5-C5Me5)Sn][B(C6F5)4], 
[2][B(C6F5)4]. 
 
C(1)-C(2) 1.426(4)  C(3)-C(8) 1.498(4) 
C(1)-C(5) 1.432(4)  C(3)-Sn 2.444(2) 
C(1)-C(6) 1.495(4)  C(4)-C(5) 1.427(4) 
C(1)-Sn 2.434(2)  C(4)-C(9) 1.499(4) 
C(2)-C(3) 1.432(4)  C(4)-Sn 2.446(3) 
C(2)-C(7) 1.498(4)  C(5)-C(10) 1.503(4) 
C(2)-Sn 2.428(2)  C(5)-Sn 2.439(3) 
C(3)-C(4) 1.428(4)    
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Table 1.8  Selected Bond Angles (°) for [(η5-C5Me5)Sn][B(C6F5)4], 
[2][B(C6F5)4]. 
 
C(2)-C(1)-C(5) 107.8(2)  C(5)-C(4)-C(9) 125.5(3) 
C(2)-C(1)-C(6) 125.4(2)  C(3)-C(4)-Sn 72.95(14) 
C(5)-C(1)-C(6) 126.6(2)  C(5)-C(4)-Sn 72.72(14) 
C(2)-C(1)-Sn 72.70(13)  C(9)-C(4)-Sn 125.3(2) 
C(5)-C(1)-Sn 73.09(14)  C(4)-C(5)-C(1) 108.2(2) 
C(6)-C(1)-Sn 124.14(19)  C(4)-C(5)-C(10) 124.7(3) 
C(1)-C(2)-C(3) 108.1(2)  C(1)-C(5)-C(10) 126.9(3) 
C(1)-C(2)-C(7) 125.1(2)  C(4)-C(5)-Sn 73.30(14) 
C(3)-C(2)-C(7) 126.6(2)  C(1)-C(5)-Sn 72.74(14) 
C(1)-C(2)-Sn 73.19(14)  C(10)-C(5)-Sn 124.5(2) 
C(3)-C(2)-Sn 73.54(14)  C(2)-Sn-C(1) 34.12(8) 
C(7)-C(2)-Sn 123.05(17)  C(2)-Sn-C(5) 56.65(9) 
C(4)-C(3)-C(2) 107.9(2)  C(1)-Sn-C(5) 34.17(9) 
C(4)-C(3)-C(8) 125.6(3)  C(2)-Sn-C(3) 34.18(8) 
C(2)-C(3)-C(8) 126.2(3)  C(1)-Sn-C(3) 56.64(8) 
C(4)-C(3)-Sn 73.11(14)  C(5)-Sn-C(3) 56.46(9) 
C(2)-C(3)-Sn 72.28(13)  C(2)-Sn-C(4) 56.63(9) 
C(8)-C(3)-Sn 125.31(18)  C(1)-Sn-C(4) 56.64(8) 
C(3)-C(4)-C(5) 108.0(2)  C(5)-Sn-C(4) 33.98(9) 




Figure 1.23  Molecular structure of [(η5-C5Me5)3Sn2][B(C6F5)4], [3][B(C6F5)4], 
showing the atom numbering scheme.  The thermal ellipsoids are shown at 
the 30% probability level.  All hydrogen atoms have been omitted for clarity. 
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Figure 1.24  Molecular structure of [(η5-C5Me5)3Sn2]+, 3+, showing the atom 
numbering scheme for the cation.  The thermal ellipsoids are shown at the 
30% probability level.  All hydrogen atoms have been omitted for clarity. 
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Table 1.9  Crystal data and structure refinement for [(η5-
C5Me5)3Sn2][B(C6F5)4], [3][B(C6F5)4]. 
Identification code  shelx14 
Empirical formula  C54 H45 B F20 Sn2 
Formula weight  1322.09 
Temperature  153(2) K 
Wavelength  0.71069 Å 
Crystal system  Monoclinic 
Space group  C2/c 
Unit cell dimensions a = 22.138(5) Å      α= 90° 
 b = 14.955(5) Å      β= 114.259(5)° 
 c = 17.097(5) Å       γ = 90° 
Volume 5161(3) Å3 
Z 4 
Density (calculated) 1.702 Mg/m3 
Absorption coefficient 1.078 mm-1 
F(000) 2616 
Crystal size 0.20 x 0.20 x 0.20 mm3 
Theta range for data collection 3.02 to 27.44°. 
Index ranges -28≤h≤28, -19≤k≤19, -22≤l≤17 
Reflections collected 26112 
Independent reflections 5869 [R(int) = 0.0383] 
Completeness to theta = 27.44° 99.4 % 
Absorption correction None 
Max. and min. transmission 0.8133 and 0.8133 
Refinement method Full-matrix least-squares on F2 
Goodness-of-fit on F2 1.077 
Final R indices [I>2sigma(I)] R1 = 0.0690, wR2 = 0.1533 
R indices (all data) R1 = 0.0837, wR2 = 0.1597 
Largest diff. peak and hole 3.251 and -4.702 e.Å-3 
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Table 1.10  Selected Bond Lengths (Å) for [(η5-C5Me5)3Sn2][B(C6F5)4], 
[3][B(C6F5)4]. 
 
C(1)-C(2) 1.414(9)  C(4)-Sn(1) 2.505(6) 
C(1)-C(5) 1.432(9)  C(5)-C(10) 1.514(9) 
C(1)-C(6) 1.490(9)  C(5)-Sn(1) 2.522(6) 
C(1)-Sn(1) 2.582(6)  C(11)-C(11A) 1.423(12) 
C(2)-C(3) 1.430(9)  C(11)-C(12) 1.427(8) 
C(2)-C(7) 1.502(9)  C(11)-C(14) 1.506(9) 
C(2)-Sn(1) 2.580(6)  C(12)-C(13) 1.430(7) 
C(3)-C(4) 1.428(9)  C(12)-C(16A) 1.508(8) 
C(3)-C(8) 1.504(9)  C(13)-C(12A) 1.430(7) 
C(3)-Sn(1) 2.511(6)  C(13)-C(15) 1.498(12) 
C(4)-C(5) 1.419(9)  C(16)-C(12A) 1.508(8) 
C(4)-C(9) 1.505(9)    
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Table 1.11  Selected Bond Angled (°) for [(η5-C5Me5)3Sn2][B(C6F5)4], 
[3][B(C6F5)4].  
 
C(2)-C(1)-C(5) 108.1(5) C(4)-C(5)-C(10) 126.5(6) 
C(2)-C(1)-C(6) 126.0(6) C(1)-C(5)-C(10) 125.4(6) 
C(5)-C(1)-C(6) 125.8(6) C(4)-C(5)-Sn(1) 73.0(3) 
C(2)-C(1)-Sn(1) 74.1(3)  C(1)-C(5)-Sn(1) 76.0(3) 
C(5)-C(1)-Sn(1) 71.4(3)  C(10)-C(5)-Sn(1) 120.7(4) 
C(6)-C(1)-Sn(1) 123.1(4)  C(11A)-C(11)-C(12) 107.9(3) 
C(1)-C(2)-C(3) 108.0(5) C(11A)-C(11)-C(14) 126.7(4) 
C(1)-C(2)-C(7) 126.1(6) C(12)-C(11)-C(14) 125.3(5) 
C(3)-C(2)-C(7) 125.7(6) C(11)-C(12)-C(13) 108.4(5) 
C(1)-C(2)-Sn(1) 74.1(3) C(11)-C(12)-C(16A) 126.4(5) 
C(3)-C(2)-Sn(1) 71.0(3) C(13)-C(12)-C(16A) 125.2(6) 
C(7)-C(2)-Sn(1) 124.1(5) C(12)-C(13)-C(12A) 107.2(7) 
C(4)-C(3)-C(2) 107.9(5) C(12)-C(13)-C(15) 126.4(3) 
C(4)-C(3)-C(8) 125.3(6) C(12A)-C(13)-C(15) 126.4(3) 
C(2)-C(3)-C(8) 126.3(6) C(4)-Sn(1)-C(3) 33.1(2) 
C(4)-C(3)-Sn(1) 73.3(3) C(4)-Sn(1)-C(5) 32.8(2) 
C(2)-C(3)-Sn(1) 76.4(3) C(3)-Sn(1)-C(5) 54.4(2) 
C(8)-C(3)-Sn(1) 123.0(5) C(4)-Sn(1)-C(2) 54.00(19) 
C(5)-C(4)-C(3) 107.9(5) C(3)-Sn(1)-C(2) 32.6(2) 
C(5)-C(4)-C(9) 126.1(6) C(5)-Sn(1)-C(2) 53.7(2) 
C(3)-C(4)-C(9) 125.3(6) C(4)-Sn(1)-C(1) 53.89(19) 
C(5)-C(4)-Sn(1) 74.2(3) C(3)-Sn(1)-C(1) 53.7(2) 
C(3)-C(4)-Sn(1) 73.7(3) C(5)-Sn(1)-C(1) 32.6(2) 
C(9)-C(4)-Sn(1) 124.9(4) C(2)-Sn(1)-C(1) 31.8(2) 




Figure 1.25  Molecular structure of [(η5-C5Me5)Pb][B(C6F5)4], [4][B(C6F5)4], 
showing the atom numbering scheme.  The thermal ellipsoids are shown at 
the 30% probability level.  All hydrogen atoms have been omitted for clarity. 
 
 
Figure 1.26  Molecular structure of [(η5-C5Me5)Pb]+, 4+, showing the atom 
numbering scheme for the cation.  The thermal ellipsoids are shown at the 
30% probability level.  All hydrogen atoms have been omitted for clarity. 
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Table 1.12  Crystal data and structure refinement for [(η5-
C5Me5)Pb][B(C6F5)4], [4][B(C6F5)4].  
Identification code  p1bar 
Empirical formula  C34 H15 B F20 Pb 
Formula weight  1021.46 
Temperature  153(2) K 
Wavelength  0.71069 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 11.642(5) Å       α= 64.003(5)° 
 b = 11.749(5) Å       β= 77.837(5)° 
 c = 13.392(5) Å        γ = 85.223(5)° 
Volume 1609.4(11) Å3 
Z 2 
Density (calculated) 2.108 Mg/m3 
Absorption coefficient 5.386 mm-1 
F(000) 972 
Crystal size 0.20 x 0.20 x 0.20 mm3 
Theta range for data collection 3.09 to 27.39°. 
Index ranges -15≤h≤12, -15≤k≤14, -17≤l≤17 
Reflections collected 12396 
Independent reflections 7270 [R(int) = 0.0171] 
Completeness to theta = 27.39° 99.3 % 
Absorption correction None 
Max. and min. transmission 0.4122 and 0.4122 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7270 / 0 / 565 
Goodness-of-fit on F2 1.046 
Final R indices [I>2sigma(I)] R1 = 0.0349, wR2 = 0.0757 
R indices (all data) R1 = 0.0391, wR2 = 0.0780 
Largest diff. peak and hole 2.710 and -2.177 e.Å-3 
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Table 1.13  Selected Bond Lengths (Å) for [(η5-C5Me5)Pb][B(C6F5)4], 
[4][B(C6F5)4]. 
 
C(1)-C(5) 1.427(6) C(3)-C(8) 1.499(6) 
C(1)-C(2) 1.428(6) C(3)-Pb(1) 2.546(4) 
C(1)-C(6) 1.504(6) C(4)-C(5) 1.424(6) 
C(1)-Pb(1) 2.539(4)  C(4)-C(9) 1.508(6) 
C(2)-C(3) 1.435(6)  C(4)-Pb(1) 2.557(4) 
C(2)-C(7) 1.503(6)  C(5)-C(10) 1.505(6) 
C(2)-Pb(1) 2.538(4) C(5)-Pb(1) 2.559(4) 
C(3)-C(4) 1.428(6)   
 
Table 1.14  Selected Angles (°) for [(η5-C5Me5)Pb][B(C6F5)4], [4][B(C6F5)4]. 
 
C(5)-C(1)-C(2) 108.1(3) C(3)-C(4)-C(9) 126.9(4) 
C(5)-C(1)-C(6) 126.8(4) C(5)-C(4)-Pb(1) 73.9(2) 
C(2)-C(1)-C(6) 124.7(4) C(3)-C(4)-Pb(1) 73.3(2) 
C(5)-C(1)-Pb(1) 74.5(2)  C(9)-C(4)-Pb(1) 123.5(3) 
C(2)-C(1)-Pb(1) 73.6(2)  C(4)-C(5)-C(1) 108.1(4) 
C(6)-C(1)-Pb(1) 123.2(3)  C(4)-C(5)-C(10) 125.8(4) 
C(1)-C(2)-C(3) 107.8(4) C(1)-C(5)-C(10) 125.7(4) 
C(1)-C(2)-C(7) 124.4(4) C(4)-C(5)-Pb(1) 73.8(2) 
C(3)-C(2)-C(7) 127.4(4) C(1)-C(5)-Pb(1) 73.0(2) 
C(1)-C(2)-Pb(1) 73.7(2) C(10)-C(5)-Pb(1) 124.8(3) 
C(3)-C(2)-Pb(1) 73.9(2) C(2)-Pb(1)-C(1) 32.66(13) 
C(7)-C(2)-Pb(1) 123.5(3) C(2)-Pb(1)-C(3) 32.80(14) 
C(4)-C(3)-C(2) 107.8(4) C(1)-Pb(1)-C(3) 54.13(13) 
C(4)-C(3)-C(8) 125.8(5) C(2)-Pb(1)-C(4) 53.99(13) 
C(2)-C(3)-C(8) 126.2(5) C(1)-Pb(1)-C(4) 53.85(13) 
C(4)-C(3)-Pb(1) 74.2(2) C(3)-Pb(1)-C(4) 32.51(14) 
C(2)-C(3)-Pb(1) 73.3(2) C(2)-Pb(1)-C(5) 53.92(13) 
C(8)-C(3)-Pb(1) 122.8(4) C(1)-Pb(1)-C(5) 32.50(12) 
C(5)-C(4)-C(3) 108.2(4) C(3)-Pb(1)-C(5) 53.83(13) 




Figure 1.27  Molecular structure of [(η5-C5Me5)3Pb2][B(C6F5)4], 
[5][B(C6F5)4], showing the atom numbering scheme.  The thermal ellipsoids 
are shown at the 30% probability level.  All hydrogen atoms have been 




Figure 1.28  Molecular structure of [(η5-C5Me5)3Pb2]+, 5+, showing the atom 
numbering scheme for the cation.  The thermal ellipsoids are shown at the 
30% probability level.  All hydrogen atoms have been omitted for clarity. 
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Table 1.15  Crystal data and structure refinement for [(η5-
C5Me5)3Pb2][B(C6F5)4], [5][B(C6F5)4]. 
Identification code  i2overa 
Empirical formula  C54 H46 B F20 Pb2 
Formula weight  1500.10 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  I2/a 
Unit cell dimensions a = 17.087(3) Å       α = 90° 
 b = 14.773(3) Å       β = 110.37(3)° 
 c = 21.811(4) Å       γ = 90° 
Volume 5161.6(18) Å3 
Z 4 
Density (calculated) 1.930 Mg/m3 
Absorption coefficient 6.625 mm-1 
F(000) 2876 
Crystal size 0.2 x 0.2 x 0.2 mm3 
Theta range for data collection 3.47 to 27.48°. 
Index ranges -22<=h<=22, -19<=k<=19, -
28<=l<=28 
Reflections collected 10513 
Independent reflections 5852 [R(int) = 0.0148] 
Completeness to theta = 27.48° 98.6 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5852 / 0 / 438 
Goodness-of-fit on F2 1.071 
Final R indices [I>2sigma(I)] R1 = 0.0198, wR2 = 0.0454 
R indices (all data) R1 = 0.0225, wR2 = 0.0465 
Largest diff. peak and hole 0.706 and -1.188 e.Å-3 
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Table 1.16  Selected Bond Lengths (Å) for [(η5-C5Me5)3Pb2][B(C6F5)4], 
[5][B(C6F5)4]. 
 
C(1)-C(2) 1.423(4) C(401)-C(4) 1.499(4) 
C(2)-C(3) 1.425(4) C(501)-C(5) 1.504(4) 
C(3)-C(4) 1.411(4) C(6)- C(601) 1.499(5) 
C(4)-C(5) 1.422(4)  C(7)- C(701) 1.494(4) 
C(1)-C(5) 1.421(4)  C(8)- C(801) 1.508(3) 
C(6)-C(7) 1.425(3)  C(1)-Pb(1) 2.592(2) 
C(7)- C(8) 1.429(3) C(2)-Pb(1) 2.620(3) 
C(101)-C(1) 1.505(4) C(3)-Pb(1) 2.673(3) 
C(201)-C(2) 1.504(4) C(4)-Pb(1) 2.672(3) 
C(301)-C(3) 1.498(4) C(5)-Pb(1) 2.605(2) 
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Table 1.17  Selected Bond Angles (°) for [(η5-C5Me5)3Pb2][B(C6F5)4], 
[5][B(C6F5)4]. 
 
C(7)-C(6)-C(7A) 108.3(3)  C(201)-C(2)-Pb(1) 120.7(2) 
C(7)-C(6)-C(601) 125.86(14)  C(4)-C(3)-C(2) 108.3(2) 
C(7A)-C(6)-C(601) 125.86(14)  C(4)-C(3)-C(301) 126.5(3) 
C(6)-C(7)-C(8) 107.8(2)  C(2)-C(3)-C(301) 125.0(3) 
C(6)-C(7)-C(701) 126.0(2)  C(4)-C(3)-Pb(1) 74.65(15) 
C(8)-C(7)-C(701) 126.2(2)  C(2)-C(3)-Pb(1) 72.31(13) 
C(8A)-C(8)-C(7) 108.07(13)  C(301)-C(3)-Pb(1) 123.4(2) 
C(8A)-C(8)-C(801) 127.11(15)  C(3)-C(4)-C(5) 108.1(2) 
C(7)-C(8)-C(801) 124.8(2)  C(3)-C(4)-C(401) 126.1(3) 
C(5)-C(1)-C(2) 107.9(2)  C(5)-C(4)-C(401) 125.6(3) 
C(5)-C(1)-C(101) 125.0(3)  C(3)-C(4)-Pb(1) 74.75(14) 
C(2)-C(1)-C(101) 126.4(3)  C(5)-C(4)-Pb(1) 71.76(14) 
C(5)-C(1)-Pb(1) 74.63(14)  C(401)-C(4)-Pb(1) 123.6(2) 
C(2)-C(1)-Pb(1) 75.25(14)  C(1)-C(5)-C(4) 108.0(2) 
C(101)-C(1)-Pb(1) 123.36(19)  C(1)-C(5)-C(501) 125.5(3) 
C(1)-C(2)-C(3) 107.7(2)  C(4)-C(5)-C(501) 126.1(3) 
C(1)-C(2)-C(201) 126.3(3)  C(1)-C(5)-Pb(1) 73.62(14) 
C(3)-C(2)-C(201) 125.8(3)  C(4)-C(5)-Pb(1) 77.00(14) 
C(1)-C(2)-Pb(1) 73.07(14)  C(501)-C(5)-Pb(1) 121.6(2) 
C(3)-C(2)-Pb(1) 76.46(14)  C(1)-Pb(1)-C(5) 31.75(8) 
C(201)-C(2)-Pb(1) 120.7(2)  C(1)-Pb(1)-C(2) 31.68(8) 
C(4)-C(3)-C(2) 108.3(2)  C(5)-Pb(1)-C(2) 52.23(8) 
C(4)-C(3)-C(301) 126.5(3)  C(1)-Pb(1)-C(4) 51.79(8) 
C(2)-C(3)-C(301) 125.0(3)  C(201)-C(2)-Pb(1) 120.7(2) 




Figure 1.29  Molecular structure of [In(η5-µ-C5Me5)In][B(C6F5)4], 
[6][B(C6F5)4], showing the atom numbering scheme.  The thermal ellipsoids 
are shown at the 30% probability level.  All hydrogen atoms have been 
omitted for clarity. 
66 
 
Figure 1.30  Molecular structure of [In[(η5-µ-C5Me5)In]+, 6+, showing the 
atom numbering scheme.  The thermal ellipsoids are shown at the 30% 
probability level.  All hydrogen atoms have been omitted for clarity. 
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Table 1.18  Crystal data and structure refinement for [(µ-
C5Me5)2In][B(C6F5)4], [6][B(C6F5)4].  
Identification code  p21c 
Empirical formula  C34 H15 B F20 In2 
Formula weight  1043.91 
Temperature  153(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 10.065(2) Å α = 90° 
 b = 23.157(5) Å β= 103.48(3)° 
 c = 16.451(3) Å γ = 90° 
Volume 3728.7(13) Å3 
Z 4 
Density (calculated) 1.860 Mg/m3 
Absorption coefficient 1.362 mm-1 
F(000) 2008 
Crystal size 0.2 x 0.2 x 0.2 mm3 
Theta range for data collection 3.65 to 27.50°. 
Index ranges -12≤h≤12, -27≤k≤29, -21≤l≤21 
Reflections collected 14935 
Independent reflections 8441 [R(int) = 0.0400] 
Completeness to theta = 27.50° 98.7 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8441 / 0 / 538 
Goodness-of-fit on F2 1.032 
Final R indices [I>2sigma(I)] R1 = 0.0495, wR2 = 0.1140 
R indices (all data) R1 = 0.0906, wR2 = 0.1269 
Largest diff. peak and hole 0.610 and -0.746 e.Å-3 
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Table 1.19  Selected Bond Lengths (Å) for [(µ-C5Me5)2In][B(C6F5)4], 
[6][B(C6F5)4].  
 
C(11)-C(1) 1.512(7) C(3)-C(13) 1.514(8) 
C(14)-C(4) 1.543(8) C(4)-C(5) 1.459(8) 
C(1)-C(2) 1.406(7) C(4)-In(2) 2.675(5) 
C(1)-C(5) 1.414(7)  C(5)-C(15) 1.509(9) 
C(2)-C(3) 1.388(8)  C(5)-In(2) 2.687(5) 
C(2)-C(12) 1.529(8)  C(5)-In(1) 2.701(4) 
C(3)-C(4) 1.411(8)   
 
Table 1.20  Selected Bond Angles (°) for [(µ-C5Me5)2In][B(C6F5)4], 
[6][B(C6F5)4]. 
 
C(2)-C(1)-C(5) 108.1(5) C(5)-C(4)-In(2) 74.7(3) 
C(2)-C(1)-C(11) 126.1(5) C(14)-C(4)-In(2) 115.0(4) 
C(5)-C(1)-C(11) 125.8(5) C(1)-C(5)-C(4) 105.9(4) 
C(3)-C(2)-C(1) 110.4(5)  C(1)-C(5)-C(15) 126.5(6) 
C(3)-C(2)-C(12) 124.4(5)  C(4)-C(5)-C(15) 127.6(6) 
C(1)-C(2)-C(12) 125.1(5)  C(1)-C(5)-In(2) 76.2(3) 
C(2)-C(3)-C(4) 107.1(5) C(4)-C(5)-In(2) 73.8(3) 
C(2)-C(3)-C(13) 124.9(6) C(15)-C(5)-In(2) 115.4(4) 
C(4)-C(3)-C(13) 128.1(6) C(1)-C(5)-In(1) 76.0(3) 
C(3)-C(4)-C(5) 108.5(4) C(4)-C(5)-In(1) 75.5(3) 
C(3)-C(4)-C(14) 125.2(7) C(15)-C(5)-In(1) 114.2(4) 
C(5)-C(4)-C(14) 126.3(7) In(2)-C(5)-In(1) 130.4(2) 
C(3)-C(4)-In(2) 77.8(3) C(4)-In(2)-C(5) 31.58(18) 
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Figure 1.31  Molecular structure of [(C5Me5)H2][B(C6F5)4], [8][B(C6F5)4], 
showing the atom numbering scheme.  The thermal ellipsoids are shown at 
the 30% probability level. 
 
 
Figure 1.32  Molecular structure of [(C5Me5)H2]+, 8+, showing the atom 
numbering scheme.  The thermal ellipsoids are shown at the 30% probability 
level. 
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Table 1.21  Crystal data and structure refinement for [(C5Me5)H2][B(C6F5)4], 
[8][B(C6F5)4]. 
Identification code  p21overc 
Empirical formula  C24 H17 B F20 
Formula weight  696.19 
Temperature  153(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 13.197(3) Å α= 90° 
 b = 13.752(3) Å β= 90.11(3)°. 
 c = 17.407(4) Å γ = 90° 
Volume 3158.9(11) Å3 
Z 4 
Density (calculated) 1.464 Mg/m3 
Absorption coefficient 0.168 mm-1 
F(000) 1384 
Crystal size 0.20 x 0.20 x 0.20 mm3 
Theta range for data collection 2.96 to 27.50°. 
Index ranges -17≤h≤17, -17≤k≤17, -22≤l≤22 
Reflections collected 28166 
Independent reflections 7256 [R(int) = 0.1108] 
Completeness to theta = 27.50° 99.8 % 
Absorption correction None 
Max. and min. transmission 0.9673 and 0.9673 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7256 / 0 / 564 
Goodness-of-fit on F2 1.038 
Final R indices [I>2sigma(I)] R1 = 0.0669, wR2 = 0.1394 
R indices (all data) R1 = 0.1382, wR2 = 0.1650 
Largest diff. peak and hole 0.292 and -0.382 e.Å-3 
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Table 1.22  Selected Bond Lengths (Å) for [(C5Me5)H2][B(C6F5)4], 
[8][B(C6F5)4].  
 
C(3)-C(2) 1.383(5)  C(4)-C(5) 1.520(5) 
C(3)-C(13) 1.470(5)  C(4)-C(14) 1.523(5) 
C(3)-C(4) 1.485(5)  C(1)-C(5) 1.463(5) 
C(2)-C(1) 1.392(5)  C(1)-C(11) 1.484(5) 
C(2)-C(12) 1.494(5)  C(5)-C(15) 1.520(6) 
 
Table 1.23  Selected Bond Angles (°) for [(C5Me5)H2][B(C6F5)4], 
[8][B(C6F5)4]. 
 
C(2)-C(3)-C(13) 125.8(3) C(5)-C(4)-C(14) 114.0(3) 
C(2)-C(3)-C(4) 112.5(3) C(2)-C(1)-C(5) 111.5(3) 
C(13)-C(3)-C(4) 121.6(3) C(2)-C(1)-C(11) 124.9(4) 
C(3)-C(2)-C(1) 107.6(3) C(5)-C(1)-C(11) 123.6(4) 
C(3)-C(2)-C(12) 126.8(3) C(1)-C(5)-C(15) 116.1(4) 
C(1)-C(2)-C(12) 125.5(3) C(1)-C(5)-C(4) 105.5(3) 
C(3)-C(4)-C(5) 102.8(3) C(15)-C(5)-C(4) 116.1(4) 
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CHAPTER 2:  GROUP 14 INDENYL-CONTAINING 
METALLOCENES 
INTRODUCTION 
 Similar to the pentamethylcyclopentadienide ligand discussed in Chapter 
1, the indenide ligand, [C9H7]¯ (Figure 2.1), can rearrange in order to compensate 
for changes in the total number of electrons in the metal coordination sphere 
(Figure 2.2).[1]  Such a rearrangement has been described as a “ring slippage” or 
“ring-folding” process[2] or by the more general term of “haptotropic shift”.[3]  
Despite the similarities in the pentamethylcyclopentadienide and indenide ligands, 
the η5-to-η3 ring slippage is significantly more facile for the indenide ligand, 
resulting in faster reaction rates.[4-10]  This increase in reaction rate has been 
termed the indenyl effect.[5]  The most widely accepted explanation for the 
increased reaction rate is the enhanced stability of the η3-C9H7 intermediates as a 
consequence of the aromaticity gain of the benzene ring formed by the six 
uncoordinated carbon atoms.  However, recent work has shown that the more 
facile η5-to-η3 ring slippage by the indenide ligand might be related to the 





Figure 2.1  General structures of the indenide, 1-trimethylsilylindenide, and 
1,3-bis(trimethylsilyl)indenide ligands.   
 
M M  
Figure 2.2  The indenyl effect showing the change of coordination from 
pentahapto to trihapto ligation. 
 
One method for determining the hapticity of indenide complexes is to 
calculate the slip parameter.  The slip parameter, ∆M-C, is defined as the difference 
in the average bond length of the metal to the ring junction carbons (C4 and C9) 
and the average metal—carbon bond length to the adjacent carbons C1 and C3 
(Figure 2.3). 
C3)C1,av.(MC9)C4,av.(M∆ CM −−−=−  




For a “true” η5-coordinated complex, ∆M-C = 0.0 Å, while for η3-coordinated 









Figure 2.3  Numbering scheme for the indenide ligand. 
 
Mono- or disubstitution of the five-membered ring of the indenide ligand 
has been shown to impact the bonding flexibility.[11]  This is due to the fact that 
the inductive effect of the trimethylsilyl group ranges from slightly more electron 
donating than a methyl group to more electron donating than a tert-butyl group.[12, 
13] 
Bis(indenide) complexes can adopt three conformations (Figure 2.4), 
namely staggered (A), gauche (B), and eclipsed (C).  In addition to impacting the 
bonding flexibility of indenide ligands, the use of bulky trimethylsilyl substituents 
has also been shown to influence these orientation of the ligands in bis(π-
indenide) compounds.[14]  Brady et al.[14] reported the synthesis and X-ray crystal 
structures of [1-(Me3Si)(η5-C9H5)]2Cr and [1,3-(Me3Si)2(η5-C9H5)]2Cr.  The 
results were surprising in that the indenide ligands are oriented in a staggered 
fashion in the monosubstituted complex, [1-(Me3Si)(η-C9H5)]2Cr, while the 
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disubstituted complex, [1,3-(Me3Si)2(η-C9H5)]2Cr, adopts a gauche conformation.  
The change from a staggered to a gauche conformation lowers the symmetry of 
the bis(indenide)metal complex and allows greater mixing of metal and ligand 
orbitals.  In turn, this changes the magnetic properties of the complexes:  [1-
(Me3Si)(η-C9H5)]2Cr  is a high-spin complex, while [1,3-(Me3Si)2(η-C9H5)]2Cr is 
a low-spin complex.[14]  The ability to tailor magnetic properties of metal 
complexes in this fashion opens opportunities for the design of novel materials.  
M M M
 
Figure 2.4  Orientations of the indenide ligand in bis(indenyl)metal 
complexes.  A)staggered, B)gauche, and C)eclipsed. 
 
A plethora of bis(π-indenide) transition metal complexes have been 
reported.  The first such complex to be crystallographically charactered was the 
ferrocene analogue, (C9H7)2Fe, in 1953.[15]  The rings were predicted to be 
oriented in a “trans” (staggered) configuration; however, a subsequent X-ray 
diffraction study indicated that in the solid state the ligands are arranged between 
a gauche and an eclipsed conformation.  An assortment of ligand arrangements 
A B C
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has been characterized in the solid state structures of transition metal—indenide 
complexes, including the fully eclipsed bis(indenide)vanadium(II)[16] and 
bis(indenide)ruthenium(II)[17] complexes and the staggered bis(indenide)nickel(II) 
complex.[18]        
Only two post-transition metal π-indenide compounds have been 
structurally characterized, namely [1,3-(Me3Si)2(η5-C9H5)](η5-C5Me5)Ge[19] and 
[1,3-(Me3Si)2(η-C9H5)]2Pb.[20]  The germanium atom in the mixed ligand 
complex, 1,3-(Me3Si)2(C9H5)](C5Me5)Ge, was determined to be η5-coordinated to 
both the 1,3-(Me3Si)2(C9H5) and the C5Me5 rings.  Interestingly, the germanium—
C5Me5 ring centroid distance is significantly shorter than that between the 
germanium atom and the 1,3-(Me3Si)2(C9H5) ring centroid.  This observation 
implies that the germanium—indenyl bond strength is appreciably weaker than 
the germanium—C5Me5 bond strength.[19]  The lead derivative [1,3-(Me3Si)2(η-
C9H5)]2Pb was found to undergo slow decomposition at room temperature; 
nevertheless, it was possible to collect single crystal X-ray diffraction data.  
Interesting features of the structure include the rotation of the indenyl ligands by 
83.3º and a gauche orientation.  The ring centroid—lead—ring centroid angle of 
av. 173.1º is only slightly deviated from linearity.[20] 
The present work focuses on the synthesis and structural characterization 
of group 14 indenide-substituted metallocenes.  The study includes both the bis(π-
79 
indenide) and the mixed ligand systems, (π-indenide)(π-C5Me5).  These structural 
data have provided useful insights into the bonding modes of group 14 indenide 
complexes and shed light on potential nano-materials applications. 
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RESULTS AND DISCUSSION 
Synthesis and Characterization of [1,3-(Me3Si)2(η5-C9H5)]Li·2THF, 9  
The compound (1,3-trimetylsilane)indenyllithium, 9, was synthesized in 
good yield via the previously reported[21] method.  The reaction of 
trimethylchlorosilane with [1-(trimethylsilyl)indenyl]lithium was followed by 
metalation with butyllithium.  The 1H NMR spectrum of 9 exhibits four proton 
signals, indicating C2v symmetry for the indenide ring.  The 13C NMR spectrum of 
9 evidences six carbon resonances, thus lending further support to the proposed 
C2v symmetry structure.      
   Recrystallization of 9 by slow cooling of a concentrated THF solution to -
20° C yielded crystals suitable for X-ray diffraction experiments.  1H and 13C 
NMR analyses of 9 were indicative of the presence of coordinated THF molecules 
and this was confirmed by X-ray analysis.  Analysis of the single crystal X-ray 
diffraction data confirmed the identity of the compound as [1,3-(Me3Si)2(η5-
C9H5)]Li·2THF (Figure 2.5).  The details of the data collection, structure solution, 
and refinement are compiled in Table 2.1 and selected metrical parameters are 
listed in Table 2.2 and Table 2.3.   
81 
 
Figure 2.5  Molecular structure of [1,3-(Me3Si)2(η5-C9H5)]Li·2THF, 9, 
showing the η5-coordination of the lithium atom to the 1,3-
bis(trimethylsilyl)indenide ligand.  Atoms are colored as follows:  carbon 
(black), silicon (cyan), lithium (violet), and oxygen (red).  Thermal ellipsoids 
are shown at the 30% probability level. 
  
The Li—Cring bond distances range from 2.246(9)—2.413(9) Å with an 
average bond length of 2.344(9) Å.  The ring-centroid (X1A)—Li distance is 
2.000(4) Å.  The close similarity of the Li—Cring indicated that the lithium atom is 
pentahapto bonded to the 1,3-(Me3Si)2(η5-C9H5) five-membered ring.  The slip 
parameter, ∆Li-C, is 0.089 Å.  The lithium atom is further coordinated to the 
oxygen atoms of two THF molecules with an average Li—O bond distance of 
1.913(8) Å. 
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Synthesis and Characterization of [1,3-(Me3Si)2(η5-C9H5)]2Sn], 10 
 Bis[1,3-bis(trimethylsilyl)indenyl]tin(II), 10, was synthesized in good 
yield via the metathetical reaction of tin(II) chloride with two equivalents of [1,3-
(Me3Si)2(η5-C9H5)]Li in THF solution.  The compound decomposes slowly at 
room temperature over the course of several weeks.  The 1H NMR spectrum of 10 
exhibited four proton signals thus indicating the equivalence of the two 1,3-
(Me3Si)2(η5-C9H5) ligands.  Similarly, the 13C NMR spectrum of 10 shows six 
carbon resonances, further supporting the argument for the symmetry equivalence 
of the two 1,3-(Me3Si)2(η5-C9H5) ligands.  The 119Sn NMR spectrum evidences a 
single peak at δ -2232. 
   Recrystallization of 10 by slow cooling of a concentrated solution to -20° 
C yielded crystals suitable for X-ray diffraction experiments.  A single-crystal X-
ray diffraction study cofirmed the identity of compound 10 as [1,3-(Me3Si)2(η5-
C9H5)]2Sn].  The molecular structure is illustrated in Figure 2.6.  Details of the 
data collection, structure solution, and refinement are compiled in Table 2.4 and 
selected metrical parameters are listed in Table 2.5 and Table 2.6.   
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Figure 2.6  Molecular structure of [1,3-(Me3Si)2(η5-C9H5)]2Sn, 10, showing 
the planarity of the 1,3-(Me3Si)2(η5-C9H5) ligands.  Atoms are colored as 
follows:  carbon (black), silicon (cyan), and tin (orange).  Thermal ellipsoids 
are shown at the 30% probability level. 
 
The Sn—Cring bond distances range from 2.580(3)—2.789(3) Å with an 
average bond length of 2.432(3) Å.  The average ring centroid (X1A/X1B)—Sn 
bond distance is 2.421(4) Å, which is significantly longer than that reported for 
Sn(η5-C5Me5)2 (2.396 Å).[22]  The bond distances obtained indicate that tin is 
pentahapto bonded to the five-membered indenyl ring, ∆Sn-C = 0.105 Å.  The 
centroid
2TMSInd (X1A)—Sn— centroid2TMSInd (X1B) bond angle is nearly linear 
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(175.9º) compared to the significantly more acute angle of av. 154.9º for Sn(η5-
C5Me5)2.[22]  The linearity of this bond angle is comparable to that determined for 
Sn(η5-C5Ph5)2 (180.0º).[23]  The question arises, where is the lone electron pair in 
the linear structure?  By means of Fenske-Hall molecular orbital calculations, 
Williamson et al.[24] determined that the lone pair resides in the tin 5s-like orbital.  
The trimethylsilyl groups orient themselves in a gauche conformation 
which can be seen in Figure 2.7.  The two ligands are rotated by approximately 
82º relative to each other, which may serve to minimize unfavorable non-bonding 
interactions between the indenyl substituents.  The gauche conformation is similar 
to that previous reported for [(Me3Si)2C9H5]2Pb.[20]   
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Figure 2.7  Molecular structure of [1,3-(Me3Si)2(η5-C9H5)]2Sn, 10, showing 
the gauche orientation of the 1,3-(Me3Si)2(η5-C9H5) ligands.  Atoms are 
colored as follows:  carbon (black), silicon (cyan), and tin (orange).  Thermal 
ellipsoids are shown at 30% probability. 
 
Synthesis and Characterization of [1,3-(Me3Si)2(η5-C9H5)](η5-C5Me5)Sn, 11 
 (Pentamethylcyclopentadienyl)[1,3-bis(trimethylsilyl)indenyl]tin(II), 11, 
was synthesized in good yield via the metathetical reaction of 
(pentamethylcyclopentadienyl)tin(II) chloride with an equimolar quantity of [1,3-
(Me3Si)2(η5-C9H5)]Li.  The product decomposes at room temperature over the 
course of several days.  The 1H NMR spectrum of 11 exhibits five proton signals.  
An intense singlet at δ 1.716 indicated the C5v symmetry of the 
ca. 82º 
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pentamethylcyclopentadienide ring, while the other four 1H NMR signals were 
indicative of the C2v symmetry of the indenide ligand.  Similarly, the 13C NMR 
spectrum of 11 showed eight carbon resonances, two for the [C5Me5]¯ ligand and 
six for the [1,3-(Me3Si)2(η-C9H5)]¯ ligand.   
   Recrystallization of 11 by slow cooling of a concentrated pentane solution 
to -20° C yielded crystals suitable for X-ray diffraction experiments.  An X-ray 
diffraction study identified the crystals as the title compound shown in Figure 2.8.  
Details of the data collection, structure solution, and refinement are compiled in 
Table 2.7 and selected metrical parameters are listed in Table 2.8 and Table 2.9.   
 
Figure 2.8  (A) Overall geometry of [1,3-(Me3Si)2(η5-C9H5)](η5-C5Me5)Sn, 11, 
and (B) the angle between Cp*centroid(X1C)—Sn—Ind2TMScentroid(X1D).  Atoms 
are colored as follows:  carbon (black), silicon (cyan), and tin (orange).  




The Sn—CCp* bond distances range from 2.474(7)—2.708(4) Å with an 
average bond length of 2.602(4) Å, while the Sn—CInd bond distances range from 
2.692(7) to 2.966(4) Å with an average bond length of 2.835(4) Å.  Significantly 
shorter than the Sn—Ind2TMScentroid(X1D) bond distance (2.561 Å), the Sn—
Cp*centroid(X1C) distance (2.313 Å) suggests appreciably stronger bonding 
between the metal center and the C5Me5 moiety.  The pattern of bond distances 
suggests that the tin atom is pentahapto bonded to both the [C5Me5]¯ ring and the 
5-membered ring of [1,3-(Me3Si)2(η5-C9H5)]¯, ∆Sn-C = 0.155 Å.  The X1C—Sn—
X1D bond angle of 151.6º in 11 (Figure 2.8) is similar to that found in Sn(η5-
C5Me5)2 (154.9º).[22] 
Synthesis and Characterization of [1,3-(Me3Si)2(η5-C9H5)]( η5-C5Me5)Pb, 12  
 (Pentamethylcyclopentadienyl)[1,3-bis(trimethylsilyl)indenyl]lead(II), 12, 
was synthesized in good yield via the metathetical reaction of 
(pentamethylcyclopentadienyl)lead(II) chloride with an equimolar amount of [1,3-
(Me3Si)2(η5-C9H5)]Li.  The product decomposes at room temperature over the 
course of a few days.  The 1H NMR spectrum of 12 exhibits five proton signals.  
An intense singlet at δ 2.012 indicated the C5v symmetry of the 
pentamethylcyclopentadienide ring, while the other four 1H NMR signals were 
indicative of the C2v symmetry of the indenide ligand.  Similarly, the 13C NMR 
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spectrum of 5 showed eight carbon resonances, two for the [C5Me5]¯ and six for 
the [1,3-(Me3Si)2(η5-C9H5)]¯ ligand.   
   Recrystallization of 12 by slow cooling of a concentrated pentane solution 
to -20° C yielded crystals suitable for X-ray diffraction experiments.  An X-ray 
diffraction study identified the crystals as the title compound shown in Figure 2.9.  
Details of the data collection, structure solution, and refinement are compiled in 
Table 2.9 and selected metrical parameters are listed in Table 2.11 and Table 
2.12.     
 
Figure 2.9  (A) Overall geometry of [1,3-(Me3Si)2(η5-C9H5)]( η5-C5Me5)Pb, 12, 
and (B) the angle between Cp*centroid(X1A)—Pb—Ind2TMScentroid(X1B).  Atoms 
are colored as follows:  carbon (black), silicon (cyan), and lead (green).  
Thermal ellipsoids are shown at 30% probability.   
 
The Pb—CCp* bond distances range from 2.585(4)—2.783(4) Å with an 
average bond length of 2.688 Å, while the Pb—CInd bond distances range from 
A B 
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2.738(4)—3.055(4) Å with an average bond length of 2.901 Å.  Significantly 
shorter than the Pb—Ind2TMScentroid(X1B) bond distance (2.634 Å), the Pb—
Cp*centroid(X1A) distance (2.406 Å) suggests appreciably stronger bonding 
between the metal center and the C5Me5 moiety.  The pattern of bond distances 
suggests that the lead atom is pentahapto bonded to both the [C5Me5]¯ ring and the 
5-membered ring of [1,3-(Me3Si)2(η5-C9H5)]¯, ∆Pb-C = 0.174 Å.  The X1A—Pb—
X1B bond angle is 148.42, which is shown in Figure 2.9.  This bond angle is 
similar to that found in Pb(η5-C5Me5)2 (151.3º).[25] 
Synthesis and Characterization of [1,3-(Me3Si)2(η5-C9H5)]2Li2·Et2O, 13 
 In an attempt to synthesize the group 15 bis(π-indenide) complexes, two 
equivalents of [1,3-(Me3Si)2(η-C9H5)]Li (0.399 g, 1.5 mmol) were treated with 
antimony(III) chloride (0.339 g, 1.5 mmol).  Recrystallization of the product by 
slow cooling of a concentrated solution to -20° C yielded crystals suitable for X-
ray diffraction experiments.  An X-ray diffraction study revealed that the product 
is the dilithio derivative [1,3-(Me3Si)2(η5-C9H5)]2Li2·Et2O illustrated in Figure 
2.10.  Details of the data collection, structure solution, and refinement are 
compiled in Table 2.13 and selected metrical parameters are listed in Table 2.14 
and Table 2.15. 
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Figure 2.10  Molecular structure of [1,3-(Me3Si)2(η5-C9H5)]2Li2·Et2O, 13, 
showing stacked structure.  Atoms are colored as follows: carbon (black), 
silicon (cyan), lithium (violet), and oxygen (red).  Thermal ellipsoids are 
shown at the 30% probability level. 
 
 In general, the structure of base-stabilized 13, is similar to that reported 
for [Li2{C24H14-(SiMe3)2}]·2THF[26] and benzene stabilized [{Li(η5-
C5Bz5)}2(C6D6)].[27]  In the case of 13, one lithium atom is capped by a diethyl 
ether moiety, the oxygen atom of which is located 1.877(4) Å from the lithium 
atom.  The Li(1)—CInd(external) bond distances range from 2.212(4)—2.433(4) Å 
with an average bond length of 2.325 Å. The Li(1)—CInd(internal) bond distances 
are on average slightly longer than the corresponding CInd(external) distances and 
range from 2.301(4)—2.678(4) Å with an average bond length of 2.492 Å.  The 
Li(2)—CInd(internal) bond distances range from 2.232(4)—2.280(4) Å and 
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average 2.333 Å.  The external ring centroid (X1A)—Li bond distance of 
1.981(4) Å is shorter than that in [{Li(η5-C5Bz5)}2(C6D6)] (2.015 Å).[27] but 
longer than that in [Li2{C24H14-(SiMe3)2}]·2THF (1.78 Å).[26]  The internal ring 
centroid (X1B)—Li bond distance of 2.175 Å is longer than that in both 
[Li2{C24H14-(SiMe3)2}]·2THF (2.094 Å)[26] and [{Li(η5-C5Bz5)}2(C6D6)] (2.03 
Å).[27]  The X1B—Li(2) bond distance (1.901 Å) is the shortest of all the Li—X 
bond distances and identical to the X1B—Li(2) bond distances in [{Li(η5-
C5Bz5)}2(C6D6)] (1.91 Å)[27] within experimental error.  For a comparison of bond 
distances in 6 and [{Li(η5-C5Bz5)}2(C6D6)], see Figure 2.11.  The pattern of bond 
distances indicates that both lithium atoms are pentahapto bonded to the five-














6 {Dohmeier}  
Figure 2.11  Comparison of bond lengths in 13 and [{Li(η5-
C5Bz5)}2(C6D6)].[27] 
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The X1A—Li(1)—X1B bond angle is nearly linear (173.6º), while the 
Li(1)—X1B—Li(2) bond angle deviates significantly from linearity (169.0º).  As 
shown in Figure 2.12, the trimethylsilyl groups are oriented in a gauche 
conformation.  The two Me3Si ligands are rotated by an angle of 92.6º with 
respect to each other.  Such a conformation may serve to minimize the 
unfavorable non-bonding interactions between the indenyl substituents.  
Interestingly, the gauche conformation is similar to that reported prviously for 
[(Me3Si)2C9H5]2Pb[20] and that determined for 10 in the present work. 
 
Figure 2.12  Molecular structure of [1,3-(Me3Si)2(η5-C9H5)]2Li2·Et2O, 13, 
showing the gauche orientation of the 1,3-(Me3Si)2(η5-C9H5) ligands.  Atoms 
are colored as follows:  carbon (black), silicon (cyan), lithium (violet), and 




At this point, the mechanism of formation of the lithium triple-decker 
metallocene, 13, is not known.  Moreover, it was not possible to reproduce the 
synthesis of this compound.  Unfortunately, no spectroscopic data were acquired 
for the complex prior to the X-ray crystallographic study. 
Reaction of an indenyl cation and a neutral metallocene 
 In an attempt to synthesize the first example of a post-transition metal, 
mixed ligand, triple-decker metallocene, the [B(C6F5)4]¯ salt of the half sandwich 
cation, [{1,3-(Me3Si)2(η5-C9H5)}Sn]+, was allowed to react in situ with an 
equimolar quantity of decamethylstannocene, Sn(η5-C5Me5)2.  The reaction was 
expected to yield the mixed ligand, triple-decker cation, [{1,3-(Me3Si)2(η5-
C9H5)}Sn(µ-η5-C5Me5)Sn(η5-C5Me5)]+; however, instead the reaction afforded the 
crystalline product [(η5-C5Me5)Sn][B(C6F5)4] (Figure 2.13).  Evidently, the less 
stable [{1,3-(Me3Si)2(η5-C9H5)}Sn]+ cation abstracted a [C5Me5]¯ moiety from 
decamethylstannocene to generate the most stable combination of products, 










Figure 2.13  Reaction scheme for the intended synthesis of mixed ligand, 
triple-decker cations.  Methyl groups have been omitted for clarity. 
 
CONCLUSIONS AND FUTURE WORK     
 The group 14 bis(π-indenyl) and (π-indenyl)(C5Me5) metallocenes have 
been successfully synthesized and structurally characterized.  Unlike several of 
their transition metal analogues, the π-indenide ligand is η5-coordinated to the 
group 14 element center in all of the complexes examined.  In the bis(π-indenyl) 
systems, the indenyl ligands orient themselves in a gauche fashion in order to 
minimize methyl group interactions. 
 The indenide ligand was found to coordinate weakly to the main group 
element centers.  In the mixed ligand systems, and [1,3-(Me3Si)2(η5-C9H5)](η5-
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C5Me5)E, the group 14 element center was significantly closer to the C5Me5 ring 
centroid, thus indicating an appreciably stronger bond to the C5Me5 ring than 
compared to the 1,3-(Me3Si)2(η5-C9H5) ring.  Additional information regarding 
the bond strengths and stability of the complexes was provided by the reaction of 
[{1,3-(Me3Si)2(η5-C9H5)}Sn]+ with decamethylstannocene.  Abstraction of a 
[C5Me5]¯ anion by the indenyl cation to yield the most stable products 
congruently with the observed thermal stabilities and the pattern of bond lengths 




5-C5Me5)Ge > [1,3-(Me3Si)2(η5-C9H5)]2Ge >
[1,3-(Me3Si)2(η
5-C9H5)](η
5-C5Me5)Sn > [1,3-(Me3Si)2(η5-C9H5)]2Sn >
[1,3-(Me3Si)2(η
5-C9H5)](η
5-C5Me5)Pb > [1,3-(Me3Si)2(η5-C9H5)]2Pb >  
 On the basis of the reactions studied, the indenide ligand is highly labile.  
Such complexes with labile ligands are ideally suited to serve as precursors to 
nanoparticles.  Future work should therefore include the testing of bis(π-indenyl) 




 All solvents were distilled over sodium benzophenone ketyl, except 
dichloromethane, which was distilled over CaH2, and degassed prior to use.  An 
M-Braun or VAC Vacuum Atmosphere argon-filled drybox was used for the 
manipulation of all solid reagents.  All reactions were performed under dry, 
oxygen-free conditions using standard Schlenk or drybox techniques.  To ensure 
the absence of water, all glassware was dried overnight in a 140° C oven before 
use. 
 The group 14 dihalides were purchased from a commercial source and 
used without further purification.  The compounds 1,3-(Me3Si)2(η-C9H5)Li[21], (η-
Me5C5)SnCl[28], and (η-Me5C5)PbCl[29] were prepared according to literature 
procedures. 
Physical Measurements 
 Low-resolution CI mass spectra were collected on a Finnigan MAT TSQ-
700 machine; high resolution mass spectra were measured on a VG Analytical 
ZAB-VE sector instrument.  Mass spectra samples were flame sealed in glass 
capillaries to prevent exposure to oxygen.  Unless otherwise noted, solution phase 
13C and 1H NMR spectra were recorded at 295 K on a GE EQ-300 instrument (1H, 
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300 MHz; 13C, 75 MHz).  Some 13C and 1H NMR spectra and all the 11B, 19F, 
119Sn, and 207Pb solution-phase NMR spectra were recorded at 295 K on a Varian 
Inova-500 spectrometer (1H, 500 MHz; 11B, 160 MHz; 13C, 125 MHz; 19F, 470 
MHz; 27Al, 130 MHz).  NMR samples were flame-sealed or run immediately 
following removal from the drybox.  The CD2Cl2 solvent was obtained in sealed 
vials from a commercial source and used without further purification.  The 1H and 
13C spectra are reported relative to tetramethylsilane (0.00 ppm) and referenced to 
the solvent.  119Sn chemical shifts are reported relative to Me4Sn (0.00 ppm), 
while 207Pb spectra are reported relative to Me4Pb (0.00 ppm).  Unless otherwise 
noted, the 13C spectra were obtained under conditions of broadband proton 
decoupling.  Melting points were obtained on a Fisher-Johns apparatus after 
flame-sealing the samples in glass capillaries under argon; the reported values are 
uncorrected. 
X-Ray Crystallography 
Structure determination and refinements were performed by the author at 
the University of Texas at Austin.  Suitable single crystals were covered with a 
perfluorinated polyether oil to minimize oxygen-exposure.  The X-ray data were 
collected on a Nonius Kappa CCD diffractometer equipped with an Oxford 
Cryostream liquid nitrogen cooling stream.    Samples were mounted on a fine 
glass fiber using commercial silicon grease as an adhesive.  All data collections 
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were performed at 153(2) K using a graphite monochromated Mo Kα radiation (λ 
= 0.71073 Å).  A correction was applied for Lorentz-polarization.  All structures 
were solved by direct methods and refined by full-matrix least squares on F2 using 
the Siemens SHELX PLUS 5.0 (PC) software package.[30]  All non-hydrogen 
atoms were allowed anisotropic thermal motion.  When possible, all hydrogen 
atoms were located via the model; however, it was occasionally necessary to 
place the hydrogen atoms in calculated positions (C—H 0.96 Å).  The hydrogen 
atoms were refined using a riding model and a general isotropic thermal 
parameter.  The total number of reflections, collection ranges, and final R-values 
for each molecule are listed in the appropriate crystallographic data tables. 
Synthesis of [1,3-(Me3Si)2(η5-C9H5)]2Sn], 10 
 A yellow solution of SnCl2 (0.405 g, 2.13 mmol) in THF (40 mL) was 
treated with a two equivalents of a 1,3-(Me3Si)2(η5-C9H5)Li (1.136 g, 4.27 mmol) 
THF solution (40 mL) of  at 0° C.  The orange-red solution was stirred at room 
for 1h.  The solvent and volatiles were removed under reduced pressure rendering 
a red oily solid.  The product was extracted into pentane (60 mL) and filtered 
through Celite® to give an orange-red solution.  A thick, red oil was obtained by 
removing the volatiles.  Storage of the oil at -20° C afforded a crop of red crystals 
of 10 (0.604g , 62.2% yield).  Spectroscopic Data:  HRMS (CI, CH4): calcd for 
C30H46Si2Sn, m/z 639.177; found, 639.1788; 1H NMR (C6D6): δ 0.348 [s, 
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(CH3)3Si], 6.36 [s, H(2)], 6.99—7.02 and 7.49—7.52 [AA’BB’ system, H(5)—
H(8)]; 13C{1H} NMR (C6D6):  δ 1.089 [s, (CH3)3Si], 110.405 [s, C(1) and C(3)], 
122.759—122.917 [s, C(4), C(9), and C(2)], 124.002 [s, C(6) and C(7)], 141.007 
[s, C(5) and C(8)]; 119Sn NMR (C6D6): δ -2168. 
Synthesis of [1,3-(Me3Si)2(η5-C9H5)](η5-C5Me5)Sn, 11 
 A yellow solution of (η5-C5Me5)SnCl (0.140 g, 0.483 mmol) in THF (40 
mL) was treated with a THF solution (40 mL) of 1,3-(Me3Si)2(η5-C9H5)Li (0.128 
g, 0.481 mmol) at 0° C.  The yellow-orange solution was stirred at room for 1h.  
The solvent and volatiles were removed under reduced pressure rendering a red 
oily solid.  The product was extracted into pentane (60 mL) and filtered through 
Celite® to give a yellow-orange solution.  The solution was concentrated under 
reduced pressure to a volume of approximately 20 mL.  Storage of this solution at 
-20° C afforded a crop of yellow crystals of 11 (~ 45% yield).  Spectroscopic 
Data:  HRMS (CI, CH4): calcd for C24H30Si2Sn, m/z 499.1299; found, 499.1319; 
1H NMR (C6D6): δ 0.499 [s, (CH3)3Si], 1.716 [s, (CH3)5C5], 6.407 [s, H(2)]; 
7.081—7.112 and 7.795—7.825 [AA’BB’ system, H(5)—H(8)]; 13C{1H} NMR 
(C6D6):  δ 0.97 [s, (CH3)3Si], 9.42 [s, (CH3)5C5],  111.54 [s, C(1) and C(3)], 
118.37 [s, (CH3)5C5], 122.22—122.34 [C(4), C(9) and C(2)], 124.06 [s, C(6) and 
C(7)], 141.03 [s, C(5) and C(8)]; 119Sn NMR (C6D6): δ -2121. 
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Synthesis of [1,3-(Me3Si)2(η5-C9H5)](η5-C5Me5)Pb, 12 
 An orange solution of (η5-C5Me5)PbCl (0.587 g, 1.55 mmol) in THF (40 
mL) was treated with a 1,3-(Me3Si)2(η5-C9H5)Li (0.413 g, 1.55 mmol) in THF 
solution (40 mL) at 0° C.  The orange-red solution was stirred at room for 1h.  
The solvent and volatiles were removed under reduced pressure rendering a red 
oily solid.  The product was extracted into pentane (60 mL) and filtered through 
Celite® to give an orange-red solution.  A thick, red oily solution was obtained by 
removal of the volatiles under reduced pressure.  Storage of the oil at -20° C 
afforded a crop of red crystals of 12 (0.334 g, 35.7% yield).  Spectroscopic Data:  
HRMS (CI, CH4): calcd for C25H38Si2Pb, m/z 603.2356; found, 603.2372; 1H 
NMR (C6D6): δ 0.493 [s, (CH3)3Si], 1.989 [s, (CH3)5C5], 6.460 [s, H(2)]; 7.118—
7.139 and 7.821—7.851 [AA’BB’ system, H(5)—H(8)]; 13C{1H} NMR (C6D6):  
δ 1.20 [s, (CH3)3Si], 9.06 [s, (CH3)5C5],  111.77 [s, C(1) and C(3)], 119.99 [s, 
(CH3)5C5] 121.85—121.88 [C(4), C(9) and C(2)], 123.66 [s, C(6) and C(7)], 
126.94 [s, C(5) and C(8)]; 207Pb NMR (CDCl3): δ -4402. 
Synthesis of [1,3-(Me3Si)2(η5-C9H5)]2Li2·Et2O, 13 
 An orange solution of SbCl3 (0.339 g, 1.5 mmol) in THF (40 mL) was 
treated with a two equivalents of 1,3-(Me3Si)2(η5-C9H5)Li (0.399 g, 1.5 mmol) in 
THF solution (40 mL) at 0° C.  The orange-red solution was stirred at room for 
1h.  The solvent and volatiles were removed under reduced pressure rendering a 
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red oily solid.  The product was extracted into pentane (60 mL) and filtered 
through Celite® to give a yellow-orange solution.  The volume of the solution was 
reduced to ca. 20 mL under reduced pressure.  Storage of this solution at -20° C 
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Figure 2.14  Molecular structure of [1,3-(Me3Si)2(η5-C9H5)]Li·2THF , 9, 
showing the atom number scheme.  Atoms are colored as follows:  carbon 
(black), silicon (cyan), lithium (violet), and oxygen (red).  The thermal 
ellipsoids are shown at the 30% probability level.  All hydrogen atoms have 
been omitted for clarity. 
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Table 2.1  Crystal Data and Structure Refinement for  
[1,3-(Me3Si)2(η5-C9H5)]Li·2THF, 9.  
Identification code  pna21 
Empirical formula  C23 H40 Li O2 Si2 
Formula weight  411.67 
Temperature  153(2) K 
Wavelength  0.71069 Å 
Crystal system  Orthorhombic 
Space group  Pna21 
Unit cell dimensions a = 15.226(5) Å     α= 90.000(5)°. 
 b = 10.240(5) Å     β= 90.000(5)°. 
 c = 16.141(5) Å     γ = 90.000(5)°. 
Volume 2516.6(17) Å3 
Z 4 
Density (calculated) 1.087 Mg/m3 
Absorption coefficient 0.155 mm-1 
F(000) 900 
Crystal size 0.20 x 0.20 x 0.20 mm3 
Theta range for data collection 2.96 to 30.19°. 
Index ranges -19≤h≤20, -13≤k≤13, -22≤l≤21 
Reflections collected 9727 
Independent reflections 5794 [R(int) = 0.1359] 
Completeness to theta = 30.19° 84.2 %  
Absorption correction None 
Max. and min. transmission 0.9696 and 0.9696 
Refinement method Full-matrix least-squares on F2 
Goodness-of-fit on F2 1.056 
Final R indices [I>2sigma(I)] R1 = 0.0769, wR2 = 0.1084 
R indices (all data) R1 = 0.2120, wR2 = 0.1432 
Absolute structure parameter 0.6(2) 
Largest diff. peak and hole 0.324 and -0.525 e.Å-3 
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Table 2.2  Selected Bond Lengths (Å) for [1,3-(Me3Si)2(η5-C9H5)]Li·2THF, 9. 
 
C(1)-C(2)  1.416(7) C(11)-Si(1)  1.859(7) 
C(1)-C(9)  1.441(7) C(12)-Si(1)  1.861(6) 
C(1)-Si(1)  1.842(5) C(13)-Si(2)  1.874(5) 
C(1)-Li  2.320(9)  C(14)-Si(2)  1.878(7) 
C(2)-C(3)  1.427(7)  C(15)-Si(2)  1.870(6) 
C(2)-Li  2.243(9)  C(16)-O(1)  1.445(6) 
C(3)-C(4)  1.448(7) C(16)-C(17)  1.490(8) 
C(3)-Si(2)  1.840(5) C(17)-C(18)  1.490(8) 
C(3)-Li  2.327(10) C(18)-C(19)  1.509(8) 
C(4)-C(5)  1.424(7) C(19)-O(1)  1.465(6) 
C(4)-C(9)  1.443(5) C(20)-O(2)  1.429(7) 
C(4)-Li  2.414(9) C(20)-C(21)  1.499(8) 
C(5)-C(6)  1.364(7) C(21)-C(22)  1.514(8) 
C(6)-C(7)  1.411(7) C(22)-C(23)  1.508(8) 
C(7)-C(8)  1.390(7) C(23)-O(2)  1.462(7) 
C(8)-C(9)  1.408(7) O(1)-Li  1.913(8) 
C(9)-Li  2.410(9) O(2)-Li  1.915(8) 
C(10)-Si(1)  1.873(5) Li-X1A 2.000(4) 
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Table 2.3  Selected Bond Angles (°) for [1,3-(Me3Si)2(η5-C9H5)]Li·2THF, 9. 
 
C(2)-C(1)-C(9) 105.3(4) C(1)-Si(1)-C(12) 110.1(3) 
C(2)-C(1)-Si(1) 126.9(4) C(11)-Si(1)-C(12) 109.1(3) 
C(9)-C(1)-Si(1) 127.7(4) C(1)-Si(1)-C(10) 110.9(2) 
C(2)-C(1)-Li 69.0(3) C(11)-Si(1)-C(10) 108.5(3) 
C(9)-C(1)-Li 75.7(3) C(12)-Si(1)-C(10) 107.9(3) 
Si(1)-C(1)-Li 122.3(3) C(3)-Si(2)-C(15) 111.4(3) 
C(1)-C(2)-C(3) 113.2(4) C(3)-Si(2)-C(13) 108.3(2) 
C(1)-C(2)-Li 74.9(4) C(15)-Si(2)-C(13) 109.2(3) 
C(3)-C(2)-Li 75.0(4) C(3)-Si(2)-C(14) 111.7(3) 
C(2)-C(3)-C(4) 103.9(4) C(15)-Si(2)-C(14) 107.6(4) 
C(2)-C(3)-Si(2) 126.8(4) C(13)-Si(2)-C(14) 108.7(4) 
C(4)-C(3)-Si(2) 129.2(4) O(1)-Li-O(2) 98.5(4) 
C(2)-C(3)-Li 68.6(3) O(1)-Li-C(2) 104.7(4) 
C(4)-C(3)-Li 75.5(3) O(2)-Li-C(2) 156.0(5) 
Si(2)-C(3)-Li 122.8(3) O(1)-Li-C(1) 117.3(4) 
C(5)-C(4)-C(9) 118.7(5) O(2)-Li-C(1) 133.8(4) 
C(5)-C(4)-C(3) 131.9(5) C(2)-Li-C(1) 36.1(2) 
C(9)-C(4)-C(3) 109.3(4) O(1)-Li-C(3) 121.6(4) 
C(5)-C(4)-Li 124.7(4) O(2)-Li-C(3) 123.5(4) 
C(9)-C(4)-Li 72.4(4) C(2)-Li-C(3) 36.3(2) 
C(3)-C(4)-Li 69.0(3) C(1)-Li-C(3) 61.4(2) 
C(6)-C(5)-C(4) 119.9(5) O(1)-Li-C(9) 151.7(5) 
C(5)-C(6)-C(7) 121.3(5) O(2)-Li-C(9) 102.5(4) 
C(8)-C(7)-C(6) 120.9(5) C(2)-Li-C(9) 58.3(2) 
C(7)-C(8)-C(9) 119.0(5) C(1)-Li-C(9) 35.4(2) 
C(8)-C(9)-C(1) 131.7(5) C(3)-Li-C(9) 59.7(3) 
C(8)-C(9)-C(4) 120.1(5) O(1)-Li-C(4) 157.1(5) 
C(1)-C(9)-C(4) 108.2(4) O(2)-Li-C(4) 97.9(4) 
C(8)-C(9)-Li 124.3(4) C(2)-Li-C(4) 58.1(3) 
C(1)-C(9)-Li 68.9(3) C(1)-Li-C(4) 59.1(2) 
C(4)-C(9)-Li 72.7(4) C(3)-Li-C(4) 35.5(2) 
C(1)-Si(1)-C(11) 110.3(3) C(9)-Li-C(4) 34.82(17) 
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Figure 2.15  Molecular structure of [1,3-(Me3Si)2(η5-C9H5)]2Sn, 10, showing 
the two independent molecules per unit cell.  Atoms are colored as follows:  
carbon (black), silicon (cyan), and tin (orange).  The thermal ellipsoids are 
shown at the 30% probability level.  All hydrogen atoms have been omitted 
for clarity. 
 
Figure 2.16  Molecular structure of the two independent molecules in the 
[1,3-(Me3Si)2(η5-C9H5)]2Sn, 10, crystal structure.  The figure indicates the 
complete atom numbering scheme.  Atoms are colored as follows:  carbon 
(black), silicon (cyan), and tin (orange).  The thermal ellipsoids are shown at 
the 30% probability level.  All hydrogen atoms have been omitted for clarity. 
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Table 2.4  Crystal Data and Structure Refinement for  
[1,3-(Me3Si)2(η5-C9H5)]2Sn, 10.  
Identification code  p1bar 
Empirical formula  C60 H60 Si8 Sn2 
Formula weight  1243.18 
Temperature  153(2) K 
Wavelength  0.71069 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 11.440(5) Å     α= 103.452(5)°. 
 b = 17.300(5) Å     β= 105.369(5)°. 
 c = 18.587(5) Å      γ = 91.091(5)°. 
Volume 3437(2) Å3 
Z 2 
Density (calculated) 1.201 Mg/m3 
Absorption coefficient 0.898 mm-1 
F(000) 1264 
Crystal size 0.20 x 0.20 x 0.20 mm3 
Theta range for data collection 3.12 to 27.43°. 
Index ranges -13≤h≤14, -20≤k≤22, -24≤l≤24 
Reflections collected 24136 
Independent reflections 15537 [R(int) = 0.0289] 
Completeness to theta = 27.43° 99.1 %  
Absorption correction None 
Max. and min. transmission 0.8409 and 0.8409 
Refinement method Full-matrix least-squares on F2 
Goodness-of-fit on F2 1.052 
Final R indices [I>2sigma(I)] R1 = 0.0433, wR2 = 0.0798 
R indices (all data) R1 = 0.0702, wR2 = 0.0889 
Extinction coefficient 0.00152(17) 
Largest diff. peak and hole 0.765 and -0.752 e.Å-3 
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Table 2.5  Selected Bond Lengths (Å) for [1,3-(Me3Si)2(η5-C9H5)]2Sn, 10. 
 
C(1)-Sn(1)  2.639(4) C(32)-C(33)  1.437(4) 
C(2)-C(3)  1.411(5)  C(32)-Sn(2)  2.643(3) 
C(3)-C(4)  1.453(4)  C(33)-C(34)  1.448(5) 
C(3)-Si(2)  1.861(3)  C(33)-Sn(2)  2.610(3) 
C(4)-C(5)  1.410(5) C(34)-C(35)  1.416(5) 
C(4)-C(9)  1.446(5) C(34)-C(39)  1.435(4) 
C(5)-C(6)  1.372(5) C(35)-C(36)  1.356(5) 
C(6)-C(7)  1.400(6) C(36)-C(37)  1.399(5) 
C(7)-C(8)  1.359(6) C(37)-C(38)  1.379(5) 
C(8)-C(9)  1.416(5) C(38)-C(39)  1.409(5) 
C(16)-C(17)  1.422(5) C(46)-C(47)  1.426(4) 
C(16)-C(24)  1.441(4) C(46)-C(54)  1.447(4) 
C(17)-C(18)  1.431(4) C(46)-Sn(2)  2.612(3) 
C(17)-Sn(1)  2.580(3) C(47)-C(48)  1.413(4) 
C(18)-C(19)  1.445(5) C(47)-Sn(2)  2.617(3) 
C(18)-Sn(1)  2.600(3) C(48)-C(49)  1.443(4) 
C(19)-C(20)  1.415(4) C(49)-C(50)  1.411(4) 
C(19)-C(24)  1.434(4) C(49)-C(54)  1.431(4) 
C(20)-C(21)  1.361(5) C(50)-C(51)  1.366(5) 
C(21)-C(22)  1.396(5) C(51)-C(52)  1.404(5) 
C(22)-C(23)  1.379(5) C(52)-C(53)  1.362(5) 
C(23)-C(24)  1.410(5) C(53)-C(54)  1.426(4) 
C(31)-C(32)  1.410(4)   
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Table 2.6  Selected Bond Angles (°) for [1,3-(Me3Si)2(η5-C9H5)]2Sn, 10. 
 
C(2)-C(1)-C(9) 104.3(3) C(34)-C(33)-Sn(2) 79.23(18) 
C(2)-C(1)-Sn(1) 75.5(2) C(35)-C(34)-C(39) 119.6(3) 
C(9)-C(1)-Sn(1) 78.04(19) C(35)-C(34)-C(33) 131.9(3) 
C(3)-C(2)-C(1) 113.4(3) C(39)-C(34)-C(33) 108.5(3) 
C(2)-C(3)-C(4) 104.7(3) C(36)-C(35)-C(34) 119.5(4) 
C(5)-C(4)-C(9) 119.3(3) C(35)-C(36)-C(37) 121.5(4) 
C(5)-C(4)-C(3) 131.8(3) C(38)-C(37)-C(36) 120.9(3) 
C(9)-C(4)-C(3) 108.9(3) C(37)-C(38)-C(39) 119.6(3) 
C(6)-C(5)-C(4) 119.4(4) C(38)-C(39)-C(34) 118.9(3) 
C(5)-C(6)-C(7) 121.0(4) C(38)-C(39)-C(31) 132.3(3) 
C(8)-C(7)-C(6) 122.0(4) C(34)-C(39)-C(31) 108.9(3) 
C(7)-C(8)-C(9) 119.2(4) C(47)-C(46)-C(54) 104.4(3) 
C(8)-C(9)-C(4) 119.2(3) C(47)-C(46)-Sn(2) 74.36(17) 
C(8)-C(9)-C(1) 132.1(3) C(54)-C(46)-Sn(2) 79.80(17) 
C(4)-C(9)-C(1) 108.6(3) C(48)-C(47)-C(46) 112.8(3) 
C(17)-C(16)-C(24) 105.0(3) C(48)-C(47)-Sn(2) 79.21(17) 
C(16)-C(17)-C(18) 112.2(3) C(46)-C(47)-Sn(2) 73.97(17) 
C(16)-C(17)-Sn(1) 79.60(19) C(47)-C(48)-C(49) 104.9(3) 
C(18)-C(17)-Sn(1) 74.73(19) C(50)-C(49)-C(54) 119.3(3) 
C(17)-C(18)-C(19) 104.8(3) C(50)-C(49)-C(48) 131.8(3) 
C(17)-C(18)-Sn(1) 73.18(18) C(54)-C(49)-C(48) 108.9(3) 
C(19)-C(18)-Sn(1) 81.14(18) C(51)-C(50)-C(49) 119.6(3) 
C(20)-C(19)-C(24) 119.3(3) C(50)-C(51)-C(52) 121.3(3) 
C(20)-C(19)-C(18) 132.0(3) C(53)-C(52)-C(51) 121.2(3) 
C(24)-C(19)-C(18) 108.7(3) C(52)-C(53)-C(54) 119.3(3) 
C(21)-C(20)-C(19) 119.8(3) C(53)-C(54)-C(49) 119.3(3) 
C(20)-C(21)-C(22) 121.3(3) C(53)-C(54)-C(46) 131.9(3) 
C(23)-C(22)-C(21) 121.0(4) C(49)-C(54)-C(46) 108.8(3) 
C(22)-C(23)-C(24) 119.5(3) C(17)-Sn(1)-C(18) 32.09(10) 
C(23)-C(24)-C(19) 119.2(3) C(17)-Sn(1)-C(1) 116.68(11)
C(23)-C(24)-C(16) 131.7(3) C(18)-Sn(1)-C(1) 124.72(11)
C(19)-C(24)-C(16) 109.0(3) C(33)-Sn(2)-C(46) 125.62(10)
C(32)-C(31)-C(39) 105.6(3) C(33)-Sn(2)-C(47) 117.81(10)
C(31)-C(32)-C(33) 112.1(3) C(46)-Sn(2)-C(47) 31.66(9) 
C(31)-C(32)-Sn(2) 79.93(18) C(33)-Sn(2)-C(32) 31.74(10) 
C(33)-C(32)-Sn(2) 72.83(18) C(46)-Sn(2)-C(32) 119.56(10)
111 
C(32)-C(33)-C(34) 104.9(3) C(47)-Sn(2)-C(32) 132.11(10)
C(32)-C(33)-Sn(2) 75.43(18)   
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Figure 2.17  Molecular structure of [1,3-(Me3Si)2(η5-C9H5)](η5-C5Me5)Sn, 11, 
showing the two independent molecules per unit cell.  Atoms are colored as 
follows:  carbon (black), silicon (cyan), and tin (orange).  The thermal 
ellipsoids are shown at the 30% probability level.  All hydrogen atoms have 
been omitted for clarity. 
 
Figure 2.18  Molecular structures and complete atom numbering schemes for 
the two independent molecules in the crystal structure of [1,3-(Me3Si)2(η5-
C9H5)](η5-C5Me5)Sn.  Atoms are colored as follows:  carbon (black), silicon 
(cyan), and tin (orange).  The thermal ellipsoids are shown at the 30% 
probability level.  All hydrogen atoms have been omitted for clarity. 
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Table 2.7  Crystal Data and Structure Refinement for [1,3-(Me3Si)2(η5-
C9H5)](η5-C5Me5)Sn, 11. 
Identification code  p21212 
Empirical formula  C50 H76 Si4 Sn2 
Formula weight  1026.85 
Temperature  153(2) K 
Wavelength  0.71069 Å 
Crystal system  Orthorhombic 
Space group  P21212 
Unit cell dimensions a = 21.232(5) Å      α= 90.000(5)°. 
 b = 24.238(5) Å      β= 90.000(5)°. 
 c = 10.398(5) Å       γ = 90.000(5)°. 
Volume 5351(3) Å3 
Z 4 
Density (calculated) 1.275 Mg/m3 
Absorption coefficient 1.053 mm-1 
F(000) 2128 
Crystal size 0.20 x 0.20 x 0.20 mm3 
Theta range for data collection 3.00 to 27.23°. 
Index ranges -27≤h≤27, -31≤k≤31, -13≤l≤13 
Reflections collected 23473 
Independent reflections 11903 [R(int) = 0.1077] 
Completeness to theta = 27.23° 99.3 %  
Absorption correction None 
Max. and min. transmission 0.8171 and 0.8171 
Refinement method Full-matrix least-squares on F2 
Goodness-of-fit on F2 1.049 
Final R indices [I>2sigma(I)] R1 = 0.0590, wR2 = 0.0850 
R indices (all data) R1 = 0.1275, wR2 = 0.1041 
Extinction coefficient 0.00174(12) 
Largest diff. peak and hole 0.941 and -1.588 e.Å-3 
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Table 2.8  Selected Bond Lengths (Å) for [1,3-(Me3Si)2(η5-C9H5)]( η5-
C5Me5)Sn, 11. 
 
C(1)-C(2)  1.423(11) C(26)-C(30)  1.404(11) 
C(1)-C(5)  1.435(11) C(26)-C(31)  1.501(11) 
C(1)-C(6)  1.499(12) C(26)-Sn(2)  2.617(6) 
C(1)-Sn(1)  2.474(7) C(27)-C(28)  1.403(10) 
C(2)-C(3)  1.337(11) C(27)-C(32)  1.516(11) 
C(2)-C(7)  1.529(12) C(28)-C(29)  1.440(10) 
C(2)-Sn(1)  2.565(7) C(28)-C(33)  1.495(10) 
C(3)-C(4)  1.367(11) C(28)-Sn(2)  2.649(7) 
C(3)-C(8)  1.561(13) C(29)-C(30)  1.438(11) 
C(4)-C(5)  1.410(12) C(29)-C(34)  1.492(10) 
C(4)-C(9)  1.516(11) C(29)-Sn(2)  2.527(7) 
C(5)-C(10)  1.505(12) C(30)-C(35)  1.520(11) 
C(5)-Sn(1)  2.570(8) C(30)-Sn(2)  2.520(8) 
C(11)-C(19)  1.409(9) C(36)-C(37)  1.415(10) 
C(11)-C(12)  1.436(9) C(36)-C(44)  1.434(9) 
C(12)-C(13)  1.438(8) C(37)-C(38)  1.460(9) 
C(13)-C(14)  1.408(9) C(38)-C(39)  1.411(9) 
C(13)-C(18)  1.432(8) C(38)-C(43)  1.430(9) 
C(14)-C(15)  1.358(9) C(39)-C(40)  1.369(10) 
C(15)-C(16)  1.404(10) C(40)-C(41)  1.384(10) 
C(16)-C(17)  1.368(9) C(41)-C(42)  1.368(10) 
C(17)-C(18)  1.410(9) C(42)-C(43)  1.413(9) 
C(18)-C(19)  1.441(9) C(43)-C(44)  1.447(9) 
C(26)-C(27)  1.401(10)   
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Table 2.9  Selected Bond Angles (°) for [1,3-(Me3Si)2(η5-C9H5)](η5-C5Me5)Sn, 
11. 
 
C(2)-C(1)-C(5) 106.4(7) C(26)-C(27)-C(28) 110.0(7) 
C(2)-C(1)-C(6) 126.9(10) C(26)-C(27)-C(32) 126.8(8) 
C(5)-C(1)-C(6) 125.4(10) C(28)-C(27)-C(32) 123.2(8) 
C(2)-C(1)-Sn(1) 77.2(4) C(27)-C(28)-C(29) 107.0(7) 
C(5)-C(1)-Sn(1) 77.2(4) C(27)-C(28)-C(33) 126.5(7) 
C(6)-C(1)-Sn(1) 121.6(6) C(29)-C(28)-C(33) 126.4(7) 
C(3)-C(2)-C(1) 108.5(7) C(27)-C(28)-Sn(2) 76.5(4) 
C(3)-C(2)-C(7) 126.1(10) C(29)-C(28)-Sn(2) 69.2(4) 
C(1)-C(2)-C(7) 124.4(10) C(33)-C(28)-Sn(2) 121.6(5) 
C(3)-C(2)-Sn(1) 81.0(5) C(30)-C(29)-C(28) 106.8(6) 
C(1)-C(2)-Sn(1) 70.1(4) C(30)-C(29)-C(34) 125.6(8) 
C(7)-C(2)-Sn(1) 123.9(6) C(28)-C(29)-C(34) 126.7(8) 
C(2)-C(3)-C(4) 110.7(8) C(30)-C(29)-Sn(2) 73.2(4) 
C(2)-C(3)-C(8) 124.6(10) C(28)-C(29)-Sn(2) 78.6(4) 
C(4)-C(3)-C(8) 124.7(10) C(34)-C(29)-Sn(2) 122.4(5) 
C(3)-C(4)-C(5) 108.6(7) C(26)-C(30)-C(29) 108.3(7) 
C(3)-C(4)-C(9) 125.3(10) C(26)-C(30)-C(35) 127.1(8) 
C(5)-C(4)-C(9) 126.1(10) C(29)-C(30)-C(35) 124.3(8) 
C(4)-C(5)-C(1) 105.9(7) C(26)-C(30)-Sn(2) 78.0(4) 
C(4)-C(5)-C(10) 126.9(10) C(29)-C(30)-Sn(2) 73.7(4) 
C(1)-C(5)-C(10) 126.8(10) C(35)-C(30)-Sn(2) 119.7(5) 
C(4)-C(5)-Sn(1) 80.0(5) C(37)-C(36)-C(44) 114.0(6) 
C(1)-C(5)-Sn(1) 69.8(4) C(36)-C(37)-C(38) 103.7(6) 
C(10)-C(5)-Sn(1) 120.8(5) C(39)-C(38)-C(43) 119.2(6) 
C(19)-C(11)-C(12) 113.0(6) C(39)-C(38)-C(37) 131.6(6) 
C(11)-C(12)-C(13) 103.8(6) C(43)-C(38)-C(37) 109.2(6) 
C(14)-C(13)-C(18) 118.2(6) C(40)-C(39)-C(38) 119.0(7) 
C(14)-C(13)-C(12) 132.3(6) C(39)-C(40)-C(41) 122.1(7) 
C(18)-C(13)-C(12) 109.5(6) C(42)-C(41)-C(40) 120.8(7) 
C(15)-C(14)-C(13) 120.2(7) C(41)-C(42)-C(43) 119.5(7) 
C(14)-C(15)-C(16) 121.2(7) C(42)-C(43)-C(38) 119.4(6) 
C(17)-C(16)-C(15) 121.2(6) C(42)-C(43)-C(44) 131.3(6) 
C(16)-C(17)-C(18) 118.6(6) C(38)-C(43)-C(44) 109.3(6) 
C(17)-C(18)-C(13) 120.6(6) C(36)-C(44)-C(43) 103.8(6) 
C(17)-C(18)-C(19) 130.7(6) C(1)-Sn(1)-C(2) 32.7(3) 
116 
C(13)-C(18)-C(19) 108.6(5) C(1)-Sn(1)-C(5) 33.0(3) 
C(11)-C(19)-C(18) 104.9(5) C(2)-Sn(1)-C(5) 52.9(3) 
C(27)-C(26)-C(30) 107.8(7) C(30)-Sn(2)-C(29) 33.1(2) 
C(27)-C(26)-C(31) 125.8(9) C(30)-Sn(2)-C(26) 31.7(2) 
C(30)-C(26)-C(31) 126.2(8) C(29)-Sn(2)-C(26) 53.2(3) 
C(27)-C(26)-Sn(2) 77.7(4) C(30)-Sn(2)-C(28) 53.0(2) 
C(30)-C(26)-Sn(2) 70.4(4) C(29)-Sn(2)-C(28) 32.2(2) 





Figure 2.19  Molecular structures of the four independent molecules of [1,3-
(Me3Si)2(η5-C9H5)](η5-C5Me5)Pb, 12, per unit cell.  Atoms are colored as 
follows:  carbon (black), silicon (cyan), and lead (green).  The thermal 
ellipsoids are shown at the 30% probability level.  All hydrogen atoms have 




Figure 2.20  Molecular structures and complete atom numbering schemes for 
the four independent molecules of [1,3-(Me3Si)2(η5-C9H5)](η5-C5Me5)Pb, 12, 
per unit cell.  Atoms are colored as follows:  carbon (black), silicon (cyan), 
and lead (green).  The thermal ellipsoids are shown at the 30% probability 
level.  All hydrogen atoms have been omitted for clarity. 
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Table 2.10  Crystal data and structure refinement for [1,3-(Me3Si)2(η5-
C9H5)](η5-C5Me5)Pb, 12. 
Identification code  pna21 
Empirical formula  C100 H152 Pb4 Si8 
Formula weight  2407.70 
Temperature  153(2) K 
Wavelength  0.71069 Å 
Crystal system  Orthorhombic 
Space group  Pna21 
Unit cell dimensions a = 35.144(5) Å     α= 90.000(5)°. 
 b = 10.548(5) Å     β= 90.000(5)°. 
 c = 31.090(5) Å      γ = 90.000(5)°. 
Volume 11525(6) Å3 
Z 4 
Density (calculated) 1.388 Mg/m3 
Absorption coefficient 5.946 mm-1 
F(000) 4768 
Crystal size 0.20 x 0.20 x 0.20 mm3 
Theta range for data collection 2.91 to 27.50°. 
Index ranges -45≤h≤45, -13≤k≤13, -40≤l≤40 
Reflections collected 24183 
Independent reflections 24183 [R(int) = 0.0000] 
Completeness to theta = 27.50° 98.5 %  
Max. and min. transmission 0.3826 and 0.3826 
Refinement method Full-matrix least-squares on F2 
Goodness-of-fit on F2 1.022 
Final R indices [I>2sigma(I)] R1 = 0.0798, wR2 = 0.1646 
R indices (all data) R1 = 0.1676, wR2 = 0.1983 
Absolute structure parameter 0.491(11) 
Largest diff. peak and hole 2.895 and -1.182 e.Å-3 
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Table 2.11  Selected Bond Lengths (Å) for [1,3-(Me3Si)2(η5-C9H5)](η5-
C5Me5)Pb, 12. 
 
C(1)-C(5)  1.42(3) C(51)-C(55)  1.37(3) 
C(1)-C(6)  1.44(4) C(51)-C(52)  1.40(3) 
C(1)-C(2)  1.46(4) C(51)-C(56)  1.54(3) 
C(1)-Pb(1)  2.637(18) C(51)-Pb(3)  2.76(2) 
C(2)-C(3)  1.35(4) C(52)-C(53)  1.38(3) 
C(2)-C(7)  1.57(4) C(52)-C(57)  1.56(3) 
C(2)-Pb(1)  2.614(19) C(52)-Pb(3)  2.595(19) 
C(3)-C(4)  1.39(3) C(53)-C(54)  1.44(3) 
C(3)-C(8)  1.54(4) C(53)-C(58)  1.55(3) 
C(3)-Pb(1)  2.71(2) C(53)-Pb(3)  2.617(18) 
C(4)-C(5)  1.38(3) C(54)-C(59)  1.41(3) 
C(4)-C(9)  1.52(4) C(54)-C(55)  1.41(3) 
C(4)-Pb(1)  2.76(2) C(54)-Pb(3)  2.766(19) 
C(5)-C(10)  1.55(3) C(55)-C(60)  1.50(4) 
C(5)-Pb(1)  2.68(2) C(55)-Pb(3)  2.78(2) 
C(11)-C(19)  1.37(2) C(61)-C(69)  1.40(3) 
C(11)-C(12)  1.45(2) C(61)-C(62)  1.51(3) 
C(11)-Pb(1)  2.846(17) C(61)-Pb(3)  2.838(16) 
C(12)-C(13)  1.41(3) C(62)-C(67)  1.40(3) 
C(12)-C(17)  1.48(3) C(62)-C(63)  1.43(3) 
C(13)-C(14)  1.35(3) C(63)-C(64)  1.36(3) 
C(14)-C(15)  1.34(3) C(64)-C(65)  1.47(3) 
C(15)-C(16)  1.41(3) C(65)-C(66)  1.37(3) 
C(16)-C(17)  1.41(3) C(66)-C(67)  1.43(3) 
C(17)-C(18)  1.45(3) C(67)-C(68)  1.41(3) 
C(18)-C(19)  1.45(3) C(68)-C(69)  1.42(2) 
C(18)-Pb(1)  2.87(2) C(69)-Pb(3)  2.760(19) 
C(19)-Pb(1)  2.75(2) C(76)-C(77)  1.40(3) 
C(26)-C(30)  1.46(3) C(76)-C(80)  1.43(3) 
C(26)-C(27)  1.48(4) C(76)-C(81)  1.52(3) 
C(26)-C(32)  1.53(4) C(76)-Pb(4)  2.704(17) 
C(26)-Pb(2)  2.61(2) C(77)-C(78)  1.41(3) 
C(27)-C(28)  1.33(3) C(77)-C(82)  1.55(3) 
C(27)-C(33)  1.42(4) C(77)-Pb(4)  2.606(16) 
C(27)-Pb(2)  2.64(2) C(78)-C(79)  1.43(3) 
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C(28)-C(29)  1.40(3) C(78)-C(83)  1.53(3) 
C(28)-C(34)  1.53(3) C(78)-Pb(4)  2.585(16) 
C(28)-Pb(2)  2.73(2) C(79)-C(80)  1.45(3) 
C(29)-C(30)  1.44(3) C(79)-C(84)  1.48(3) 
C(29)-C(35)  1.54(3) C(79)-Pb(4)  2.702(18) 
C(29)-Pb(2)  2.78(2) C(80)-C(85)  1.48(3) 
C(30)-C(31)  1.58(4) C(80)-Pb(4)  2.783(18) 
C(30)-Pb(2)  2.698(19) C(86)-C(94)  1.42(3) 
C(36)-C(44)  1.38(3) C(86)-C(87)  1.42(3) 
C(36)-C(37)  1.47(3) C(87)-C(88)  1.45(3) 
C(37)-C(42)  1.43(2) C(87)-Pb(4)  2.81(2) 
C(37)-C(38)  1.44(3) C(88)-C(89)  1.44(3) 
C(38)-C(39)  1.39(3) C(88)-Pb(4)  2.87(2) 
C(39)-C(40)  1.38(3) C(89)-C(94)  1.45(2) 
C(40)-C(41)  1.38(3) C(89)-C(90)  1.46(3) 
C(41)-C(42)  1.39(2) C(90)-C(91)  1.32(3) 
C(42)-C(43)  1.43(3) C(91)-C(92)  1.43(3) 
C(43)-C(44)  1.43(3) C(92)-C(93)  1.42(3) 
C(43)-Pb(2)  2.86(2) C(93)-C(94)  1.37(3) 
C(44)-Pb(2)  2.74(2)   
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Table 2.12  Selected Bond Angles (°) for [1,3-(Me3Si)2(η5-C9H5)](η5-
C5Me5)Pb, 12. 
 
C(5)-C(1)-C(6) 125(3) C(61)-C(69)-Pb(3) 78.7(10) 
C(5)-C(1)-C(2) 103(2) C(68)-C(69)-Pb(3) 80.2(11) 
C(6)-C(1)-C(2) 132(3) C(77)-C(76)-C(80) 111.0(18) 
C(5)-C(1)-Pb(1) 76.3(10) C(77)-C(76)-C(81) 128.2(19) 
C(6)-C(1)-Pb(1) 122.4(18) C(80)-C(76)-C(81) 120.5(19) 
C(2)-C(1)-Pb(1) 73.0(10) C(77)-C(76)-Pb(4) 70.9(8) 
C(3)-C(2)-C(1) 111(2) C(80)-C(76)-Pb(4) 78.0(10) 
C(3)-C(2)-C(7) 124(3) C(81)-C(76)-Pb(4) 123.4(13) 
C(1)-C(2)-C(7) 124(3) C(76)-C(77)-C(78) 106.8(18) 
C(3)-C(2)-Pb(1) 79.1(12) C(76)-C(77)-C(82) 127(2) 
C(1)-C(2)-Pb(1) 74.8(10) C(78)-C(77)-C(82) 125.3(19) 
C(7)-C(2)-Pb(1) 120.7(15) C(76)-C(77)-Pb(4) 78.7(9) 
C(2)-C(3)-C(4) 107(2) C(78)-C(77)-Pb(4) 73.4(8) 
C(2)-C(3)-C(8) 127(3) C(82)-C(77)-Pb(4) 121.3(12) 
C(4)-C(3)-C(8) 125(3) C(77)-C(78)-C(79) 109.4(18) 
C(2)-C(3)-Pb(1) 71.5(12) C(77)-C(78)-C(83) 126.5(19) 
C(4)-C(3)-Pb(1) 77.5(12) C(79)-C(78)-C(83) 123.3(19) 
C(8)-C(3)-Pb(1) 123.4(16) C(77)-C(78)-Pb(4) 75.0(8) 
C(5)-C(4)-C(3) 109(2) C(79)-C(78)-Pb(4) 78.9(10) 
C(5)-C(4)-C(9) 127(3) C(83)-C(78)-Pb(4) 120.8(13) 
C(3)-C(4)-C(9) 123(3) C(78)-C(79)-C(80) 107.1(17) 
C(5)-C(4)-Pb(1) 72.1(12) C(78)-C(79)-C(84) 126.5(19) 
C(3)-C(4)-Pb(1) 73.1(12) C(80)-C(79)-C(84) 126.5(19) 
C(9)-C(4)-Pb(1) 121.6(16) C(78)-C(79)-Pb(4) 69.9(10) 
C(4)-C(5)-C(1) 110(2) C(80)-C(79)-Pb(4) 77.7(10) 
C(4)-C(5)-C(10) 121(3) C(84)-C(79)-Pb(4) 119.0(13) 
C(1)-C(5)-C(10) 129(3) C(76)-C(80)-C(79) 105.6(17) 
C(4)-C(5)-Pb(1) 78.6(12) C(76)-C(80)-C(85) 127.3(19) 
C(1)-C(5)-Pb(1) 72.9(11) C(79)-C(80)-C(85) 127.0(19) 
C(10)-C(5)-Pb(1) 123.8(15) C(76)-C(80)-Pb(4) 71.9(10) 
C(19)-C(11)-C(12) 108.8(16) C(79)-C(80)-Pb(4) 71.6(10) 
C(19)-C(11)-Pb(1) 71.9(11) C(85)-C(80)-Pb(4) 122.5(13) 
C(12)-C(11)-Pb(1) 81.6(10) C(94)-C(86)-C(87) 108.3(17) 
C(13)-C(12)-C(11) 136.6(17) C(86)-C(87)-C(88) 110.8(18) 
C(13)-C(12)-C(17) 118.0(17) C(86)-C(87)-Pb(4) 77.9(12) 
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C(11)-C(12)-C(17) 105.2(16) C(88)-C(87)-Pb(4) 77.4(12) 
C(14)-C(13)-C(12) 121.1(18) C(89)-C(88)-C(87) 103.4(17) 
C(15)-C(14)-C(13) 121.9(18) C(89)-C(88)-Pb(4) 78.8(12) 
C(14)-C(15)-C(16) 122.2(19) C(87)-C(88)-Pb(4) 73.0(12) 
C(15)-C(16)-C(17) 118.6(19) Si(8)-C(88)-Pb(4) 121.6(9) 
C(16)-C(17)-C(18) 132.2(18) C(88)-C(89)-C(94) 111.1(17) 
C(16)-C(17)-C(12) 118.2(17) C(88)-C(89)-C(90) 130.8(19) 
C(18)-C(17)-C(12) 109.6(17) C(94)-C(89)-C(90) 117.9(19) 
C(19)-C(18)-C(17) 103.8(16) C(91)-C(90)-C(89) 121.2(19) 
C(19)-C(18)-Pb(1) 70.5(11) C(90)-C(91)-C(92) 120.8(17) 
C(17)-C(18)-Pb(1) 81.3(11) C(93)-C(92)-C(91) 119.5(18) 
C(11)-C(19)-C(18) 112.5(16) C(94)-C(93)-C(92) 120.8(19) 
C(11)-C(19)-Pb(1) 79.8(11) C(93)-C(94)-C(86) 134.1(17) 
C(18)-C(19)-Pb(1) 79.6(11) C(93)-C(94)-C(89) 119.7(18) 
C(30)-C(26)-C(27) 106.2(19) C(86)-C(94)-C(89) 106.2(17) 
C(30)-C(26)-C(32) 130(3) C(2)-Pb(1)-C(1) 32.2(8) 
C(27)-C(26)-C(32) 123(3) C(2)-Pb(1)-C(5) 50.1(7) 
C(30)-C(26)-Pb(2) 77.3(12) C(1)-Pb(1)-C(5) 30.9(7) 
C(27)-C(26)-Pb(2) 74.5(12) C(2)-Pb(1)-C(3) 29.3(9) 
C(32)-C(26)-Pb(2) 115.3(17) C(1)-Pb(1)-C(3) 51.3(8) 
C(28)-C(27)-C(33) 130(3) C(5)-Pb(1)-C(3) 49.5(7) 
C(28)-C(27)-C(26) 107.8(19) C(2)-Pb(1)-C(19) 101.6(7) 
C(33)-C(27)-C(26) 121(3) C(1)-Pb(1)-C(19) 104.0(6) 
C(28)-C(27)-Pb(2) 79.6(13) C(5)-Pb(1)-C(19) 133.0(7) 
C(33)-C(27)-Pb(2) 121.9(17) C(3)-Pb(1)-C(19) 125.2(8) 
C(26)-C(27)-Pb(2) 72.8(13) C(2)-Pb(1)-C(4) 48.3(8) 
C(27)-C(28)-C(29) 112(2) C(1)-Pb(1)-C(4) 50.0(7) 
C(27)-C(28)-C(34) 122(2) C(5)-Pb(1)-C(4) 29.3(7) 
C(29)-C(28)-C(34) 125(2) C(3)-Pb(1)-C(4) 29.3(7) 
C(27)-C(28)-Pb(2) 71.8(13) C(19)-Pb(1)-C(4) 149.8(6) 
C(29)-C(28)-Pb(2) 77.3(12) C(2)-Pb(1)-C(11) 107.4(6) 
C(34)-C(28)-Pb(2) 125.4(14) C(1)-Pb(1)-C(11) 123.8(6) 
C(28)-C(29)-C(30) 107.8(19) C(5)-Pb(1)-C(11) 154.5(6) 
C(28)-C(29)-C(35) 128(2) C(3)-Pb(1)-C(11) 118.7(7) 
C(30)-C(29)-C(35) 124(2) C(19)-Pb(1)-C(11) 28.3(5) 
C(28)-C(29)-Pb(2) 73.2(13) C(4)-Pb(1)-C(11) 147.7(6) 
C(30)-C(29)-Pb(2) 71.6(12) C(2)-Pb(1)-C(18) 123.1(8) 
C(35)-C(29)-Pb(2) 121.7(13) C(1)-Pb(1)-C(18) 110.3(6) 
C(29)-C(30)-C(26) 106(2) C(5)-Pb(1)-C(18) 128.2(6) 
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C(29)-C(30)-C(31) 129(2) C(3)-Pb(1)-C(18) 151.5(8) 
C(26)-C(30)-C(31) 125(2) C(19)-Pb(1)-C(18) 29.9(5) 
C(29)-C(30)-Pb(2) 78.1(11) C(4)-Pb(1)-C(18) 157.4(6) 
C(26)-C(30)-Pb(2) 70.9(12) C(11)-Pb(1)-C(18) 48.5(5) 
C(31)-C(30)-Pb(2) 119.3(14) C(26)-Pb(2)-C(27) 32.7(9) 
C(44)-C(36)-C(37) 102.6(16) C(26)-Pb(2)-C(30) 31.8(7) 
C(42)-C(37)-C(38) 119.4(15) C(27)-Pb(2)-C(30) 52.2(7) 
C(42)-C(37)-C(36) 109.4(17) C(26)-Pb(2)-C(28) 50.2(7) 
C(38)-C(37)-C(36) 131.1(16) C(27)-Pb(2)-C(28) 28.6(7) 
C(39)-C(38)-C(37) 117.1(17) C(30)-Pb(2)-C(28) 50.0(6) 
C(40)-C(39)-C(38) 122(2) C(26)-Pb(2)-C(44) 100.7(7) 
C(39)-C(40)-C(41) 122.1(18) C(27)-Pb(2)-C(44) 98.8(7) 
C(40)-C(41)-C(42) 118.4(17) C(30)-Pb(2)-C(44) 130.0(6) 
C(41)-C(42)-C(43) 130.6(17) C(28)-Pb(2)-C(44) 123.4(6) 
C(41)-C(42)-C(37) 120.8(18) C(26)-Pb(2)-C(29) 50.6(6) 
C(43)-C(42)-C(37) 108.7(15) C(27)-Pb(2)-C(29) 49.4(6) 
C(42)-C(43)-C(44) 103.8(15) C(30)-Pb(2)-C(29) 30.3(6) 
C(42)-C(43)-Pb(2) 81.6(11) C(28)-Pb(2)-C(29) 29.5(6) 
C(44)-C(43)-Pb(2) 70.3(11) C(44)-Pb(2)-C(29) 147.7(6) 
C(36)-C(44)-C(43) 115.4(17) C(26)-Pb(2)-C(43) 122.2(8) 
C(36)-C(44)-Pb(2) 82.4(12) C(27)-Pb(2)-C(43) 106.0(6) 
C(43)-C(44)-Pb(2) 80.1(11) C(30)-Pb(2)-C(43) 154.0(6) 
C(55)-C(51)-C(52) 106.9(18) C(28)-Pb(2)-C(43) 119.0(6) 
C(55)-C(51)-C(56) 125(2) C(44)-Pb(2)-C(43) 29.6(5) 
C(52)-C(51)-C(56) 128(2) C(29)-Pb(2)-C(43) 148.1(6) 
C(55)-C(51)-Pb(3) 76.4(12) C(52)-Pb(3)-C(53) 30.7(6) 
C(52)-C(51)-Pb(3) 68.5(11) C(52)-Pb(3)-C(51) 30.2(7) 
C(56)-C(51)-Pb(3) 119.0(15) C(53)-Pb(3)-C(51) 49.7(6) 
C(53)-C(52)-C(51) 108.9(18) C(52)-Pb(3)-C(69) 104.0(7) 
C(53)-C(52)-C(57) 122(2) C(53)-Pb(3)-C(69) 98.6(6) 
C(51)-C(52)-C(57) 128(2) C(51)-Pb(3)-C(69) 132.8(6) 
C(53)-C(52)-Pb(3) 75.5(11) C(52)-Pb(3)-C(54) 50.5(6) 
C(51)-C(52)-Pb(3) 81.3(12) C(53)-Pb(3)-C(54) 30.9(6) 
C(57)-C(52)-Pb(3) 119.2(15) C(51)-Pb(3)-C(54) 49.2(6) 
C(52)-C(53)-C(54) 108.8(18) C(69)-Pb(3)-C(54) 122.6(6) 
C(52)-C(53)-C(58) 123(2) C(52)-Pb(3)-C(55) 48.9(7) 
C(54)-C(53)-C(58) 127(2) C(53)-Pb(3)-C(55) 49.2(6) 
C(52)-C(53)-Pb(3) 73.8(11) C(51)-Pb(3)-C(55) 28.7(7) 
C(54)-C(53)-Pb(3) 80.3(11) C(69)-Pb(3)-C(55) 147.8(6) 
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C(58)-C(53)-Pb(3) 118.2(14) C(54)-Pb(3)-C(55) 29.6(6) 
C(59)-C(54)-C(55) 131(2) C(52)-Pb(3)-C(61) 108.7(6) 
C(59)-C(54)-C(53) 125(2) C(53)-Pb(3)-C(61) 117.7(6) 
C(55)-C(54)-C(53) 104.2(18) C(51)-Pb(3)-C(61) 127.9(6) 
C(59)-C(54)-Pb(3) 118.1(16) C(69)-Pb(3)-C(61) 28.9(5) 
C(55)-C(54)-Pb(3) 75.6(12) C(54)-Pb(3)-C(61) 147.3(6) 
C(53)-C(54)-Pb(3) 68.9(10) C(55)-Pb(3)-C(61) 156.2(6) 
C(51)-C(55)-C(54) 111.1(19) C(78)-Pb(4)-C(77) 31.6(6) 
C(51)-C(55)-C(60) 124(3) C(78)-Pb(4)-C(79) 31.3(6) 
C(54)-C(55)-C(60) 125(3) C(77)-Pb(4)-C(79) 51.8(6) 
C(51)-C(55)-Pb(3) 74.9(13) C(78)-Pb(4)-C(76) 50.5(6) 
C(54)-C(55)-Pb(3) 74.8(11) C(77)-Pb(4)-C(76) 30.4(6) 
C(60)-C(55)-Pb(3) 121.0(16) C(79)-Pb(4)-C(76) 50.2(6) 
C(69)-C(61)-C(62) 102.1(15) C(78)-Pb(4)-C(80) 51.0(6) 
C(69)-C(61)-Pb(3) 72.4(10) C(77)-Pb(4)-C(80) 51.0(6) 
C(62)-C(61)-Pb(3) 79.9(8) C(79)-Pb(4)-C(80) 30.7(6) 
C(67)-C(62)-C(63) 120.8(18) C(76)-Pb(4)-C(80) 30.1(6) 
C(67)-C(62)-C(61) 108.4(17) C(78)-Pb(4)-C(87) 101.9(6) 
C(63)-C(62)-C(61) 130.6(18) C(77)-Pb(4)-C(87) 97.2(6) 
C(64)-C(63)-C(62) 120.8(19) C(79)-Pb(4)-C(87) 131.2(6) 
C(63)-C(64)-C(65) 118.6(18) C(76)-Pb(4)-C(87) 122.1(6) 
C(66)-C(65)-C(64) 120.7(17) C(80)-Pb(4)-C(87) 148.2(6) 
C(65)-C(66)-C(67) 120.4(18) C(78)-Pb(4)-C(88) 123.3(6) 
C(62)-C(67)-C(68) 110.4(17) C(77)-Pb(4)-C(88) 105.1(6) 
C(62)-C(67)-C(66) 118.5(18) C(79)-Pb(4)-C(88) 154.4(6) 
C(68)-C(67)-C(66) 131.1(19) C(76)-Pb(4)-C(88) 117.2(6) 
C(67)-C(68)-C(69) 104.8(17) C(80)-Pb(4)-C(88) 146.5(6) 




Figure 2.21  Molecular structure and complete atom numbering scheme for 
one of the two independent molecules in the crystal structure of [1,3-
(Me3Si)2(η5-C9H5)]2Li2·Et2O, 13.  Atoms are colored as follows:  carbon 
(black), silicon (cyan), lithium (violet), and oxygen (red).  The thermal 
ellipsoids are shown at the 30% probability level.  All hydrogen atoms have 
been omitted for clarity. 
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Table 2.13  Crystal Data and Structure Refinement for  
[1,3-(Me3Si)2(η5-C9H5)]2Li2·Et2O, 13. 
Identification code  p21overc 
Empirical formula  C34 H56 Cl0 Li2 Mg0 O P0 Si4 
Formula weight  607.03 
Temperature  153(2) K 
Wavelength  0.71069 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 9.959(5) Å        α= 90.000(5)°. 
 b = 21.193(5) Å      β= 93.506(5)°. 
 c = 18.068(5) Å      γ = 90.000(5)°. 
Volume 3806(2) Å3 
Z 4 
Density (calculated) 1.059 Mg/m3 
Absorption coefficient 0.179 mm-1 
F(000) 1320 
Crystal size 0.20 x 0.20 x 0.20 mm3 
Theta range for data collection 2.96 to 27.50°. 
Index ranges                                               -12<=h<=12, -27<=k<=27, -23<=l<=23 
Reflections collected 16921 
Independent reflections 8721 [R(int) = 0.0951] 
Completeness to theta = 27.50° 99.7 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8721 / 0 / 590 
Goodness-of-fit on F2 1.015 
Final R indices [I>2sigma(I)] R1 = 0.0569, wR2 = 0.0929 
R indices (all data) R1 = 0.1489, wR2 = 0.1144 
Extinction coefficient 0.0023(4) 
Largest diff. peak and hole 0.264 and -0.349 e.Å-3 
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Table 2.14  Selected Bond Lengths (Å) for [1,3-(Me3Si)2(η5-C9H5)]2Li2·Et2O, 
13. 
 
C(1)-C(9)  1.419(3) C(17)-Li(2)  2.280(5) 
C(1)-C(2)  1.422(3) C(17)-Li(1)  2.352(4) 
C(1)-Li(1)  2.212(5) C(18)-C(19)  1.415(3) 
C(2)-C(3)  1.444(3) C(18)-C(23)  1.439(3) 
C(2)-Li(1)  2.342(5) C(18)-Li(2)  2.263(4) 
C(3)-C(4)  1.408(3) C(18)-Li(1)  2.570(5) 
C(3)-C(8)  1.444(3) C(19)-C(20)  1.369(3) 
C(3)-Li(1)  2.433(5) C(20)-C(21)  1.408(4) 
C(4)-C(5)  1.370(4) C(21)-C(22)  1.363(3) 
C(5)-C(6)  1.410(4) C(22)-C(23)  1.421(3) 
C(6)-C(7)  1.368(4) C(23)-C(24)  1.446(3) 
C(7)-C(8)  1.412(3) C(23)-Li(2)  2.262(4) 
C(8)-C(9)  1.440(3) C(23)-Li(1)  2.678(5) 
C(8)-Li(1)  2.382(5) C(24)-Li(2)  2.267(4) 
C(9)-Li(1)  2.256(5) C(24)-Li(1)  2.557(5) 
C(16)-C(24)  1.421(3) C(31)-C(32)  1.472(5) 
C(16)-C(17)  1.436(3) C(32)-O(1)  1.450(4) 
C(16)-Li(2)  2.232(5) C(33)-O(1)  1.445(3) 
C(16)-Li(1)  2.301(5) C(33)-C(34)  1.479(5) 
C(17)-C(18)  1.454(3) Li(2)-O(1)  1.877(4) 
C(1)-C(9)  1.419(3) C(17)-Li(2)  2.280(5) 
C(1)-C(2)  1.422(3) C(17)-Li(1)  2.352(4) 
C(1)-Li(1)  2.212(5) C(18)-C(19)  1.415(3) 
C(2)-C(3)  1.444(3) C(18)-C(23)  1.439(3) 
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Table 2.15  Selected Bond Angles (º) for [1,3-(Me3Si)2(η5-C9H5)]2Li2·Et2O, 13. 
 
C(9)-C(1)-C(2) 113.1(2) Li(2)-C(24)-Li(1) 114.38(16) 
C(9)-C(1)-Li(1) 73.17(17) O(1)-C(32)-C(31) 109.0(3) 
C(2)-C(1)-Li(1) 76.88(17) O(1)-C(33)-C(34) 108.5(2) 
C(1)-C(2)-C(3) 104.5(2) C(1)-Li(1)-C(9) 37.03(10) 
C(1)-C(2)-Li(1) 66.87(16) C(1)-Li(1)-C(16) 132.5(2) 
C(3)-C(2)-Li(1) 75.86(16) C(9)-Li(1)-C(16) 163.2(2) 
C(4)-C(3)-C(2) 131.8(2) C(1)-Li(1)-C(2) 36.25(10) 
C(4)-C(3)-C(8) 119.3(2) C(9)-Li(1)-C(2) 62.05(13) 
C(2)-C(3)-C(8) 108.8(2) C(16)-Li(1)-C(2) 118.16(19) 
C(4)-C(3)-Li(1) 129.75(19) C(1)-Li(1)-C(17) 168.3(2) 
C(2)-C(3)-Li(1) 69.01(16) C(9)-Li(1)-C(17) 154.3(2) 
C(8)-C(3)-Li(1) 70.62(16) C(16)-Li(1)-C(17) 35.93(10) 
C(5)-C(4)-C(3) 120.0(3) C(2)-Li(1)-C(17) 138.9(2) 
C(4)-C(5)-C(6) 120.6(3) C(1)-Li(1)-C(8) 58.96(13) 
C(7)-C(6)-C(5) 121.2(3) C(9)-Li(1)-C(8) 36.04(10) 
C(6)-C(7)-C(8) 119.8(2) C(16)-Li(1)-C(8) 160.4(2) 
C(7)-C(8)-C(9) 132.0(2) C(2)-Li(1)-C(8) 59.60(12) 
C(7)-C(8)-C(3) 119.0(2) C(17)-Li(1)-C(8) 131.17(19) 
C(9)-C(8)-C(3) 108.7(2) C(1)-Li(1)-C(3) 58.18(13) 
C(7)-C(8)-Li(1) 128.88(19) C(9)-Li(1)-C(3) 59.85(13) 
C(9)-C(8)-Li(1) 67.21(16) C(16)-Li(1)-C(3) 131.3(2) 
C(3)-C(8)-Li(1) 74.49(16) C(2)-Li(1)-C(3) 35.13(10) 
C(1)-C(9)-C(8) 104.8(2) C(17)-Li(1)-C(3) 125.3(2) 
C(1)-C(9)-Li(1) 69.80(16) C(8)-Li(1)-C(3) 34.89(9) 
C(8)-C(9)-Li(1) 76.75(17) C(1)-Li(1)-C(24) 113.67(18) 
C(24)-C(16)-C(17) 113.0(2) C(9)-Li(1)-C(24) 130.5(2) 
C(24)-C(16)-Li(2) 72.92(17) C(16)-Li(1)-C(24) 33.49(9) 
C(17)-C(16)-Li(2) 73.24(16) C(2)-Li(1)-C(24) 122.90(18) 
C(24)-C(16)-Li(1) 83.18(17) C(17)-Li(1)-C(24) 57.86(12) 
C(17)-C(16)-Li(1) 73.99(16) C(8)-Li(1)-C(24) 165.8(2) 
Li(2)-C(16)-Li(1) 127.00(18) C(3)-Li(1)-C(24) 154.4(2) 
C(16)-C(17)-C(18) 104.27(19) C(1)-Li(1)-C(18) 150.1(2) 
C(16)-C(17)-Li(2) 69.66(16) C(9)-Li(1)-C(18) 125.12(19) 
C(18)-C(17)-Li(2) 70.73(16) C(16)-Li(1)-C(18) 55.52(11) 
C(16)-C(17)-Li(1) 70.09(15) C(2)-Li(1)-C(18) 172.7(2) 
C(18)-C(17)-Li(1) 81.25(16) C(17)-Li(1)-C(18) 33.99(9) 
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Li(2)-C(17)-Li(1) 122.30(17) C(8)-Li(1)-C(18) 124.80(18) 
C(19)-C(18)-C(23) 119.4(2) C(3)-Li(1)-C(18) 144.71(19) 
C(19)-C(18)-C(17) 131.7(2) C(24)-Li(1)-C(18) 54.58(11) 
C(23)-C(18)-C(17) 108.81(18) C(1)-Li(1)-C(23) 122.74(19) 
C(19)-C(18)-Li(2) 120.21(19) C(9)-Li(1)-C(23) 116.53(19) 
C(23)-C(18)-Li(2) 71.41(16) C(16)-Li(1)-C(23) 53.65(11) 
C(17)-C(18)-Li(2) 71.95(16) C(2)-Li(1)-C(23) 149.53(19) 
C(19)-C(18)-Li(1) 125.78(18) C(17)-Li(1)-C(23) 55.31(11) 
C(23)-C(18)-Li(1) 78.25(16) C(8)-Li(1)-C(23) 139.07(19) 
C(17)-C(18)-Li(1) 64.76(15) C(3)-Li(1)-C(23) 173.62(19) 
Li(2)-C(18)-Li(1) 114.00(16) C(24)-Li(1)-C(23) 31.96(8) 
C(20)-C(19)-C(18) 119.2(2) C(18)-Li(1)-C(23) 31.75(8) 
C(19)-C(20)-C(21) 121.4(2) O(1)-Li(2)-C(16) 154.2(2) 
C(22)-C(21)-C(20) 121.3(2) O(1)-Li(2)-C(23) 132.4(2) 
C(21)-C(22)-C(23) 119.3(2) C(16)-Li(2)-C(23) 60.72(13) 
C(22)-C(23)-C(18) 119.3(2) O(1)-Li(2)-C(18) 144.4(2) 
C(22)-C(23)-C(24) 131.5(2) C(16)-Li(2)-C(18) 60.98(13) 
C(18)-C(23)-C(24) 109.12(19) C(23)-Li(2)-C(18) 37.09(10) 
C(22)-C(23)-Li(2) 121.24(19) O(1)-Li(2)-C(24) 135.7(2) 
C(18)-C(23)-Li(2) 71.50(16) C(16)-Li(2)-C(24) 36.80(10) 
C(24)-C(23)-Li(2) 71.57(16) C(23)-Li(2)-C(24) 37.23(10) 
C(22)-C(23)-Li(1) 128.20(18) C(18)-Li(2)-C(24) 62.51(13) 
C(18)-C(23)-Li(1) 70.00(15) O(1)-Li(2)-C(17) 161.0(2) 
C(24)-C(23)-Li(1) 69.40(15) C(16)-Li(2)-C(17) 37.10(10) 
Li(2)-C(23)-Li(1) 110.15(17) C(23)-Li(2)-C(17) 62.39(13) 
C(16)-C(24)-C(23) 104.84(19) C(18)-Li(2)-C(17) 37.32(10) 
C(16)-C(24)-Li(2) 70.27(16) C(24)-Li(2)-C(17) 63.17(13) 
C(23)-C(24)-Li(2) 71.20(16) C(33)-O(1)-C(32) 112.8(2) 
C(16)-C(24)-Li(1) 63.33(15) C(33)-O(1)-Li(2) 117.0(2) 
C(23)-C(24)-Li(1) 78.63(15) C(32)-O(1)-Li(2) 127.3(2) 
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CHAPTER 3:  DHQS AND EPSPS,  STRUCTURE-FUNCTION 
STUDIES ON TWO SHIKIMATE PATHWAY ENZYMES 
INTRODUCTION 
The seven step shikimate pathway links metabolism of carbohydrates to 
biosynthesis of aromatic compounds (Figure 3.1).  Phosphoenolpyruvate (PEP) 
and erythrose 4-phosphate (E4P) are converted to chorismate, the precursor of 
many aromatic amino acids.  The shikimate pathway is found only in 
microorganisms and plants, leaving animals to obtain most of their aromatic 
amino acids via diet.[1-3]   
The sixth step of the shikimate pathway is the target of the inhibitor 
glyphosate (N-phophomethylglycine)[4] the active ingredient in the herbicide 
Roundup® (Monsanto).  Glyphosate is under investigation as a lead compound 
against parasites which cause diseases like toxoplasmosis and malaria.[5]  Other 
branches from the shikimate pathway lead to the production of vitamins E and 












































































Figure 3.1  The shikimate pathway. 
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Two enzymes in the shikimate pathway, 3-dehydroquinate synthase 
(DHQS)[6, 7] and 5-enolpyruvylshikimate 3-phosphate synthase (EPSPS),[8-10] have 
been crystallographically observed to undergo conformational changes during 
catalysis.  In the presence of substrate and substrate-analogues, the enzymes exist 
in a tightly packed structure called the “closed” form, whereas in the absence of 
substrate or substrate-analogue, the enzyme exists in an “open” conformation.  
The availability of three-dimensional structural information for both the open and 
closed conformations of the enzymes presents the unique opportunity to 
investigate the cause of the conformational changes that occur.  A computational 
software program, GRID, will be employed to investigate the binding recognition 
sites in the open structure, as well as the binding site of potential substrate and 
inhibitor molecules in the closed structure of each enzyme.   
3-Deoxy-D-Arabino-Heptulosonate 7-Phosphate Synthase 
 Condensation of PEP and E4P to yield 3-deoxy-D-arabino-heptulosonate 
7-phosphate (DAHP) and inorganic phosphate is the first step of the shikimate 
pathway (Figure 3.1).[3]  The synthesis of DAHP is catalyzed by DAHP synthase, 
which is a metalloprotein inhibited by chelating agents.[11]  Several divalent 




 The second reaction of the shikimate pathway is the elimination of 
phosphate from DAHP to yield 3-dehydroquinate (DHQ) (Figure 3.1).[3]  The 
elimination reaction is catalyzed by DHQ synthase (DHQS), an enzyme requiring 
the presence of a divalent cation for activity.[14]  Catalytic amounts of the cation 
nicotinamide adenine dinucleotide (NAD+) are required for DHQS to be active.[15]  
The reaction involves an oxidation, a β-elimination of phosphate, a reduction, a 
ring opening, and an intramolecular aldol condensation.[16-18] 
3-Dedydroquinate Dehydratase-Shikimate Dehydrogenase 
 Dehydration of DHQ to give 3-dehydroshikimate (DHS) is the third step 
of the shikimate pathway (Figure 3.1).[3]  The dehydration is catalyzed by DHQ 
dehydratase and the reaction proceeds by way of a Schiff base mechanism where 
a lysine residue may serve as an amino donor.[19] 
Reduction of DHS to Shikimate 
 The forth step in the shikimate pathway, the reduction of DHS to 
shikimate, is catalyzed by a NADP-dependent shikimate dehyrdrogenase (Figure 
3.1).[20]  Pryrole quinoline is typically used as a cofactor.[21] 
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Shikimate Kinase 
 In the fifth step of the shikimate pathway shikimate is phosphorylated to 
yield shikimate 3-phosphate (S3P) (Figure 3.1).  The reaction is catalyzed by 
shikimate kinase.[3] 
5-Enolpyruvylshikimate 3-Phosphate Synthase 
 The sixth step in the shikimate pathway is the condensation of PEP with 
shikimate 3-phosphate to produce 5-enolpyruvylshikimate 3-phosphate (EPSP) 
and phosphate (Figure 3.1).  The reaction is catalyzed by EPSP synthase 
(EPSPS).[3]  The reaction can be inhibited by glyphosate which does not bind to 
the apoenzyme, but rather to the enzyme-shikimate 3-phosphate complex.[4]  
Glyphosate binding is competitive with respect to PEP;[22] however, site-directed 
mutagenesis studies have indicated that these two molecules do not bind in 
identical sites on the enzyme.[23-26] 
Chorismate Synthase 
 The final step of the shikimate pathway is the trans-1,4 elimination of 
phosphate from EPSP to yield chorismate, which introduces a second double bond 
to the ring (Figure 3.1).[27, 28]  The reaction is catalyzed by chorismate synthase 
and requires reduced flavin for activity despite being redox neutral.  This behavior 
makes it similar to DHQS, the second enzyme in the shikimate pathway.  
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Carbon—oxygen bond cleavage may be initiated by flavin acting as an electron 
donor to EPSP. 
3-Dehydroquinate Synthase Structure and Mechanism 
The three-dimensional X-ray crystal structures of Aspergillus nidulans 
dehydroquinate synthase in the open[7, 29] conformation has been determined 
(Figure 3.2a).  DHQS was observed to be a homodimer arranged in a “head-to-
tail” orientation.  Each monomer consists of an N-terminal α/β domain and C-
terminal α-helical domain.  The N-terminal domain is the NAD+-binding domain 
and has the characteristic Rossman fold of NAD+-binding proteins.  The NAD+ is 
bound in an inverted orientation with respect to other classic Rossman-fold 
proteins.  This orientation of NAD+ is rare, but not unique to DHQS.[30]  The two 
domains are joined only at the interface running along the bottom of the cleft 
parallel with the NAD+-binding site.  The majority of contacts between the two 
monomers occur at the N-terminal domain.  The C-terminal domain is primarily 
composed of an anti-parallel α-helical barrel.  The structure has a wide solvent 
channel located at the junction of the monomers.[7, 29]  
The structure of DHQS in the closed conformation was solved containing 
Zn2+, the co-factor NAD+ and the slowly-reversible inhibitor carbaphosphonate 
(CRB).[6]  In the presence of carbaphosphonate, DHQS forms a tightly packed 
structure called the “closed” form,[6, 7, 29] whereas in the absence of substrate or 
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substrate-analogues the enzyme exists in an “open” conformation.[7, 29]  The 
closing of the structure involves a 14° rotation about an axis, which brings the C-
terminal of DHQS into contact with the N-terminal of the other monomer of the 
dimer (Figure 3.2b).  The active site of the enzyme is located in the cleft between 
the domains.  The C-terminal domain contains most of the catalytic residues and 
the Zn2+- and substrate-binding residues.  The conformational change from the 
open to the closed form of DHQS places residue R130 in the active site region of 
the closed structure where it plays an integral role in catalysis.[6] 
 
Figure 3.2  a) DHQS “open” structure with Zn2+ (yellow) and b) DHQS 
“closed” structure with Zn2+ (yellow) and carbaphosphonate (green).  The 
flexible loops that are important for formation of the active site are shown in 
red.  NAD+ has been omitted for clarity.  The N- and C-terminal domains are 
indicated in cyan and blueviolet, respectively.  Figures were created using 


















Structural studies by Carpenter et al.[6] have allowed for elucidation of the 
residues involved in binding the Zn2+ and the substrate-analogue, 
carbaphosphonate.  Analysis of the structure indicated a phosphate binding 
pockets involving residues N162, K356, R130(B), K152, Wat33, and N268 for 
the carbaphosphonate phosphonate group.  The carboxylate moiety of the 
carbaphosphonate molecule interacts with residues K250, R264, and K152.  Two 
histidine residues (H271 and H287) and E194 form interactions with the Zn2+ 
(Figure 3.3). 
Several hypotheses of the mechanism for the conversion of DAHP to 
DHQ by DHQS have been proposed.  Two early examples of mechanistic work 
were done by Bartlett et al.[18] and Knowles et al.[16, 17]  Structural information 
acquired by Carpenter et al.[6] has contributed to the understanding of the 
individual residues participating in the mechanism (Figure 3.3).  The substrate is 
first oxidized at C5 by NAD+, which involves hydride transfer from C5 of DAHP 
to C4 of the nicotinamide moiety of NAD+.[16]  Simultaneously, the C5 hydroxyl 
group of DAHP loses a proton[16] which is relayed to Wat7.[6]  An adjacent 
histidine (H275) could accept the proton.[6]  The second step of the reaction is the 
β-elimination of the phosphate group from intermediate A.  The structure 
indicates the presence of a phosphate binding pocket (K152, N162, N268, H275, 
and K356) which interacts with the phosphate positioning it so that an oxygen can 
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remove a proton from C6 of A.[6]  The third step of the reaction is the reduction of 
the C5 ketone of intermediate B by NADH.[16]  The hydride ion from C4 of 
NADH is transferred back to C5 of intermediate B.  A ring-opening involving the 
deprotonation of the hydroxyl at C2 of intermediate C is the fourth step of the 
reaction mechanism.[17]  The structure indicates that the side chain of R260 could 
act as the base that accepts a proton from Wat20.[6]  Rotation about the C5—C6 
bond is followed by an intramolecular aldol condensation to reform the ring.[17]  
No epimerization occurs about the C2 bond in the enzyme-mediated reaction.[18]  
The absence of epimerization is critical for the continuation of the shikimate 
pathway as the product, DHQ, must correctly interact with dehydroquinase in the 
following step in order to produce DHS.  The absence of epimerization could be 
due to hydrogen bond interactions between the carboxylic acid group on C2 of 
intermediate D and the side chains of residues K152, K250, and R264, as well as 
by the interactions between the hydroxyl or ketone functional groups on C2 of 
intermediate D with N268 and Wat20.[6]  By binding the intermediates, the protein 











































































































Figure 3.3  DHQS mechanism including the residue interactions as proposed 





5-Enolpyruvylshikimate 3-Phophate Synthase Structure, Mechanism, and 
Inhibition 
Stallings et al.[33] initially determined the three-dimensional X-ray crystal 
structure of E. coli EPSPS in 1991; however, since then two higher resolution 
structures have been determined.[8, 9]  The structure consists of two globular 
domains connected by a double-stranded hinge (Figure 3.4a).  The two-domain 
structure appears to be formed by 6-fold replication of a protein folding unit 
comprising two parallel helices and a four-stranded β-sheets.  Three of these 
subunits comprise each domain with approximate three-fold symmetry.  The two 
domains of EPSPS are nearly hemispheric and equal in size; however, the amino 
and carboxyl terminus of the polypeptide backbone are located only in the lower 
domain.  The N-termini point toward the active site, which has been suggested to 
favor the binding of the negatively charged substrates and inhibitors.[33] 
A conformational change has been observed for EPSPS during the 
catalysis.[8, 10] In the presence of shikimate, EPSPS forms a tightly packed 
structure called the “closed” form whereas in the absence of substrate it exhibits 
an “open” conformation (Figure 3.4).  The closing of the structure involves a 64° 
rotation about an axis close to the active site.  Several important binding residues 
including S197 and K411 are rearranged into the active site by the conformational 
change.[29]  Structural studies by Schönbrunn et al.[8] and Carpenter et al.[9] have 
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indicated two phosphate binding pockets exist in the closed EPSPS enzyme.  
Residues S170, K340, S169, N336, and S197 form the shikimate 3-phosphate 
phosphate moiety binding pocket, while the phosphonate moiety of the glyphosate 
interacts with residues K22, Q171, R124, G96, N94, and K411 (Figure 3.5).  The 
carboxylate region of the shikimate molecule interacts with residues R27 and S23, 
while the nearest neighbor residues to the glyphosate’s carboxylate moiety are 
R386, R344, D313, and K22.  In addition to possessing phosphate and 
carboxylate groups, which can be involved in hydrogen bonding, Lennard-Jones 
and electrostatic interactions, the shikimate 3-phosphate molecule has three 
hydroxyl groups which interact with residues D313, K22, and K340.[29] 
                  
Figure 3.4  a) EPSPS “open” structure and b) EPSPS “closed” structure with 
glyphosate (orange) and shikimate-3-phosphate (green).  The flexible loops 
that are important for formation of the active site are shown in red.  The N- 
and C-terminal are indicated in cyan and blueviolet, respectively.  Figure 







N-phosphomethylglycine (glyphosate) has been found to act as an 
inhibitor in EPSPS.  Plants do not appear to have the ability to degrade or 
inactivate glyphosate, which then accumulates in the meristematic areas of the 
plant producing phytotoxic effects.[4]  Glyphosate acts as a competitive inhibitor 
with respect to PEP and a non-competitive inhibitor with respect to shikimate 3-
phosphate in the EPSPS reaction.[34]  PEP and glyphosate act as competitive 
inhibitors; however, their binding sites do not appear to be totally equivalent.  
Although PEP and glyphosate have similar functional groups, their structures are 
not identical, which creates variations in their binding site preferences.  This 
difference in binding sites has been demonstrated via several site-directed 
mutagenesis studies.[23-26]  A key study by Padgette et al.[25] has indicated that 
EPSPS G96A selectively destabilizes the interaction of enzyme with glyphosate 
compared to PEP.  The difference between interaction of the enzyme with the 
inhibitor and substrate after single-site mutagenesis suggests that their binding 































































Figure 3.5  The active site of EPSPS indicating the important residue 
interactions with shikimate 3-phosphate and glyphosate.  Residues located in 
The N- and C-terminal domains are shaded in blue and peach, respectively. 
 
In the reaction catalyzed by EPSPS the intact enolpyruvyl group of the 
PEP is transferred to the 5-hydroxyl group of shikimate 3-phosphate producing 
EPSP and inorganic phosphate.[3]  The reaction is reversible and occurs without 
the presence of metals or cofactors.[35]  There are multiple mechanisms proposed 
for the reaction.  Bondinell, et al.[36] suggested the reaction proceeds exclusively 
with C—O cleavage at the PEP phosphate group, followed by transfer of the 
intact enolpyruvyl group to the acceptor molecule (Figure 3.6).  This makes the 
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reaction unusual as most other enzyme-catalyzed processes utilizing PEP proceed 
through P—O cleavage.  The suggested reversible addition-elimination 
mechanism proposes the protonation of C3 of PEP is associated with nucleophilic 
attack on C2 by the 5-hydroxyl group of shikimate 3-phosphate resulting in the 
formation of the tetrahedral intermediate (Figure 3.6).  EPSP is generated 
following the elimination of phosphate.[36] 
Anton et al.[37] proposed an alternative to the Bondinell mechanism which 
involves the stabilization of intermediate I (Figure 3.7) when a negatively charged 
active site residue of EPSPS forms a covalent bond to PEP.  The 5-hydroxyl of 
shikimate 3-phosphate could then attack C2 of PEP to form the tetrahedral 
intermediate (Figure 3.7).  Conversely, phosphate could be eliminated to form a 
covalent enolpyruvyl enzyme adduct which would react with shikimate 3-













































































































GRID, a computational program by P. J. Goodford,[38] was designed for 
detecting energetically favorable binding sites on proteins which have been 
structurally determined by X-ray crystallography or nuclear magnetic resonance.  
The target molecule is the species being evaluated.  The probe molecule is a small 
biologically active species such as water, amine nitrogen, carboxy oxygen, or 
hydroxyl.  GRID calculates the interactions between a probe molecule and a 
target molecule accounting for both the shape and energy of the two species.  The 
Lennard-Jones potential is a function which displays energy minima 
corresponding to preferred nonbonded atoms by combining the attractive and 




AE −=  
Equation 3.1  Lennard-Jones energy equation. 
 
In Equation 3.1, d is the distance between a pair of non-bonded atoms and 
A and B are parameters, which will be discussed later.  When d is small, the A/d12 
term predominates corresponding to a large positive value of E indicating 
repulsion.  The value of d defines the minimum separation between atoms, giving 
them a radius.  However, when d is large the Elj corresponds to the minimum 
value or bottom of the trough on the Lennard-Jones curve (Figure 3.8).  Both 
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maximum and minimum values can be extended to macromolecular systems and 


























Figure 3.8  A Lennard-Jones curve for the interaction between two 
nonbonded atoms.  Distances d’ and d” define a zone of interatomic 
attraction. 
 
  At distances d’ and d” a zone of mutual attraction exists (Figure 3.8).  
GRID uses the d’ to d” zone, as well as electrostatic and hydrogen bond effects to 
calculate interactions of a probe group with the target molecule.  An array of 
energy values is computed at sample positions of the probe throughout the target 
allowing contour plots to be drawn. 
d’ d”
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 The atomic coordinates for the target molecules are acquired from the 
Protein Data Bank (PDB)[41] and checked for missing atoms.  Ligands such as 
water, chloride ions, and cofactors are removed, unless they are structurally 
significant.  GRUB, a table of parameters included in the GRID software package, 
is needed to evaluate the Lennard-Jones and other empirical energy functions.  
GRIN adds the parameters from GRUB to the atomic coordinates file preparing 
the file for use by GRID.  The parameters in GRUB are based on the “extended” 
atom concept used for the program CHARMM.[42, 43]  In the “extended” atom 
concept, a common functional group is represented as a single-entity rather than 
as multiple atoms.  Significant computing time is saved as the single “extended” 
group replaces multiple atoms.  For example, the amino group is treated as a 
single entity with a van der Waals radius of 1.75 Å.  This value is somewhat 
larger than that of a nitrogen atom. 
 Once GRIN has successfully modified the atomic coordinates file, GRID 
is employed.  An array of points is established throughout the target molecule 
creating the GRID.  The potential energy, Exyz, of the probe is calculated at the 
first point on the first XY plane of the GRID.  The analysis proceeds until an 
energy value has been assigned for every point. 
 Favorable interactions between the probe and the target can be determined 
by the presence of modest negative energy values.  The –B/d6 term of the 
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Lennard-Jones function, electrostatic effects, and hydrogen-bond interactions all 
contribute to the slightly negative energy value. 
 The nonbonded interaction energy, Exyz, of the probe at each location on 
the GRID is comprised of three components (Equation 3.2).  One pairwise 
interaction between the probe at the GRID point xyz and an atom of the target 
composes each term in the summation.  The summation extends over all target 
atoms. 
∑ ∑∑ ++= hbelljxyz EEEE  
Equation 3.2  The energy equation for nonbonded interactions between 
atoms where Elj, Eel, and Ehb is the energy from the Lennard-Jones 
interactions, electrostatic effects and hydrogen-bond interactions, 
respectively. 
  
 To save computing time, Elj is set to zero if the probe and the pairwise 
target are more than 8 Å apart.  At this distance, Elj is typically –0.01 kcal/mol-1 
and is diminishing according to the sixth power of the interatomic distance.  This 
assumption does introduce an error on the order of 0.1 kcal/mol-1 in ΣElj.  The 
values of A and B in Equation 3.1 are calculated from the effective number of 
electrons, Neff, the polarizability, α1, and the van der Waals radius, r, of the 
interacting atoms, which was previously reported by Hopfinger.[44] 
 The electrostatic interaction, Eel, does not diminish rapidly with distance.  
Therefore, it was necessary to evaluate the individual terms pairwise between the 
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probe group and every target atom.  Equation 3.3 is a compromise between 
procedures based on the algorithm of Warwicker and Watson,[45] which requires 
extensive computing times and the classical functions which inadequately 
describe the dielectric effect arising from shielding and coupling effects of the 



















Equation 3.3  The energy equation for electrostatic interactions between 
atoms.  
 
The variables p and q are the electrostatic charges on the probe group and 
the pairwise target atom, respectively.  Distance between the probe and the target 
is d and K is equal to 4πεo, where εo = 8.854 F m-1.[44]  If a probe has less than 
seven protein neighbor atoms within a 4 Å distance then it is assumed to be in the 
solution phase and the 4spsq term is set to zero to shorten computational time.  The 
dielectric constants ε and ζ were set to 80 and 4, respectively.  Equation 3.3 yields 
an effective dielectric term if the pairwise groups are embedded in the protein and 
close enough together that the effect of the solution may be neglected.  
 Hydrogen bonding effects are determined by a direction-dependent 6-4 
function (Equation 3.4), which more accurately predicts the hydrogen-bond 
energy minimum than the commonly used 12-10 function.[43]  Experimentally, the 
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hydrogen-bond energy minimum has been determined to be considerably broader 








 −=  
Equation 3.4  The energy equation for hydrogen bond interactions between 
atoms.  
 
When two identical atoms are interacting, the tabulated values for C and 
D, which are specific constants for each donor-acceptor pair, determine their 
interatomic separation, dmin.  If the atoms are of different types, the geometric 
mean of their individual D values and the arithmetic mean of their dmin separations 
are used.  The value of C is calculated by setting the differentiated form of 
Equation 3.4 to zero (Equation 3.5). 
2
min6660 Dd. C =  
Equation 3.5  The equation for calculating the value of C in Equation 3.4.  
 
Two possibilities exist for hydrogen bonding between the probe and target 
molecules.  If the target donates a hydrogen bond, then the bond direction is 
determined by the hydrogen position.  The angle DHP (Figure 3.9) where D is the 
target donor atom, H is the hydrogen, and P is the probe accepting the hydrogen 
bond is represented by θ (Equation 3.4).  The m term in Equation 3.4 is typically 
4, but Ehb is zero when θ ≤ 90°.  If the probe donates the hydrogen bond then it is 
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assumed that it can orient itself in order to form the most effective hydrogen-bond 
























Figure 3.9  Angle θ is the angle between the protein donor atom, D, the 
hydrogen atom, H, and the probe accepting the hydrogen bond, P. 
 
Utilizing the ability of GRID to predict energetically favorable binding 
sites for small molecules, experiments were undertaken to investigate the binding 
potentials for various probes in DHQS and EPSPS, two enzymes of the shikimate 
pathway.  As previously discussed, both DHQS and EPSPS undergo 
conformational changes upon binding of the substrate molecules.  GRID was 
employed to investigate the differences in the small molecule binding sites of the 
“open”, substrate free, and “closed”, substrate bound, forms of each enzyme.  
Atomic coordinates for DHQS closed (1DQS)[6], and EPSPS closed (1G6S)[8] 
were obtained from the PDB,[41] while coordinates for the DHQS and EPSPS 
open structures were obtained from a personal communication.[46]  The structures 




Figure 3.10  a) DHQS "open" with NAD+ and Zn2+ all shown in black, b) 
DHQS "closed" structure with NAD+, Zn2+, and carbaphosphonate all shown 
in black, c) EPSPS "open" and d) EPSPS "closed" structure with shikimate 
3-phosphate, and glyphosate both indicated in black.  All structures appear 





Two experiments were performed using GRID on each protein structure.  
The first experiment investigated the small molecule binding potential of the 
protein structure containing only co-factors, where applicable.  All substrate-
analogues, water molecules, and metal ions were removed from the structure file 
prior to the initial calculations.  GRID was then used to evaluate the energetically 
favorable binding sites of counterions and appropriate small molecules.  The 
second experiment was performed on the protein structure file containing the co-
factors, where applicable, as well as any substrate-analogues and metal ions that 
were present in the crystal structure.  Again, the structure was evaluated with 
appropriate small molecule probes to locate the most energetically favorable 
binding sites. 
GRID RESULTS  
GRID calculations were performed on both the open and closed forms of 
DHQS.  Zn2+ and carbaphosphonate (in the closed form) were removed from the 
structure files and initial calculations were preformed on the NAD+-containing 
enzyme only.  The metal cation and the substrate-analogue were added back into 
the coordinate files and the enzymes were reanalyzed using GRID.  Unless 
otherwise stated, all calculations are assumed to be on the enzyme bound only to 
the cofactor NAD+. 
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Several probes were used to investigate potential binding sites on the 
enzyme.  The probes are designed to locate energetically favorable binding sites 
on the enzyme for the functional moiety they represent.  Based on the functional 
groups of the substrate, DAHP, and a substrate-analogue, carbaphosphonate, 
probes were chosen (Figure 3.11).  The hydroxyl probe was chosen to represent 
the three OH moieties present on both the DAHP and carbaphosphonate 
molecules.  The carboxy, carbonyl, and multi-atom carboxy probes were selected 
due to the presence of a carboxy functional group on both DAHP and 
carbaphosphonate (Figure 3.11).  The phosphate or phosphonate moeity on DAHP 
and carbaphosphonate, respectively, is a primary component of both the substrate 
and substrate-analogue (Figure 3.11).  The hydrogen phosphate monoanion and 
phosphate dianion probes were chosen to search for binding sites in the enzyme 


















Figure 3.11  The hydroxyl, carboxy, carbonyl, multi-atom carboxy, hydrogen 
phosphate monoanion, and phosphate dianion probes will be used to locate 
the binding pocket for the color coordinated functional groups on the DHQS 
substrate and substrate-analogue.  
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GRID calculation output was displayed as contour maps using Insight II 
(Accelrys, Cambridge, UK) and DS ViewerPro 5.0 (Accelrys, Cambridge, UK).  
By adjusting the visible contour level, the total energy cut off value was set for 
each calculation.  Although qualitative comparisons can be made across systems, 
quantitative analysis is not recommended as the energy values are probe and 
target specific.   
The presence of energetically favorable sites was determined by visual 
inspection of the size and shape of the countour within a probe/enzyme system.  
The user is required to apply knowledge of the biochemistry of the protein being 
evaluated to determine whether sites identified as energetically favorable are 
significant to the posed question.  
DHQS Calculations 
Hydroxyl Probe 
The open DHQS structure was explored with the hydroxyl probe to locate 
regions of the protein that favor interaction with an OH moiety.  A number of 
favorable interactions were located throughout the protein with similar energetic 
favorability.  None of the locations were significantly more favorable when 
compared to other interactions and, therefore, did not merit being labeled a 
hydroxyl binding pocket.  
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 The hydroxyl probe was used to investigate the DHQS closed structure for 
a potential area of interaction for an alkyl hydroxyl group on the enzyme.  
Energetically favorable interactions were located at residues D146, N162, E194, 
N268, H271, and H275, corresponding to the binding location of the hydroxyl 
moieties of the carbaphosphonate molecule (Figure 3.12).   
 
Figure 3.12  The energetically favorable binidng sites for the hydroxyl probe 
on the DHQS closed structure.  Contour level is set at –10 kcal/mol.  The 
carbaphosphonate molecule is overlayed to aid in visualization. 
 
Carboxy Probe 
 The open DHQS structure was explored with the carboxy probe to located 
regions of the protein that favor interaction with an anionic carboxy oxygen atom. 
Although no energetically favorable binding sites were found near the active site, 
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the probe showed favorable interaction with residues K89(A) and K89(B) at the 
dimer interface (Figure 3.13). 
 
 
Figure 3.13  a) The energetically favorable binding sites for the carboxy 
probe on the DHQS open structure and b) the zoomed view of the 
energetically favorable region.  Contour level set at –10 kcal/mol.  
 
 The DHQS closed structure was analyzed with the carboxy probe to locate 
the most favorable binding site for sp2 carboxy oxygen atoms.  The carboxy probe 
located an energetically favorable binding site near residues K152, K250, and 
Energetically favorable 
interaction with nearest 
neighbor residues 
K89(A) and K89(B) 
a) b)
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R264, which corresponds to the residues associated with the carboxy group of the 
carbaphosphonate (Figure 3.14). 
 
Figure 3.14  Stereoview of the most energetically favorable binding sites for 
the carboxy probe on the DHQS closed structure.  Contour level is set at       
–10.5 kcal/mol.  The carbaphosphonate and Zn2+ (green) have been overlayed 
on the data map to aid in visualization.  
 
Carbonyl Probe 
The carbonyl probe, a small molecule probe designed to locate 
energetically favorable sites for interaction with a carbonyl oxygen atom, 
identified residues K152, K250, and R264 as a potential binding pocket in the 
DHQS open structure.  The dimer interface was also determined to be an 
energetically favorable site for sp2 carbonyl oxygen binding. 
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Figure 3. 15  Energetically favorable binding site for the carbonyl probe in 
the DHQS open structure.  Contour is set at –7 kcal/mol. 
 
 The same probe was used to investigate the DHQS closed structure.  The 
nearest neighbor residues for the most energetically favorable site were K152, 
K250, and R264, which are identical to those found by the carboxy probe, (Figure 
3.16).   
 
Figure 3.16  The most energetically favorable binding sites for the carbonyl 
oxygen binding in the DHQS closed structure.  Contour level set at –8.5 
kcal/mol.  The carbaphosphonate (CRB) and Zn2+ (green) molecules have 
been overlayed on the data map to aid in visualization. 
Energetically favorable site 
also located at phosphonate 
binding location 
Most energetically 
favorable site at 
COO binding 
position of CRB  
CRB
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Carboxy Multi-atom Probe 
 The carboxy multi-atom probe was designed to represent the entire 
carboxy moiety.  The multi-atom probe consists of two sp2 oxygen atoms bonded 
to the sp2 carboxy carbon, which is itself bonded to another β-carbon atom in a 
methylene group.[38]  The probe contains four lone pairs that can accept up to four 
hydrogen bonds.  The multi-atom probe is a more accurate model of a carboxy 
group than is the single-atom carboxy probe, which represents only an sp2 oxygen 





Figure 3.17  The carboxy multi-atom probe is represented with the red box 
indicating the carboxy single-atom probe. 
 
The DHQS closed structure was analyzed with the carboxy multi-probe to 
locate the most favorable binding site for a carboxy moiety.  The nearest neighbor 
residues for the first energetically favorable site were determined to be K152, 
K250, and R264.  The size and shape of the contours were found to be nearly 
identical to those found for the carboxy probe (Figure 3.16).   
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Phosphate Dianion Probe 
 Modeling a phosphate dianion with no hydrogens, the phosphate dianion 
probe was used to investigate the DHQS open structure.  The most energetically 
favorable binding site was identified at the dimer interface with nearest neighbor 
residues K89(A), K89(B), R86(A), and R86(B) (Figure 3.18).  This site is similar 
to that found to be energetically favorable towards the carbonyl and carboxy 
probe, but additionally includes residues R86(A) and R86(B).  A second binding 
site for a PO42 functional group was determined to have R130(B), N162, and 
K152 as nearest neighbor residues.  These residues correspond to the known 




Figure 3.18  a) View of the DHQS open structure indicating the most 
energetically favorable binding site for the phosphate dianion probe.  Zn2+ 
and NAD+ are indicated in black. b) Detailed view of the energetically 
favorable site.  The contour level is set at –15 kcal/mol in both views. 
 
 A closer view of the phosphate binding pocket can be seen in Figure 3.19.  
Residues N162, K152, and R130(B) interact with the phosphate dianion probe 
with residue N268 in position to interact upon closure of the structure.   
Energetically favorable 
interaction with K89(A), 






Figure 3.19  View of the phosphate binding pocket in the open DHQS 
structure.  Contour level set at –12 kcal/mol. 
 
 The phosphate dianion probe was used to located energetically favorable 
binding sites in the DHQS closed structure.  The most energetically favorable site 
for PO42 binding in the enzyme is located near residues N162, K356, K152, 
N268, and R130(B).  These residues correspond to the binding site of the 
phosphonate unit on the carbaphosphonate in the closed DHQS structure.  The 
second energetically favorable site recognized by the PO42 probe is the carboxy 
binding site of the carbaphosphonate, which has nearest neighbor residues K250, 
K152, and R264 (Figure 3.20). 
169 
 
Figure 3.20  The two most energetically favorable binding sites for the 
phosphate dianion probe in the DHQS closed structure.  Contour level set at 
–17 kcal/mol.  The carbaphosphonate (CRB) and Zn2+ (green) have been 
overlayed on the data map to aid in visualization. 
 
Hydrogen Phosphate Anion Probe 
 The open DHQS structure was explored with the hydrogen phosphate 
anion probe to locate favorable sites on the protein for HPO4 interaction.  
Although similar to the phosphate dianion probe, the hydrogen phosphate probe is 
monoanionic and has one hydrogen atom (Figure 3.21).   
CRB
Energetically favorable 
site also located at COO 
binding position 
Most energetically favorable site 
at PO42















Figure 3.21  The a) phosphate dianion and b) hydrogen phosphate anion 
probes.  The R group indicates the attachement point of the moiety. 
 
Several energetically favorable binding sites were located; however the most 
favorable site was located at the dimer interface.  This location has nearest 
neighbor residues K89A, K89B, R86A, and R86B.  A second binding site was 
determined to have R130(B), N162, and K152 as nearest neighbor residues.  
These residues correspond to the known binding site of the phosphonate moiety of 
the carbaphosphonate in the closed DHQS structure.  The size and shape of the 
energy contours for the HPO4 were nearly identical to those found for the 
phosphate dianion probe (Figure 3.20).  
 The hydrogen phosphate monoanion probe was employed to determine 
favorable binding pockets for HPO4 in the DHQS closed structure.  The most 
energetically favorable binding site was located at residues K250, R264, and 
K152, which forms the carboxy binding pocket of the carbaphosphonate 
molecule.  The second site located by the hydrogen phosphate monoanion probe 
is a surface site.  The phosphonate binding pocket of the carbaphosphonate 
a) b)
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molecule is identified as the third most energetically favorable binding site with 
nearest neighbor residues N162, K356, K152, N268, and R130(B).   
Zinc Dication Probe 
 The zinc dication probe was used to analyze the DHQS open structure for 
potential Zn2+-binding sites.  Two energetically favorable binding sites were 
located on the surface.  The first energetically favorable site to occur at the 
interior of the protein had nearest residue neighbors E194, H287, and H271.  The 
residues involved matched the structurally characterized binding site of Zn2+ 
within a distance of 1.1 Å (Figure 3.22).  This can be considered nearly equivalent 
considering the margin of error for GRID (0.5 Å) and the resolution of the three-
dimensional structure (1.8 Å). 
 
Figure 3.22  An energetically favorable binding sites for Zn2+ in the DHQS 
open structure.  The contour level is set at –50 kcal/mol.  The Zn2+ cation 
(green) has been overlayed on the data map to aid in visualization. 
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The Zn2+ was incorporated into the DHQS open structure file and the 
structure was reanalyzed for potential Zn2+-binding sites.  An energetically 
favorable site was located near residues E81, K84, N162, and D156 (Figure 3.23). 
 
Figure 3.23  View of energetically favorable site for Zn2+ binding in the 
DHQS open structure containing the structurally characterized Zn2+ cation.  
Contour level set at –55 kcal/mol. 
 
The zinc dication probe was employed to investigate the DHQS closed 
structure for Zn2+-binding sites.  The zinc dication probe located two energetically 
favorable binding sites, the first having nearest neighbor residues E81, K84, 
N162, and D156, and the second E194, H287, and H271 (Figure 3.24).  The point 
corresponding to the later was 2.1 Å from the structurally characterized binding 
site of Zn2+ (Figure 3.24), indicating a close approximation by GRID of the 




Figure 3.24  One monomer indicating the three most energetically favorable 
sites for the DHQS closed structure, one at the surface and two near the 
experimentally known active site.  The residues near the two regions of 
interest have been featured in more detailed figures.  The carbaphosphonate 
(CRB) and Zn2+ (green) molecules have been overlayed on the data map to 
aid in visualization.   The contour level is set at –50 kcal/mol.  
 
Zn2+ was incorporated into the DHQS closed structure and it was 
reanalyzed.  Two energetically favorable binding sites were found on the surface.  
The first energetically favorable site to occur on the interior of the enzyme had 
nearest neighbor residues E81, K84, N162, and D156, which are identical to the 





Zn2+ active site 
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most energetically favorable binding site for Zn2+ in the DHQS closed structure is 
located 14.8 Å away from the experimentally known Zn2+ active site.  
 
Figure 3.25  The most energetically favorable binding sites for the zinc 
dication probe for the DHQS closed structure.  Contour level set at –50 
kcal/mol.  The interacting residues are indicated as ball-and-stick models. 
 
EPSPS Calculations 
GRID calculations were performed on both the open and closed forms of 
EPSPS.  All sulfate and water molecules were removed from the open structure 
and calculations were preformed on the apoenzyme.  In the closed form, the 
water, formate, glyphosate, and shikimate 3-phosphate molecules were removed 
prior to the initial calculations.  The shikimate 3-phosphate molecule was then 
placed back into the structure file to simulate binding energies after the first step 
of the ordered mechanism[47] and the calculations repeated.  Unless otherwise 
stated, all calculations are assumed to be on the apoenzyme. 
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Several probes were used to investigate potential binding sites on the 
enzyme.  The probes are designed to locate energetically favorable binding sites 
on the enzyme for the functional moiety they represent.  Based on the structure of 
the substrates, shikimate 3-phosphate and PEP, inhibitor glyphosate, probes were 
chosen to model their functional groups (Figure 3.26).  The carboxy, carbonyl, 
and multi-atom carboxy probes were selected due to the presence of a carboxy 
functional group on all three molecules (Figure 3.26).  The phosphate or 
phosphonate moeity on shikimate 3-phosphate, PEP, and glyphosate respectively, 
is a primary binding feature of all three structures (Figure 3.26).  The hydrogen 
phosphate monoanion and phosphate dianion probes were chosen to search for 
binding sites in the enzyme for HPO4 and PO42, respectively.  The hydroxyl 
probe was chosen to simulate the two OH moieties present on the shikimate 3-
phosphate molecule.  The hydroxyl functional group is one of the only probes, 
which could be used to distinguish shikimate 3-phosphate binding from PEP and 






























Figure 3.26  The hydroxyl, carboxy, carbonyl, multi-atom carboxy, hydrogen 
phosphate monoanion, and phosphate dianion probes will be used to locate 
the binding pocket for the color coordinated functional groups on the DHQS 
substrate and substrate-analogue. 
 
Hydroxyl Probe 
The open EPSPS structure was explored with the hydroxyl probe to locate 
regions of the protein that favor interaction with an OH moiety.  A number of 
favorable interactions were located throughout the protein with similar energetic 
favorability.  None of the locations were significantly more favorable when 
compared to other interaction and, therefore, did not merit being labeled as a 
hydroxyl binding pocket.  
 The hydroxyl probe was used to investigate the EPSPS closed structure for 
a potential area of interaction for an alkyl hydroxyl group on the enzyme.  
Energetically favorable interactions were located at the phosphate binding pocket 
for the shikimate 3-phosphate molecule and the carboxy binding pocket for the 
glyphosate molecule (Figure 3.27).  Weak interactions were also found between 
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the hydroxyl probe and residues D313 and K22, corresponding to the binding 
location of the hydroxyl moieties of the shikimate 3-phosphate molecule (Figure 
3.27). 
 
Figure 3.27  The two most energetically favorable binding sites for the 
hydroxyl probe on the EPSPS closed structure.  Contour level set at –10 
kcal/mol.  The shikimate 3-phosphate (S3P) and glyphosate (GPJ) molecules 
have been overlayed on the data map to aid in visualization. 
 
Carboxy Probe 
 The open EPSPS structure was investigated with the carboxy probe to 
located regions of the protein that favor interactions with an anionic carboxy 
oxygen atom.   Several energetically favorable sites were located both on the 
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experimentally known phosphonate binding pocket of glyphosate in the closed 
structure, R124, Q171, G96 and N94.  At energy values around –8 kcal/mol 
favorable binding sites are found near residues R27 and S23, which correspond to 
the structurally known carboxy group binding site of shikimate 3-phosphate in the 
closed EPSPS structure (Figure 3.28). 
 
Figure 3.28  View of glyphosate phosphonate binding pocket recognized by 
the carboxy probe in the EPSPS open structure.  Contour set at –9.5 
kcal/mol.  Interacting residues are indicated as ball-and-stick models. 
 
 The EPSPS closed structure was investigated with the carboxy probe to 
locate the most favorable binding site for sp2 carbonyl oxygen atoms.  Again, 
several energetically favorable sites were located both on the surface and in the 
interior of the enzyme.  Residues K340 and S170 were identified to form 
favorable interactions with a carboxy functional group.  These residues compose 
part of the phosphate binding pocket of the shikimate 3-phosphate molecules.  A 
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second site of interaction for a carboxy moiety was determined by GRID to 
involve residues R344 and R386, which form the carboxy binding pocket of the 
glyphosate molecule in the EPSPS closed conformation (Figure 3.29).   
 
Figure 3.29  The energetically favorable binding sites for the carboxy probe 
in the EPSPS closed structure.  Contour level set at –11 kcal/mol.  The 
shikimate 3-phosphate (S3P) and glyphosate (GPJ) molecules have been 
overlayed on the data map to aid in visualization. 
 
Carbonyl Probe 
 The carbonyl probe, a small molecule probe designed to locate 
energetically favorable sites for interaction with a carbonyl oxygen atom, was 
Most energetically 
favorable site found at 
phosphate binding site 
of S3P 
Energetically favorable 
site found at phosphonate 




used to locate favorable sites in the open EPSPS structure.  A potential binding 
site for a sp2 carbonyl oxygen functional group was found near residues R124, 
Q171 and G96.  The size and shape of the contours were found to be nearly 
identical to those found for the carboxy probe (Figure 3.28). 
 The EPSPS closed structure was evaluated with the carbonyl probe.  An 
energetically favorable binding site for a sp2 carbonyl oxygen functional group 
was found near residues K340 and R344.  The site corresponds to the structurally 
identified binding pocket of the carboxy functional group on glyphosate.  The size 
and shape of the contours, which are involved in the interaction, were found to be 
nearly identical to the carboxy probe (Figure 3.29). 
Carboxy Multi-atom Probe 
 The carboxy multi-atom probe (Figure 3.17) was employed to locate the 
most energetically favorable binding sites for a carboxy functional group in the 
EPSPS open enzyme.  Energetically favorable binding sites for the carboxy multi-
atom probe were found to have nearest neighbor residue interactions S23 and R27 
(Figure 3.30).  These residues are known to form the carboxy binding pocket for 
the shikimate 3-phosphate molecule in the closed EPSPS structure.   
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Figure 3.30  View of the full structure of the apoenzyme illustrating the 
binding pocket located by the carboxy multi-atom probe in the EPSPS open 
structure.  The contour level is set at –12 kcal/mol. 
 
The EPSPS closed structure was evaluated for energetically favorable 
binding sites for a COO functional group using the carboxy multi-atom probe.  
Energetically favorable sites were located near residues S170, Q171, and S197.  
These residues correspond to the known binding region of the phosphate unit of 
the shikimate 3-phosphate molecule.  After locating the shikimate 3-phosphate 
binding region, the phosphonate binding residues of the glyphosate molecule, 
R124, G96, and Q171, were identified as energetically favorable residues toward 
a carboxy multi-atom probe (Figure 3.31).   
Energetically favorable carboxy 
binding pocket before enzyme closes  
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Figure 3.31  The energetically favorable binding sites for the carboxy multi-
atom probe in the EPSPS closed structure.  Contour level set at –15 kcal/mol.  
The shikimate 3-phosphate (S3P) and glyphosate (GPJ) molecules have been 
overlayed on the data map to aid in visualization. 
 
Phosphate Dianion Probe 
 The EPSPS open structure was analyzed with the phosphate dianion probe 
to simulate a phosphate dianion with no hydrogens.  The probe located three 
important energetically favorable binding sites for a PO42 moiety.  Residues 
Q171, R124, N94, K411, and G96 create a binding pocket for phosphate, which is 
known to be the active site for the phosphonate group of the glyphosate molecule.  
The residues participating in the binding site of the phosphate functional group on 
the shikimate 3-phosphate molecule were also identified, S170, S169, and S197.  
Additionally, residues R344 and R386 were determined to create a binding pocket 
energetically favorable for PO42 bonding; however, the location is the structurally 
Energetically favorable 
site at phosphate 
binding pocket of S3P  
Energetically 
favorable site at 
phosphonate binding 
pocket of GPJ 
GPJS3P
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characterized binding site of the carboxy moiety of the glyphosate molecule 
(Figure 3.32).   
 
 
Figure 3.32  a) View of the full structure of the apoenzyme illustrating the 
three important binding pockets located by the phosphate dianion probe in 
the EPSPS open structure.  S3P and GPJ represent shikimate 3-phosphate 
and glyphosate, respectively.  b) A detailed view of the active site with the N- 
and C-terminal domains indicated in red and blue respectively. The contour 
level is set at –12 kcal/mol.   
phosphate binding 
pocket of S3P 
phosphonate binding 
pocket of GPJ 
carboxy binding 




 The EPSPS closed structure was evaluated with the phosphate dianion 
probe to locate the most favorable binding sites for a PO42 moiety.  Residues 
interacting with the most energetically favorable binding site were G96, R124, 
and K411, which are the known nearest neighbor residues of the phosphonate 
group of the bound gylphosate molecule.  A second site favorable for phosphate 
binding was located with nearest neighbor residue interactions K340, S170, and 
S197, which is the binding pocket of the shikimate 3-phosphate molecule (Figure 
3.33).   
 
Figure 3.33  Energetically favorable binding sites for the phosphate dianion 
probe in the EPSPS closed structure.  Contour level set at –18 kcal/mol.  The 
shikimate 3-phosphate (S3P) and glyphosate (GPJ) molecules have been 
overlayed on the data map to aid in visualization. 
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Hydrogen Phosphate Monoanion Probe 
 The open EPSPS structure was explored with the hydrogen phosphate 
monoanion probe to locate energetically favorable sites on the protein for HPO4 
interactions to occur.  Residues K411, R124, G96, Q171, and N94 create a 
binding pocket for HPO4 functional groups.  The site is known to be the active 
site for the phosphonate group of the glyphosate molecule.  The residues 
participating in the binding site of the phosphate functional group on the 
shikimate 3-phosphate molecule were also identified, S170, S169, and S197.  
Additionally, residues R344 and R386 were determined to create a binding pocket 
energetically favorable for HPO4 interactions; however, the location is the 
structurally determined binding site of the carboxy moiety of the glyphosate 
molecule.  The size and shape of the countour maps were nearly identical to those 
determined using the phosphate dianion probe (Figure 3.32). 
Using the hydrogen phosphate anion probe to locate energetically 
favorable binding pockets for HPO4 in the EPSPS closed structure, similar results 
were observed to those found using the phosphate dianion probe.  Residues 
interacting with the most energetically favorable binding site were G96, R124, 
and K411, which are the known nearest neighbor residues of the phosphonate 
group of the bound gylphosate molecule.  A second site favorable for phosphate 
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binding was located with nearest neighbor residue interactions K340, S170, and 
S197, which is the structurally determined binding pocket of the shikimate 3-
phosphate molecule.  The size and shape of the contours for the hydrogen 
phosphate monoanion probe and the phosphate dianion probe on the EPSPS 
closed structure were nearly identical (Figure 3.33).  
DISCUSSION AND CONCLUSIONS  
DHQS Discussion 
DHQS is a multi-functional enzyme, which is believed to perform five 
consecutive chemical reactions in a single active site.[15-18, 48-50]  Whether the 
enzyme is actively involved in each of these steps,[15, 18] or rather several steps 
occur spontaneously[16, 17, 48] has been the topic of considerable debate.  The 
substrate-analogue, carbaphosphonate, has been crystallographically characterized 
bound to the enzyme and has provided insight into the residues which could play 
key roles in the binding of the inhibitor and the catalytic mechanism.[6]  The 
structure provided evidence to support DHQS’s ability to perform multi-step 
catalysis without the formation of unwanted by-products.   
Another interesting characteristic of DHQS is that it exists in two forms, 
open[7, 29] and closed.[6, 7, 29]  Prior to binding of the substrate, DHQS is loosely 
packed with a moderately exposed active site; however, in the presence of 
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substrate or substrate analogue, the structure under goes a conformational change 
to a more tightly packed form (Figure 3.10 a and b). 
In addition to performing multi-step catalysis and interesting 
conformational changes, DHQS, is of appeal as a potential target for the 
development of antimicrobials.[3]  Because the shikimate pathway is absent from 
mammals, antimicrobials targeted at DHQS are expected to have limited toxicity 
in humans.[3]    
To aid in understanding the substrate binding site potentials in the active 
site region, the program GRID was implemented.  The use of GRID has provided 
information regarding the active site recognition features in the open DHQS 
structure and potential interactions, which may initiate enzyme closure.  Residues 
involved in the catalytic mechanism of DHQS were determined using GRID 
software.  Identification of the key active site binding pockets has allowed for the 
design of a potential antimicrobial target compound. 
In an attempt to identify substrate recognition pockets in the open enzyme, 
the DHQS open structure based on crystallographic analysis was evaluated using 
several GRID probes.  The substrate, DAHP, has both a carboxy and a 
phosphonate moiety, which play an important role in binding and orienting the 
substrate molecule in the enzyme.  The known carboxy binding pocket was 
corroborated using GRID analysis.  The carboxy, carbonyl, and carboxy multi-
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atom probes located interactions with the Cδ and amino group of the side chain of 
K250 and the amino group of K152.  The phosphate dianion and hydrogen 
phosphate monoanion probes identified similar interactions, the Nε of the side 
chain and the terminal amino group of the side chain of R264, the side chain 
amino group of K152 and K250 (Figure 3.13 and Figure 3.18).  The phosphate 
binding pocket for the substrate was determined using phosphate dianion and 
hydrogen phosphate monoanion probes (Figure 3.35).  Energetically favorable 
interactions with the side chain amino groups of R130(B) and the side chain 
amino groups of K152 and N162 indicate the presence of a phosphate binding 
pocket prior to the conformational change (Figure 3.19).   
 
Figure 3.34  Cartoon diagram of binding pockets and carbaphosphonate 
prior to the closure of DHQS followed by the docking of the substrate and 
enzyme closure.  The phosphate and carboxy binding pockets are indicated 
in red and green respectively. 
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The presence of the energetically favorable phosphate binding site in the 
open structure may indicate a substrate binding recognition feature.  The 
phosphate functional group of the substrate could initially bind in the pocket 
formed by R130(B), K152, and N162, which would correctly position the 
molecule before the closure of the enzyme.  DHQS undergoes a conformational 
change in the presence of substrate or substrate-analogue;[6, 7, 29] GRID 
calculations indicate that open structure binding recognition features may play a 
vital role in the conformational change which occurs in the enzyme.          
Evaluation of the DHQS closed structure with GRID probes has increased 
our understanding of which residues play an important role in the catalytic 
mechanism of converting DAHP to DHQ.  The carboxy, carbonyl, and multi-atom 
carboxy probe located similar energetically favorable binding pockets.  The most 
energetically favorable pocket involved residues K152, K250, and R264.  These 
residues are proposed to play an important role in the catalytic mechanism of 
DHQS by binding the carboxy functional group of the substrate.[6]  Based on 
GRID output, the backbone nitrogen and oxygen of K152, the side chain amino 
group of K250, as well as the backbone oxygen and the side amino group of R264 
are the moieties that create a binding pocket energetically favorable for a carboxy 
functional group (Figure 3.35).  Residues K256, N268, R130(B), N162, and K356 
also show energetically favorable interactions with the carboxy, carbonyl, and 
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multi-atom carboxy probes (Figure 3.35).  Based on the X-ray crystal structure, 
these residues form the phosphate binding pocket of the substrate-analogue 
molecule.  Analysis of the DHQS closed structure with the hydrogen phosphate 
monoanion and phosphate dianion probes indicated identical atom interactions as 
those found using the carboxy, carbonyl, and multi-atom carboxy probes (Figure 
3.14, Figure 3.16, and Figure 3.20).    
 
Figure 3.35  Residues in the active site of DHQS with energetically favorable 
interactions towards the carbonyl, carboxy, carboxy multi-atom probes 
indicated in green, while residues with energetically favorable interactions 
towards the phosphate and hydrogen phosphate probes shown in red.  The 
green/red residue interacts with both the carboxy and phosphonate moieties 
of carbaphosphonate.  Zn2+ is indicated in orange.  Figure created using 










Evaluating the residue interactions proposed by Carpenter et al.[6] and the 
new information provided via GRID calculations, specific atomic interactions 
participating in the mechanism can be discussed.  The substrate is held in place by 
energetically favorable binding pockets toward the carboxy and phosphate 
moieties.  During the ring-opening step, the possibility of epimerization at C2 of 
intermediate D (Figure 3.3) arises.  Previous work has indicated that no 
epimerization occurs about the C2 bond in the enzyme-mediated reaction.[18]  
GRID calculations indicate that the absence of epimerization is due to strong 
bonding interactions between the carboxy group on C2 of intermediate D and the 
backbone nitrogen and oxygen groups of K152, the side chain nitrogen of K250 
and the backbone oxygen and side chain amino group of R264.   
Interestingly, H275 is not believed to contribute to the binding pocket for 
the phosphate moiety of the substrate; however, it is recognized by all five GRID 
probes explored to be energetically favorable toward carboxy-type and phosphate-
type probes.  The nitrogen atom and CH group of the histidine ring of H275 were 
all determined to be part of an energetically favorable region for phosphate and 
carboxy binding.  H275 is hypothesized to participate in a proton-shuffling 
system[6] during formation of intermediates A and C of the mechanism (Figure 
3.3).  In the formation of intermediate A, H275 acts as a proton acceptor, while it 
is a proton donor for the formation of intermediate C (Figure 3.3).  Considering 
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the proximity to the active site and the amphoteric nature of this histidine residue, 
it is not surprising that it acts favorably toward the GRID probes utilized. 
Inhibitors designed to target DHQS are promising as antimicrobial agents 
due to the presence of the shikimate pathway in microorganisms, but not 
mammals.[51]  Carbaphosphonate is a nanomolar-level, slowly reversible inhibitor 
of DHQS, which was designed to competitively bind with the substrate DAHP.[16, 
17]  Modifications to the functional groups of carbaphosphonate, such as 
replacement of the phosphonate moiety with CH3(CO2H)2 and mono saturation of 
the cyclohexanol ring, have also produced DHQS inhibitors.[50]  Based on GRID 
calculations and previous methods used to inhibit metalloenzymes (e.g. [52]), 
potential inhibitors of DHQS could involve coordination to the Zn2+ and blocking 
of the active site.  Taking advantage of the high affinity of Zn2+ for S, an 
inhibitor, such as that shown in Figure 3.36, has the potential to occupy the 
substrate binding pocket.  The carboxy functional group of the proposed inhibitor 
would bind to residues K250, R264, and K152, in a manner similar to the 
substrate, while the sulfide moiety interacts with the Zn2+.  The substrate, DAHP, 
has an overall charge of –3, while that of the proposed inhibitor is –2 making it 













Figure 3.36  Proposed inhibitor for DHQS, which utilizes both the carboxy 
binding pocket and the Zn2+ cation. 
 
DHQS requires the presence of a divalent cation,[14] such as Zn2+ for 
activity.  However, in vitro trivalent lanthanides,[53] such as Sm3+ and Eu3+, have 
also been shown to activate the enzyme.  Interestingly, the presence of large 
quantities of metal ions in solution has been shown to decrease the activity of the 
enzyme, suggesting the presence of an allosteric site.[54]  Investigating the DHQS 
open and closed structures for the presence of Zn2+ active sites has provided 
additional evidence to support the hypothesis of an allosteric site.  The zinc 
dication probe located two potential Zn2+ binding sites near the active site of both 
the open and closed DHQS structure (Figure 3.22 and Figure 3.24).  In the open 
structure the most energetically favorable site was determined to interactions with 
residues H287, E194, and H271.  This site matched the known binding site of 
Zn2+ within a distance of approximately 1 Å.  In the DHQS closed structure, the 
zinc dication probe found residues E81, K84, N162, and D156 to provide the most 
energetically active site for Zn2+ binding.  This site is approximately 15 Å away 
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from the structurally characterized binding site of Zn2+.  The known Zn2+ binding 
site, H287, E194, and H271, was also determined to be energetically favorable in 
the DHQS closed structure.  GRID provides significant evidence for the presence 
of an allosteric site, which could account for the reduced activity when the 
enzyme is in the presence of a large excess of metal cations.    
During catalysis, DHQS has been shown to undergo a conformational 
change (Figure 3.34).  DHQS forms a tightly packed structure in the presence of 
substrate called the “closed” form,[6, 7, 29] whereas in the absence of substrate it 
exists in an “open” conformation.[7, 29]  The availability of structural data for both 
the open and closed forms of DHQS has allowed for a computational study to 
identify recognition features of the enzyme that induce the substrate-dependent 
conformational change.   Both the carboxy and phosphate binding pockets are 
present prior to the closure of the structure.  If the substrate initially binds to the 
carboxy site then the charge on the phosphate moiety could potentially attract the 
binding pocket residues, R130 and N162, initiating the conformational change 
(Figure 3.37). 
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Figure 3.37  Carboxy (green) and phosponate (red) binding pockets present 
in DHQS a) open and b) closed conformations.  Zn2+ is indicated in orange, 
while carbaphosphonate is depicted in yellow with the carboxy and 
phosphonate moieties highlighted in green and red, respectively.  Figure 
created using Pymol (DeLano Scientific, San Carlos, California).  
 
EPSPS Discussion 
EPSPS is one of the most extensively studied enzymes in the shikimate 
pathway due to the commercial use of the inhibitor glyphosate as an herbicide.[34]  
Glyphosate does not bind to the apoenzyme, but rather to the enzyme—shikimate 
3-phosphate complex.[34]  Much work has been devoted to determining the exact 
binding site of glyphosate and how it competes with PEP.[8, 23-25]  GRID 
calculations were undertaken to investigate the binding site of glyphosate and 
shikimate 3-phosphate EPSPS. 
a) b)
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In addition to locating functional group binding pockets in EPSPS, GRID 
calculations were utilized to investigate the residues which play a vital role in the 
catalytic mechanism of EPSPS.  Considerable debate over the possibility of a 
random rather than an ordered mechanism for substrate binding in EPSPS has 
occurred.[36, 37]  The use of GRID will provide insight into which mechanism is 
most likely to occur based on the presence of binding pockets in the apoenzyme.   
High resolution X-ray crystal structures of EPSPS, uncomplexed and two 
complexed structures (one with shikimate 3-phosphate and glyphosate[9, 29] and 
the other with shikimate 3-phosphate and formate),[8, 9, 29] have improved our 
understanding of the mechanism and inhibition of EPSPS.  The availability of 
both forms of EPSPS, open and closed, provides the opportunity to perform 
computational analysis to further investigate the environment around the active 
site.  GRID calculations were employed to provide insight into the interactions of 
shikimate 3-phosphate and glyphosate with EPSPS and identify the presence of 
binding pockets, which may contribute to the conformational change that occurs 
in the enzyme.    
The shikimate pathway has been identified as a potential drug target for 
the development of new antimicrobial agents.[51]  The presence of the shikimate 
pathway in bacteria, fungi, plants and some apicomplexan parasites, but not in 
mammals,[5] indicates that antimicrobial agents aimed to disrupt this pathway may 
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have minimal side effects on mammals.  A primary use of GRID calculations is 
the design of lead compounds based on information regarding energetically 
favorable binding sites in a structure.  GRID calculations were performed on the 
structure of EPSPS to search for potential energetically favorable binding sites for 
antimicrobial lead compounds.   
As discussed previously, EPSPS catalyzes the condensation of PEP with 
shikimate 3-phosphate to produce EPSP (Figure 3.1).[3]  The reaction can be 
inhibited by glyphosate which does not bind to the apoenzyme, but rather to the 
enzyme-shikimate 3-phosphate complex.[4]  In an attempt to identify substrate and 
inhibitor recognition pockets in the open enzyme, the EPSPS open structure was 
evaluated using several GRID probes.  Four binding pockets were located, the 
phosphate/phosphonate binding pockets for shikimate 3-phosphate and glyphosate 




Figure 3.38  Cartoon diagram of phosphate and carboxy binding pockets 
prior to the closure of EPSPS.  The enzyme closes and the shikimate 3-
phosphate and glyphosate molecules are shown in their docking sites.  The 
phosphonate and carboxy binding pockets of glyphosate are indicated in red 
and green, respectively, while the phosphate and carboxy binding pockets of 
shikimate 3-phosphate are indicated in orange and light green. 
 
The carboxy binding pocket of shikimate 3-phosphate was determined to 
be present in the open EPSPS structure (Figure 3.38).  Analysis with the carbonyl, 
carboxy, and carboxy multi-atom probes indicated interactions with side chain 
oxygen of S23 and amino group of R27 (Figure 3.27).  The importance of R27 in 
enzyme activity has been demonstrated by the mutation from arginine to alanine 
resulting in a complete loss of activity.[55]  This mutation, along with the GRID 
calculations, indicates the vital role played by the presence of the basic guanido 
group in the binding of the carboxy functional group of shikimate 3-phosphate. 
The phosphate functional group of shikimate 3-phosphate is known to 
bind to S170, S169, and S197; this was corroborated using GRID calculations.  
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The hydrogen phosphate and phosphate probes located interactions with the 
backbone nitrogen and side chain oxygen of S170, the side chain oxygen of S169 
and S197 (Figure 3.33).  The presence of this energetically favorable binding site 
prior to the closure of the enzyme may indicate it plays a critical role in substrate 
initiated conformational change.       
The carboxy binding pocket of shikimate 3-phosphate was determined to 
be present in the open EPSPS structure (Figure 3.38).  Analysis with the carbonyl, 
carboxy, and carboxy multi-atom probes indicated interactions with the side chain 
amino groups of R344 and R386 (Figure 3.29 and Figure 3.31).  These residues 
may play an important role in the EPSPS mechanism by positioning PEP within 
the active site to enable protonation of PEP by the 5-hydroxyl of shikimate 3-
phosphate.[56]    
GRID calculations using the phosphate and hydrogen phosphate probes 
located an energetically favorable binding site involving residues G96, R124 and 
Q171 (Figure 3.33).  These residues are known to be involved in forming the 
phosphonate binding pocket of glyphosate and are potentially involved in the 
binding of PEP.  The phosphate-type probes interacted with the backbone 
nitrogen group of G96, the amino side chain groups of R124 and the side chain 
amino group of Q171.  Based on site-directed mutagenesis studies, the residue has 
been shown to play a vital role in glyphosate binding.  Mutation of the glycine to 
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an alanine greatly reduces the enzyme’s affinity for glyphosate.[25, 57]  The 
mutation and the information acquired from GRID calculations indicate the 
presence of the hydrogen to be important for the binding of the phosphonate 
moiety of glyphosate.   
The EPSPS reaction involves the transfer of the enolpyruvyl group of PEP 
to the 5-hydroxyl group of shikimate 3-phosphate to produce EPSP and inorganic 
phosphate (Figure 3.1).  The most widely accepted mechanism (Figure 3.6)[36] 
proposes that the reaction involves protonation of C2 of PEP by the acquisition of 
a proton from a base in the enzyme, with associated nucleophilic attack on C2 of 
PEP by the C5 hydroxyl of shikimate 3-phoshpate to form the tetrahedral 
intermediate (Figure 3.6).  The following step is the removal of a proton from the 
C5 hydroxyl by a proton acceptor in the enzyme, resulting in the formation of 
EPSP and inorganic phosphate (Figure 3.6).[36]  
GRID calculations were utilized to provide additional insight into the 
mechanism for the catalytic conversion of shikimate 3-phosphate to 5-
enolpyruvylshikimate 3-phosphate by EPSPS.  Both shikimate 3-phosphate and 
PEP have a carboxy and a phosphate moiety.  The GRID probes, carboxy, 
carbonyl, carboxy multi-atom, hydrogen phosphate monoanion, and phosphate 
dianion, located identical binding pockets in the closed structure which were the 
phosphate/phosphonate binding pockets of shikimate 3-phosphate and glyphosate.  
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Important atomic interactions in the shikimate 3-phosphate binding pocket were 
identified as the side chain oxygen and the backbone nitrogen group of S170 and 
the side chain oxygens of S169 and S197.  The amino group of K411, the side 
chain amino groups of R124, the backbone nitrogen of G96, the side chain 
oxygen and amino group of Q171 and the oxygen of N94 were identified as the 
energetically favorable binding pocket for glyphosate (Figure 3.39).   
The phosphate/phosphonate binding pockets play an important role in 
positioning the substrates in the enzyme.  In order for protonation of C2 of PEP to 
occur, the C5 hydroxyl of shikimate 3-phosphate must be within approximately 
2.7 Å of the C2 of PEP to initiate a nucleophilic attack.[58]  Additionally, PEP and 
the proton acceptor residue, believed to be G341,[8] must be within a distance of 
approximately 2.8 Å to transfer a proton.[59]  After formation of the tetrahedral 
intermediate, a proton is removed from the C5 hydroxyl by a proton acceptor in 
the enzyme, G341.[8]  Again, the phosphate binding pockets may functions to 
maintain the correct position and orientation of the small molecules during the 
deprotonation step. 
The similarities in functional groups on PEP and glyphosate make it 
impossible to distinguish between the binding sites of the two molecules utilizing 
GRID.  Both structures contain a carboxy and phosphate moiety (Figure 3.26); the 
primary difference between the two structures is the separation between the 
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carboxy and phosphate groups.  The maximum separation between the carboxy 
and phosphate groups is 5.2 Å and 4.2 Å for glyphosate and PEP, respectively.  
GRID is designed only to identify potential functional group binding sites with no 
distinction made for the distance between two moieties.  However, based on the 
lack of additional energetically favorable sites, PEP and glyphosate binding sites 




























































Figure 3.39  The active site of EPSPS indicating the important residue 
interactions with shikimate 3-phosphate and glyphosate.  Residues located in 
The N- and C-terminal domains are shaded in blue and peach, respectively.  
Residues found to be energetically favorable toward all probes used are 
shown in red.   
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Because the shikimate pathway is absent from mammals, EPSPS is an 
attractive target for the development of new antimicrobial agents.[3]  Based on the 
structure and mechanism of the widely used inhibitor glyphosate, several attempts 
have been made to develop lead compounds in the design of new EPSPS 
inhibitors (e.g. [60, 61]).  Most work has been targeted at altering the structure of 
glyphosate to improve inhibition;[61] however, a different approach is the design 
of a bisubstrate inhibitor which will simultaneously occupy both the S3P- and 
PEP-binding sites.[60]  Previous attempts at designing an EPSPS bisubstrate 
inhibitor include compounds A[62] and B[63] in Figure 3.40.  Compound A mimics 
the S3P-PEP intermediate and is a potent EPSPS inhibitor.  Compound B is also 
an effective EPSPS inhibitor due to its multiple anionic charge at the five position 
of the dihydroxylbenzoate.  Both inhibitors utilize the more synthetically 


















Based on data acquired from GRID calculations, the energetically 
favorable binding pocket for a phosphate or phosphonate moiety makes the 
presence of such a group in a potential inhibitor advantageous to assure strong 
binding.  Prior to substrate binding, phosphate binding pockets are present for 
both the substrate and inhibitor.  An energetically favorable binding location for 
the carboxy moiety of the substrate is also present.  Once the structure closes, the 
two phosphate binding pockets are most energetically favorable.  A potential 
method for inhibiting the functioning of the enzyme it to take advantage of the 
two phosphate binding pockets by creating a bisubstrate inhibitor which will 
interact with both pockets.  One possibility is the ester shown in Figure 3.41.  The 
phosphate and carboxy functional groups on the shikimate-like structure would 
bind, correctly orienting the phosphate functional group on the aromatic system to 
interact with the PEP binding pocket.  The flexibility of the ester chain would 
allow for adjustment of the inhibitor to fit in the binding pocket.  Like compounds 
A and B (Figure 3.40), the proposed inhibitor also utilizes the synthetically more 


















Figure 3.41  Structure of proposed inhibitor for EPSPS based on GRID 
calculations. 
 
Kinetic evidence by Boocock and Coggins[47] has supported the hypothesis 
of an ordered sequential mechanism in which binding of shikimate 3-phosphate 
precedes binding of PEP.  GRID calculations utilizing the carboxy, carbonyl, 
multi-atom carboxy, hydrogen phosphate and phosphate probes lend additional 
evidence to strengthen the hypothesis of an ordered binding mechanism.  As 
previously discussed, the carboxy and phosphate binding pockets for shikimate 3-
phosphate proved to be more energetically favorable toward the appropriate 
probes than were the carboxy and phosphate binding pockets of glyphosate.  The 
appropriate substrate will be bound to the most energetically favorable binding 
site before the secondary binding sites will be occupied.  In this case, the 
shikimate 3-phosphate would first dock into the pocket containing residues S170, 
S169, and S197 (i.e. the most energetically favorable site) prior to the docking of 
the glyphosate molecule.  
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It has been shown via small-angle X-ray scattering (SAXS) studies that 
shikimate 3-phosphate can induce a conformational change in EPSPS.[10]  The 
structure is a tightly packed and called the “closed” form whereas in the absence 
of substrate it exhibits an “open” conformation.  The availability of structural data 
for both the open and closed forms of EPSPS has allowed for a detailed 
computational study to identify recognition features of the enzyme that induce the 
substrate-dependent conformational change.  GRID calculations indicate that 
strong phosphate and carboxy binding pockets exist in the open EPSPS structure.  
These energetically favorable pockets provide a means by which the molecules 
can bind before the enzyme closes.  As indicated by GRID, the most probable 
mechanism for this is the initial binding of the phosphate moiety into the 
energetically favorable binding pocket involving residues S170, S169, and S197.  
The phosphate binding pocket orders the orientation of the shikimate molecule 
directing the carboxy group toward the carboxy binding pocket located in the 
opposite domain (Figure 3.32).  Due to the proximity of the carboxy moiety on 
the shikimate molecule to the energetically favorable binding pocket, the 
attractive forces would be predicted to initiate the closing of the enzyme. 
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Figure 3.42  The carboxy (green) and phosponate (red) binding pockets for 
glyphosate and the carboxy (light green) and phosphate (orange) binding 
pockets for shikimate 3-phosphate are shown in the EPSPS a) open and b) 
closed conformations.  Glyphosate amd shikimate 3-phosphate molecules are 
shown with gray carbon atoms, blue nitrogen atoms, red oxygen atoms and 
pink phosphorous atoms.  Figure created using Pymol (DeLano Scientific, 
San Carlos, California).   
 
Conclusions and Future Work 
GRID calculations were determined to be a valuable method for acquiring 
information regarding the binding sites for two shikimate pathway enzymes, 
DHQS and EPSPS.  Binding site recognition features, which are present in the 
substrate free structures, were identified using GRID and their role in 




calculations allowed for identification of residues which play a key role in the 
catalytic mechanism of the enzyme.  As both enzymes are potential targets for 
antimicrobials, suggestions for prospective inhibitors were made based on GRID 
analysis. 
The presence of a phosphate binding pocket in DHQS prior to the 
conformational change of the enzyme indicated that the carbaphosphonate 
molecule may initially dock into the phosphate binding pocket and then initiate 
the structural change by attracting the carboxy binding pocket (Figure 3.34 and 
Figure 3.38).  The residue interactions proposed by Carpenter et al.[6] for the 
catalytic mechanism of DHQS were corroborated by GRID analysis.  A plausible 
inhibitor, based on the strong interactions formed between Zn2+ and S, as well as 
the location of the carboxy binding pocket, was proposed (Figure 3.36). 
EPSPS showed energetically favorable binding interactions toward GRID 
probes in the open enzyme.  It was concluded that the conformational change 
occurs when the phosphate moiety of the shikimate 3-phosphate molecule binds 
to the open enzyme and attracts the carboxy binding pocket located in the 
opposite domain (Figure 3.38 and Figure 3.42).  Based on GRID analysis, a 
potential inhibitor was proposed which utilized the presence of the strong 
phosphate binding pockets and the proximity of the shikimate 3-phosphate and 
glyphosate binding sites (Figure 3.41). 
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The future direction of this project should include mutations of the 
phosphate binding pockets in DHQS and EPSPS to determine whether their 
absence in the open structure will impact the ability of the enzyme to close in the 
presence of substrate molecules, as predicted by GRID analysis.  Additionally, 
crystallization of DHQS in the presence of excess dications has the potential to 
provide structural information regarding the location of an allosteric binding site.  
GRID analysis provided information regarding the design of potential DHQS and 
EPSPS inhibitors.  These inhibitors should be synthesized and their potential 




 All calculations were performed using the Linux operating system and the 
GREAT, GRIN, and GRID software package[38] version 21.  Structure files were 
obtained from the PDB,[41] with the exception of the EPSPS and DHQS open 
structures which were provided by Dr. E. P. Carpenter.  All remarks and water 
molecules were removed from the protein database file before processing.  PDB 
files consist of two atom-type records, HETATM, which is used to define the 
properties of any molecule such as solvent molecules, ions, inhibitors, etc., while 
ATOM records are normally restricted to amino-acids, peptides, proteins, nucleic 
acids, other biological macromolecules such as sugars.   GRID uses a similar 
format, therefore; all substrates, inhibitors, and metal ions were identified as 
heteroatoms by changing the ATOM record to HETATM before beginning the 
calculations.   
Proteins of similar nature, e.g. DHQS open and DHQS closed, were 
superpositioned by XtalView software[64] version 3.2.1 to according to their Cα 
position to place them in a similar orientation for future comparison.  Protein 
residues missing from the protein database file were modeled in idealized 
positions according to the location of the side chain using XtalView software and 
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refined using CNSsolve,[65] Crystallography and NMR System software version 
1.1 at one refinement cycle of two hundred minimization steps.   
The files were prepared for use in GRID using program GRIN.  The 
charge of the protein was calculated in GRIN and counterions of Na+ or Cl were 
added appropriately to create a charge balanced structure.  To determine the best 
placement positions for the counterions, a GRID calculation was performed using 
the Na+ or Cl probe to locate the most energetically favorable binding site for the 
counterions.  The counterions were then manually entered in suggested positions 
away from the active site and set to move in response to the probe.  As the probe 
moves around the GRID and into the vicinity of the counterion, the counterion 
reacts and shifts slightly to avoid being “seen” by the probe.  Moving counterions 
prevent a large charged area from being present during the experiment.   
All GRID calculations were performed on the charge balanced protein 
coordinate files with the following directives: NETA (Number of Extra Target 
Atoms) equal to the number of HETATM records setting the small molecules to 
be included as part of the target, NPLA (Number of Planes) equal to 2 thus the 
GRID points were 0.5 Å apart to improve the accuracy of the contour surfaces, 
and MOVE equal to -1 to allow the counterions to be flexible with respect to the 
probe.   
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Probes used in the course of the experiment included both single-atom 
multi-atom types.  The hydroxyl probe used was modeled to locate energetically 
favorable areas for phenol or carboxy OH binding.  Three closely related probes 
were the carbonyl, carboxy and multi-atom carboxy.  The carbonyl probe was 
designed to locate regions of favorable binding energy toward sp2 carbonyl 
oxygens, while the carboxy probe was modeled as an sp2 carboxy oxygen atom.  
The multi-atom carboxy probe is a combination of both the single-atom carboxy 
and carbonyl probe, which more accurately reflects the binding affinity of a 
carboxy group.  The zinc probe used was modeled as the zinc dication.  The 
hydrogen phosphate monoanion, HPO4-, and the phosphate dianion, PO42-, probes 
were investigated but yielded different results only in the presence of a hydrogen-
accepting region.   
Visualization of Data 
The output data generated by GRID were read into MSI Insight II 
(Accelrys, Cambridge, UK) software version 2000 for visualization of the energy 
maps.  The data map files were output from Insight II (Accelrys, Cambridge, UK) 
as ascii files and reopened in DS Viewer Pro 5.0 (Accelrys, Cambridge, UK) for 
generation of the graphics.  Alwyn Jones’ O software[66] was used to visualize the 
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 In 2001, the World Health Organization reported that 1 in 3 people are 
infected with latent Mycobacterium tuberculosis worldwide.  There are 8 million 
new cases of active tuberculosis (TB) annually and 5000 individuals will die from 
an infectious pulmonary disease per day.[1]  Tuberculosis is a global problem, 
which requires further research to completely eradicate the disease. 
Streptomycin entered the market in 1946 as the first agent used to treat 
TB.[2]  Today, a combination therapy of four drugs: isonicotinic acid hydrazide 
(isoniazid, INH), rifampicin, pyrazinamide, and ethambutol/streptomycin[3] are 
used to treat tuberculosis.  However, there is a growing resistance to INH and 
rifampicin among the TB strains.  Some drug-resistant strains have been found to 
be resistant to 7 drugs.[4]  The development of new chemotherapeutic agents is 
hampered by a lack of knowledge regarding the pathogenesis of M. tuberculosis. 
Catalase-peroxidase (CP), encoded by the katG gene, has been shown to 
restore INH-sensitivity in resistant Mycobacterium smegmatis and M. tuberculosis 
strains[5] indicating a clear functional link between the katG gene and INH 
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activity.[6]  The exact role of CP in INH-sensitivity is unknown despite several 
attempts at uncovering its function.  Investigating the chromosomal DNA from a 
group of eight INH-resistant strains of M. tuberculosis revealed that two-thirds of 
the highly resistant strains completely lacked the katG gene.  Cole et al.[7] thereby 
suggested gene deletion as the mechanism behind INH-resistance.  In many cases, 
rather than being deleted from the chronosome, the katG gene was found to 
contain point mutations, deletions, or insertions of a few bases.[8]  Still other 
findings suggest that the katG gene is present in 78% of INH-resistant isolates.[9] 
M. tuberculosis CP is a dual-function enzyme, which is both catalase and 
peroxidase active.  The catalatic activity is comparable to that of monofunctional 
catalases, such as Horseradish peroxidase isozyme C (HRPC).  M. tuberculosis 
CP shows a broad spectrum of peroxidatic activity and can oxidize a wide range 
of one electron donors.     
Catalase Activity 
 The CPs show no significant homology to known catalase sequences and 
it seems that this dissimilarity may imply different active site architecture 
compared to conventional heme catalases.  However, inhibition studies with 
potassium cyanide, hydroxylamine, and azide have indicated the catalatic activity 
is mediated at the heme moiety.[10]  Mutation of one residue in the putative active 
site of CP can reduce both catalase and peroxidase functionality.[11, 12]  Therefore, 
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it has been suggested that the catalase activity proceeds via reduction of 
Compound I with H2O2 (Figure 4.1).  However, addition of H2O2 to CP 
Compound I using excess peroxoacetic acid did not lead to ferric CP; electron 
donation from H2O2 appeared to be blocked.  The peroxoacetic acid may 
sterically impede access to the two electron donor site, indicating that 
peroxoacetic acid is still bound or catalase activity may not proceed via 
Compound I.[13] 
ROHROOH












Fe = ferric protoporphyrin IX
 
Figure 4.1  Schematic of dual peroxidase and catalase mechanism.  Catalase 
mechanism is highlighted in the shadow box. 
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Peroxidase Activity 
Catalase-peroxidases can oxidize a wide range of one-electron donors.  
The oxidation proceeds in an enzyme like HRPC via the peroxidase cycle,[14, 15] 
which begins with the resting state ferric enzyme reacting with one equivalent of 
H2O2 to give Compound I (Figure 4.2).  Compound I is an oxyferryl iron-
protoporphyrin IX π-cation radical which is reduced by a single electron from the 
substrate to yield Compound II.  The final step is the reduction of Compound II to 
the resting state by another single electron typically from a second substrate 
molecule (Figure 4.2).[16-18]  In the case of yeast cytochrome c peroxidase (CcP), 
the cation radical is not localized on the protoporphyrin ring but is stabilized on a 
tryptophan residue adjacent to the heme.[19-21] 


















Figure 4.2  Peroxidase mechanism. 
 
A mechanism for the reduction of the pseudo-stable CP Compound I 
intermediate has been proposed by Regelsberger et al.[13] where both the heme 
protoporphyrin radical and the Fe(IV) species are reduced simultaneously by two 
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electrons.  One electron originates from a substrate molecule and one from an 
amino acid residue near the heme moiety.  The neighboring residue could 
potentially stabilize the radical, similar to W191 in CcP Compound I.[19, 22]  The 
oxidized residue is then reduced by the donation of a second electron from 
another substrate molecule (Figure 4.2). 
Until recently, the M. tuberculosis CP radical was assigned to the 
protoporphyrin π-cation radical of Compound I;[23] however, evidence for the 
presence of a tyrosyl radical in M. tuberculosis CP has been presented.[24]  Using 
rapid freeze-quench electron paramagnetic resonance Chouchane et al.[24] 
demonstrated the formation of tyrosyl radical in high yield from the resting 
enzyme treated with alkyl peroxide. 
In addition to showing catalase and peroxidase activity, M. tuberculosis 
CP exhibits activity toward numerous other systems.  This flexible enzyme 
behaves as a haloperoxidase capable of oxidizing chloride, bromide, and iodide in 
a peroxide- and enzyme-dependent manner.[25]  M. tuberculosis CP demonstrates 
effective removal of ONOOH at a rate comparable to that exhibited by other 
peroxynitrite decomposition catalysts.[26]  P450-like mono-oxygenase activity is 
yet another property exhibited by the versatile CP.[27]  Wengenack et al. reported 
that a catalytic quantity of superoxide dismutase (SOD) abolished INH turnover, 
while addition of a superoxide-generating system to M. tuberculosis CP plus INH 
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increases the oxidation rate of INH 5-fold.[26]  Based on these results, it was 
concluded that M. tuberculosis CP exhibits a superoxide-dependent pathway for 
INH oxidation.  However, the SOD-INH oxidation pathway has been criticized 
due to the presence of a SOD in M. tuberculosis, which has the potential to break 
down any superoxide present prior to its utilization by CP to oxidize INH.  
Magliozzo et al.[28] have reported that M. tuberculosis CP demonstrates Mn(II) 
peroxidase activity; however, this hypothesis has been disputed based on evidence 
by Bondiguel et al.[29] that Mn2+ has the ability to catalyze INH oxidation in the 
absence of enzyme.   
Soon after its introduction into clinical use, bacterial resistance to INH 
was reported.[6, 30]  Analysis of M. tuberculosis indicated that INH was 
metabolized to a number of products with 4-pyridylmethanol and isonicotinic acid 
predominating (Figure 4.3).[31, 32]  However, the metabolized products were not 
observed in INH-resistant organisms.[6]  Many INH-resistant isolates lack catalase 
and peroxidase activity.[30, 33]  After Zhang et al.[34] restored INH-sensitivity to an 
INH-resistant catalase-negative strain by introducing the katG gene, it is widely 
accepted that CP oxidizes INH[35, 36] and the M. tuberculosis katG gene confers 
INH sensitivity in vivo.[5]  However, the activated form of INH and the 
mechanism by which INH is metabolized remain highly disputed. 
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Figure 4.3  Product profiles for INH oxidation by whole cells of M. 
tuberculosis (in vivo) and by purified CP (in vitro). 
 
Mechanistic analysis of INH oxidation has yielded varied results between 
in vivo and in vitro studies.  Isonicotinic acid, isonicotinamide, and pyridine-4-
carboxyaldehyde are the three oxidation products formed during in vitro analysis 
(Figure 4.3).[28, 29, 35, 37]  Isonicotic acid and pyridine-4-carboxyaldehyde, as well 
as isonicotinol, which has not been seen in vitro, were determined to be oxidation 
products of INH in vivo (Figure 4.3).[38] 
In vivo, the predominant oxidation product is the alcohol, which is not 
detected in vitro.  Conversely, the isonicotinamide derivative has not been 
observed in vivo.[38]  Pyridine-4-carboxaldehyde may play an important role in 
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vivo since it is rapidly reduced to the alcohol when fed exogenously to whole cells 
of M. tuberculosis.[6]  The differences observed in vitro versus in vivo are most 
likely due to the difference that arises when measuring the systems.  In vitro the 
ability to detect less abundant products exists due to the limited system; where as, 
in vivo the plethora of components may interfere with observing reaction products 
and/or intermediates. 
Using 18O NMR, Johnsson and Schultz determined that there are two 
simultaneous metabolic pathways operating in INH metabolism to form 
isonicotinic acid.[35]  An acyl radical and an acyldiazonium ion were the 
postulated intermediates in the pathway.[35]  15N NMR studies led to the 
development of a mechanism which involves splitting of the N—N bond in 
INH.[35]  Additional HPLC studies involving 15N-labelled INH have led to the 
proposal of a C—N bond splitting mechanism.[29]  Formation of an acyl radical 
and diazene is followed by its transformation into hydrazine, which in turn 
becomes ammonia.[29]  The initial reduction of INH to a hydrazyl radical by one 
electron has been determined from square wave and cyclic voltammograms.[39]      
 Peroxidatic activity of CPs is believed to mediate INH activation.  CP-
dependent INH-oxidation requires O2 in vitro[28, 40] and in vivo.[6, 41]  Under 
aerobic conditions, H2O2 is a requirement in vitro.[28, 29]  Additionally, the 
observation that INH can be oxidized by HRPC has contributed to the hypothesis 
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of peroxidatic activity as the activation mediator for INH.[23, 42]  However, INH is 
oxidized both in the presence and absence of peroxide[28, 35, 43] raising questions 
regarding oxidation via a Compound I/II pathway.  Although the exact pathway is 
unknown, cyclic and square wave voltammetry show that the ferric CP midpoint 
potientials are too small to promote INH oxidation without formation of a high 
valent intermediate such as Compound I and II or oxyferrous CP.[39] 
 Two alternative mechanisms to the peroxidatic pathway for INH 
activation are a cytochrome P450-like pathway[28] and a superoxide-dependent 
pathway.[26]  The P450-like pathway involves reduction of the heme iron followed 
by binding of O2 to produce the oxyferrous form of the enzyme, which are 
analogous to Compound III (Figure 4.1) in peroxidases.  The oxyferrous CP then 
oxidizes INH, which returns it to the ferric resting state (Figure 4.4).[26]  Based on 
generation of superoxide during INH oxidation by HRPC, myeloperoxidase and 
extracts of M. tuberculosis H37Ra (a strain with attenuated virulence),[44-46] the 
superoxide-dependent pathway for INH oxidation was formulated.  Trace metals 
can autooxidize hydrazines by O2 generating superoxide.[44, 47, 48]  Oxyferrous CP 
is formed by binding of superoxide to the resting state ferric enzyme, which is 
followed by subsequent oxidation of INH and CP returning to the resting state 





















Figure 4.4  Proposed cytochrome P450-like pathway for iron activation and 
oxidation of INH. AH2 and AOH represent a substrate molecule and an 




























Figure 4.5  Proposed superoxide-dependent pathway for iron activation and 
oxidation of INH.  AH2 and AOH represent a substrate molecule and an 
oxidized substrate molecule, respectively. 
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 The presence and importance of the iron protoporphyrin IX moiety in INH 
oxidation is well documented; however, other metal ions have been reported to 
play a role in the catalytically competent form of CP.  Both Cu2+[48] and Mn2+[28] 
have been found to stimulate in vitro INH oxidation.  However, Mn2+ has been 
shown to oxidize INH in the absence of CP[29, 48] spawning much debate regarding 
the role, if any, of Mn2+ in INH oxidation.  The proposed Mn2+ binding site, 
determined by sequence alignment of M. tuberculosis CP with fungal manganese 
peroxide, is shown in Figure 4.6. 
 
Figure 4.6  The key aspartate residue in manganese peroxidase (MnP) is 
found in M. tuberculosis CP and is predicted to be at the start of a loop 
(bold) as in MnP.  The positively charged arginine residue of MnP is 
conserved in M. tuberculosis as lysine (underlined). 
 
NMR measurements have proven to be a valuable tool in determining the 
location and distances of INH-binding in M. tuberculosis.  Using 15N-labelled 
INH and longitudinal relaxation measurements, the iron-nitrogen distance from 
the heme to the hydrazide moiety of INH was determined to be 3.8 Å for wild-
type M. tuberculosis.[49]  Iron-hydrogen distances from the heme to INH were 
found to be approximately 12 Å,[50] much longer than the iron-nitrogen distances.  
Two-dimensional nuclear overhauser effect spectroscopy (NOESY), corroborated 
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these findings.[51] The presented data suggests that the INH hydrazide moiety 
points towards the heme iron atom. 
Based on 14N15N and 15N14N NMR for HRPC[51] and M. tuberculosis,[29] as 
well as INH incubation studies of the two enzymes,[29, 35, 37] Horseradish 
Peroxidase C (HRPC) has been suggested as a model compound for the 
mechanism and activation of INH in M. tuberculosis.[51]  In an NMR-based three 
dimensional model of INH bound to HRPC, Banci et al.[51] described the residues 
involved in binding INH.  The pyridine moiety of INH is located in a hydrophobic 
“aromatic binding pocket”,[52] near the heme-18 methyl and makes non-bonded 
interactions with residues G69, A140, P141, and F179, as well as the heme 
itself.[51]  The hydrazide moiety forms hydrogen bond to the backbone carbonyl 
oxygen of P139 at a distance of 2.7-2.8 Å and to a nitrogen atom of the distal 
histidine residue, H42, at a distance of 3.0 Å.  Considering the similarities in 
HRPC and M. tuberculosis CP, the model of INH bound to HRPC provides a 
structural framework to further understand the molecular interactions controlling 
INH binding and turnover.[51] 
 Structural information about M. tuberculosis can be derived from 
HRPC,[51] a peroxidase belonging to the Class III superfamily of plant, fungal, 
and bacterial peroxidase.[53]  HRPC has similar active site architecture at the N-
terminal domain of M. tuberculosis.[54]  The availability of a three dimensional 
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crystal structure of HRPC has clarified the residues located in the distal and 
proximal pockets of the heme molecule, identified the location of Ca2+ ions and 
indicated the presence of a substrate access channel.  The 306 residue structure of 
HRPC is composed primarily of α-helices and the structure is similar to other 
crystallographically characterized peroxidases (Figure 4.7a).[55]  The distal pocket 
of the heme moiety is composed of key catalytic residues R38, F41, and H42.  
Residues H170, Q176, S73, S35, and R31 form the proximal heme pocket.  Two 
Ca2+ ions are present in the structure.  The distal Ca2+ site is seven-coordinate 
with carbonyl and side chain oxygen atoms as ligands, while the proximal Ca2+ is 
located near T171.  Interestingly, Ca2+ is a requirement for the formation of the 
structural environment of the heme during in vitro folding of the denatured 
apoprotein.[56]  F68, F142, and F179 form a hydrophobic patch near the exposed 
heme edge, which is the suggested site of the pre-electron transfer complex 
formed between substrate and high oxidation state intermediates.[54] 
 Benzhydroxamic acid, a compound structurally similar to INH has been 
crystallographically characterized bound to HRPC.[52]  INH is predicted to occupy 
the same region of the active site in HRPC and have a similar orientation to that 
seen in the crystal structure of the HRPC-BHA complex.[51]  However, 
spectroscopic studies have indicated that HRPC has a higher affinity for BHA 
then INH.[57, 58]  It has been suggested that HRPC’s reduced affinity for INH is 
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associated with unfavorable desolvation of the pyrindinyl group predicted to 
remain non-hydrogen-bonded in the complex.[51, 58] 
 Cytochrome c peroxidase (CcP), a class I peroxidase, has been structurally 
characterized to contain ten helical segments with two clearly defined domains.[59]  
The heme moiety is located between the domains with only one of the pyrrol ring 
edges exposed to the external environment.  The junction between the domains is 
lined with aliphatic and aromatic side chains.  The heme iron atom is coordinated 
to a tryptophan, arginine, and histidine on the distal side and a histidine side chain 
on the proximal side of the heme.  The tryptophan residue is thought to be the site 
of free radical formation in CcP comound I.[19-21]  A threonine side chain forms a 
hydrogen bond with one of the heme propionates and a water molecule serves as 
the sixth heme ligand.[59]  The heme iron atom is displaced 0.3 to 0.5 Å below the 
plane of the heme toward the proximal histidine.  The most exposed surface 
occurs near the guanidinium group of the distal arginine residue and is the most 
direct route for ligands entering the pocket.[59] 
 The X-ray crystal structure of another class I peroxidase, ascorbate 
peroxidase (APX), has been reported.[60]  The overall fold of APX is nearly 
identical to that determined for CcP.  The active site structure is the same, 
including the hydrogen bonding interactions between the promixal histidine 
ligand, a buried aspartic acid residue and a tryptophane residue.  Unlike CcP, a 
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cation binding site is present approximately 8 Å from the α-carbon atom of the 
tryptophan residue in APX.[60]  The cation in APX was hyphothesized to be one 
factor that makes it more difficult to oxidize W179 than the corresponding W191 
in CcP, allowing for the formation of a prophyrin π-cation radical in compound I 
rather than a tryptophan radical.[60] 
 Ascorbate, the natural substrate of APX, was successfully crystallized 
bound to the enzyme.  The overall structure of the enzyme and active site were 
unaffected by ascorbate binding.  Previously, the δ-heme edge has been 
implicated as the binding site for aromatic substrates[61, 62] and ascorbate;[62, 63] 
however,  ascorbate was crystallographically determined to bind at the γ-meso 
position of the heme.[64]  The basic residues, R172, and K30, which are involved 
in binding of ascorbate, are not present in CcP.[64]  This difference accounts for 
the low activity of CcP towards ascorbate.[65]  A potassium cation was not 
observed near W179 in the APX-ascorbate structure; therefore, a more concise 
explanation was presented for formation of the prophyrin π-cation radical rather 
than a tryptophan radical.  The direct coupling of the substrate to the heme 6-
propionate bypasses the need for involvement of W179 in ascorbate oxidation and 
compound I is reduced through a porphyrin π-cation intermediate.[64] 
 The crystal structures of two CP homologues have been reported,  
Haloarcula marismortui[66] and Burkholderia pseudomallei[67] CP, which share 56 
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% identity / 70 % similarity and 65 % identity / 77 % similarity, respectively, with 
M. tuberculosis CP.  Structural information from these enzymes, H. marismortui 
CP and B. pseudomallei CP, has provided valuable insight into the architecture of 
M. tuberculosis CP by molecular modeling techniques.   
 H. marismortui CP is a dimer composed of two identical subunits related 
by non-crystallographic two-fold symmetry (Figure 4.7b).[66]  Two structurally 
similar domains, the N-terminal domain and C-terminal domain, constitute each 
subunit.  The arrangements of secondary structure in the two domains are 
identical to that of CcP and APX.[66]   
The heme active site is buried inside the N-terminal domain and is similar 
in structure to the active site of CcP and APX.[66]  The proximal site residues are 
H259, D372, and W311, while the distal residues are R95, W92, and H96.  Unlike 
APX, a potassium cation is not observed near the proximal tryptophan residue in 
H. marismortui CP.  The electronic environment around the proximal side of the 
heme most closely resembles that of CcP, which may support formation of a 
tryptohan radical rather than a prophyrin π-cation radical as formed by APX.[66] 
Similar to HRPC, H. marismortui CP has a substrate access channel.  
Around the heme iron atom, the cylindrical channel is approximately 3.5 Å in 
diameter at S305 and the conical channel increases in diameter as it approaches 
the surface.  Surface residues G194 and G271 mark the acidic entrance to the 
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access channel.  The size of the substrate access channel prevents large substrates 
from accessing the heme.[66] 
Novel covalent modifications were observed near the active site of H. 
marismortui CP between Cε1 of Y218 and Cη2 of W95, as well as Cε2 of Y218 
and Sδ of M244 [66].  The conservation of W95, Y218, M44, and R409 suggests 
that the covalent bonds may be common among all CPs.[66]  Mutation of W95 
causes loss of catalase activity,[12, 68] indicating that the covalent bonds may be 
important for the catalase activity in CPs. 
 Carpena et al.[67] reported the structure of B. pseudomallei in 2003 (Figure 
4.7c).  Similar to H. marismortui CP, B. pseudomallei CP is a dimer with one 
heme group per subunit, which is located in the N-terminal domain.  One 
unidentified metal ion (mostly likely sodium based on its refinement properties) 
per subunit is coordinated to G122, G124, and S494, as well as two water 
molecules which interact with the side chains of G128, G198, and D427.  The 
position of this unidentified metal ion is about 7 Å from the position of Ca2+ in 
HRPC.[54, 67]   
The distal side of the heme active site is composed of residues R108, 
W111, and H112, while the proximal site residues are H279 in close association 
with D389 and W330.  The access route to the distal side of the heme active is via 
a funnel shaped channel which is approximately 14 Å from the heme iron atom.  
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Unlike H. marismortui CP, there is an addition of at least two atoms to the vinyl 
group on ring I of the heme moiety.[67]  Carpena et al.[67] hypothesized that 
hydrogen peroxide is the likely source of the modification due to its accessibility 
to the active site. 
 The covalent bonding network first identified in H. marismortui CP, was 
also observed in B. pseudomallei CP.[67]  The presence of the W-Y-M adduct in 
both H. marismortui CP and B. pseudomallei CP suggests that it may be a general 
feature of CPs.  The purpose of the modification is unclear; however, one 
possibility is they stabilize the enzyme by reducing the likelihood of other more 
damaging oxidations from occurring.[67] 
Interestingly, the structure of B. pseudomallei CP contained an 
unidentified mass of electron density prior to the constricted region of the access 
channel.  Carpena et al.[67] proposed that the site is potentially the active site for 
INH activation (Figure 4.7d).  Proposed interactions are residues W323 and S324 
for the hydrazide functional group and water coordinated to W309.  Building on 
the hypothesis of this being the site for INH activation, a means of electron 
transfer was devised, which involves the transfer of electrons from the main-chain 
carbonyl group of A265 to M264.[67]  
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Figure 4.7  Structure of a) HRPC, b)H. marismortui CP, c)B. pseudomallei 
CP, and d)proposed INH active site.  The N-terminal domain is indicated in 
cyan, while the C-terminal domain is in blueviolet.  The heme moiety is 
shown in red.  The Ca2+ ions in HRPC are shown in yellow.  The figure was 





Despite the lack of a complete three-dimensional structure, the active site 
of M. tuberculosis CP was partially characterized (Figure 4.8 and Figure 4.9).  
Using EXAFS, Powers et al.[71] generated a three dimensional structure of the E. 
coli katG active site showing a heme group interacting with residues W105, 
H267, R102, and H106 (Figure 4.9).  The iron center has been shown by Raman 
and optical spectroscopy to be a high spin-state, Fe3+, 5-coordinate complex with 
some six-coordinate character.[23]  The oxidized species appears to be a mixture of 
both six-coordinate low spin and five-coordinate high spin state heme molecules. 
 
 
Figure 4.8  Iron protoporphyrin IX prosthetic group. 
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Figure 4.9  Active site of M. tuberculosis CP as determined by EXAFS by 
Powers et al.  Figure created in Swiss PDB Viewer[72] and rendered in Pov-
Ray.[73] 
  
To aid in better understanding the binding and mechanism of INH 
activation, a homology model for M. tuberculosis has been created (Figure 
4.10)[74] from the crystal structure of H. marismortui CP.[66]  The enzyme is a 
dimer with two identical subunits and is composed primarily of α-helices.  The 
active site is located in the N-terminal domain, which consists of approximately 
430 residues, with the heme moiety sequestered within the structure.  Substrate 
access to the active site is through a narrow channel that prevents access of a large 
substrate.[74]  The active site is identical to that described by Powers et al.[71] using 
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EXAFS analysis.  A comparison of residues in the active site pockets of H. 
marismortui CP, B. pseudomallei CP, HRPC, and the M. tuberculosis CP model 
can be seen in Table 4.1. 
 
Figure 4.10  M. tuberculosis CP model.  The N-terminal domain is indicated 
in cyan, while the C-terminal domain is in blueviolet.  The heme moiety is 
shown in red.  The figure was created in MOLSCRIPT[69] and rendered in 
Render 3D.[70] 
 
Enzyme Distal H2O2 binding pocket 
Proximal 
Heme iron pocket 
PDB 
code 
mtCP R104 W107 H108 H270 W321 D381  
haCP R92 W95 H96 H259 W311 D372 1ITK[66] 
bpCP R108 W111 H112 H279 W330 D389 1MWV[67] 
HRPC R38 F41 H42 H170 F221 D247 1ATJ[54] 
Table 4.1  Comparison of postulated active site residues of M. tuberculosis CP 
with other peroxidase and CP enzymes. 
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Both the HRPC and B. pseudomallei CP crystal structures indicate the 
presence of metal cations.  M. tuberculosis CP is expected to have similar sites.  
To help identify which metal cations may be present in M. tuberculosis CP, 
induced coupled plasma atomic emission spectroscopy study was undertaken.   
GRID calculations were conducted to comparatively analyze the 
similarities in homology around the active site of HRPC, B. pseudomallei CP, and 
M. tuberculosis CP.  The binding location, as well as residues which participate in 
the binding of INH, were investigated.  Based on information acquired via GRID 
calculations, hypotheses regarding INH binding and activation are proposed. 
The availability of a three dimensional X-ray crystal structure of M. 
tuberculosis CP would provide the structure of the heme pocket, as well as 
provide information regarding potential binding and activation sites for INH.  Of 
particular interest is the presence or absence the access channel proposed for INH 
activation in B. pseuodomallei CP.  In an attempt to allucidate structural 
information for M. tuberculosis CP, crystallization studies were performed.    
RESULTS 
ICP-AES 
Results of the ICP-AES analysis of the wild-type, heme-added M. 
tuberculosis CP are summarized in Table 4.2.  The high phosphorous content 
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originates from the KH2PO4/K2HPO4 buffer used during preparation of the 
enzyme.  The presence of sulfur is expected from the cysteine and methionine 
residues.  The iron concentration indicates a stoichiometry of approximately 2 
hemes per M. tuberculosis CP dimer based on the sulfur to iron ratio for the 
known genetic sequence.  Interestingly, there was a significant quantity of zinc 
present, which indicated the need to perform GRID analysis to investigate 
potential binding sites for a zinc dication in the protein.  Other trace elements 
such as copper and magnesium were observed in the sample.    
 Al Ca Cr Fe K Mn 
Mean concentration 
(ppm) 
8.063 7.267 12.74 71.662 424.103 1.68 
 Na Ni P S Zn  
Mean concentration 
(ppm) 
1.747 8.606 284.18 127.9 28.02  
Table 4.2  ICP-AES results shown for wild-type heme added M. tuberculosis 
CP.  Concentrations are shown in ppm with the contribution from the blank 
subtracted.  Only metals which were present in greater than a 1 ppm 
quantity are shown. 
 
GRID Calculations 
Utilizing the ability of GRID to predict energetically favorable binding 
sites for small molecules, experiments were undertaken to investigate both the 
binding potential for INH and a probable location for a structural metal cation, 
such as Zn2+.  Since an X-ray crystal structure for M. tuberculosis CP was 
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unavailable, atomic coordinates for the H. marismortui homology model created 
by Eady et al.[74] was utilized (Figure 4.10).  In addition to the M. tuberculosis CP 
model, the HRPC, APX, CcP, and B. pseudomallei CP structures were analyzed.  
The atomic coordinates for B. pseudomallei CP and Horseradish Peroxidase 
(HRP) were acquired from the PDB (1ATG, 1APX, 1CCP, and 1MWV, 
respectively).  The INH-HRPC model developed by Banci et al.[51] was used to 
illustrate the suggested binding location of INH in HRPC.  
Water molecules were removed from the structure file prior to the 
calculations.  GRID was then used to evaluate the energetically favorable binding 
sites of counterions.  Counterions were placed in positions to avoid the active site 
cavity, as well as sites known to contain electron density. Appropriate small 
molecule probes were then used to analyze the electronically neutral structure.   
Several probes were used to investigate potential binding sites for INH in 
the enzyme.  The probes are designed to locate energetically favorable binding 
sites in the enzyme for the functional moiety they represent.  Based on the 
structure of INH and proposed oxidation products, probes were chosen to model 
their functional groups (Figure 4.11).  The carboxy and carbonyl probes were 
selected due to the presence of a carbonyl moiety on INH.  The N1 and N2 probes 
represent neutral, flat NH and NH2 groups, respectively, which are present at the 
hydrazide moiety of INH.  The aliphatic neutral amide multi-atom probe, conhr, 
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was used to simulate the hydrazinocarbonyl group of INH (Figure 4.11).  The 
closest representation of INH is the multi-atom probe, ar.conhr, which was 
employed to locate energetically favorable binding positions for aromatic neutral 
amide functional groups (Figure 4.11).  The ar.conhr probe was set to position the 
NH moiety trans with respect to the carbonyl oxygen and closely represents the 
pyridine-like ring and hydrazinocarbonyl group.  Figure 4.12 illustrates the 
structures of HRPC, APX, CcP, B. pseudomallei CP, and M. tuberculosis CP prior 




















Figure 4.11  Probes used to investigate potential binding locations of INH are 
indicated on the right and are color coordinated to the diagram of INH on 
the left.   
 
GRID calculation output was displayed as contour maps using Insight II 
(Accelrys, Cambridge, UK) and DS ViewerPro v. 5.0 (Accelrys, Cambridge, 
UK).  By adjusting the visible contour level, the total energy cut off value was set 
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for each calculation.  Although qualitative comparisons can be made across 
systems, quantitative analysis is not recommended as the energy values are probe 
and target specific.   
The presence of energetically favorable sites was determined by visual 
inspection of the size and shape of the contour within a probe/enzyme system.  
The user is required to apply knowledge of the biochemistry of the protein being 
evaluated to determine whether sites identified as energetically favorable are 




Figure 4.12  The structure of a)CcP, b)APX, c)HRPC, d)B. pseudomallei CP, 
and e)M. tuberculosis CP prior to GRID calculations.  The heme moiety is 
indicated in black. 
 
NH Probe 
A neutral, flat NH group probe, N1, was implicated to investigate 
favorable binding sites for INH.  In CcP, APX, HRPC, B. pseudomallei CP, and 
a) b) c) 
d) e) 
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M. tuberculosis CP, an energetically favorable site was located near the heme 
active site.  The class I peroxidases, CcP and APX, had similar interactions with 
the NH probe.  In CcP, energetically favorable interaction included R48, W51, 
H52, and the iron and pyridinyl nitrogen atoms of the heme moiety (Figure 
4.13a), while in APX, residues R38, W41, H42, and the iron and pyridinal 
nitrogen atoms of the heme moiety were determined to be energetically favorable 
(Figure 4.13b).  The site involved interactions with residues R38, F41, H42, N70, 
as well as the iron and pyridinyl nitrogen atoms of the heme moiety in HRPC 
(Figure 4.13c), a class III peroxidase.  A similar site was found for B. 
pseudomallei CP involving interactions with residues H112, W111, R108, and the 
iron and pyridinyl nitrogens of the heme moiety (Figure 4.13d).  The NH probe 
used to analyze M. tuberculosis CP located energetically favorable interactions 
with residues H108, W107, N137, R104, and the iron and pyridinyl nitrogens of 
the heme moiety (Figure 4.13e). 
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Figure 4.13  Energetically favorable binding site for the NH probe with 
a)CcP, b)APX, c)HRPC, d)B. pseudomallei CP, and e)M. tuberculosis CP.  
Contour levels are set at -8, -7.5, –7, -8, and -8 kcal/mol, respectively.  INH 






The structure of CcP was analyzed with the N2 probe, which is designed 
to locate favorable sites for neutral, flat NH2 functional group binding.  An 
energetically favorable binding site was located involving residues R48, W51, and 
H52.  In APX, residues R38, W41, H42, and the iron and pyridinal nitrogen atoms 
of the heme moiety were determined to interact with the N2 probe.  The HRPC 
structure was analyzed with the N2 probe.  Interactions with residues H42, P139, 
L138, and G69, as well as the heme moiety were identified for HRPC (Figure 
4.14a).  Analyzing B. pseudomallei CP with the NH2 probe showed energetically 
favorable interactions with residues H112, W111, N141, as well as the pyridinyl 
carbon atoms of the heme (Figure 4.14b).  In M. tuberculosis CP, favorable 
interactions between the NH2 probe and residues W107 and N137 and the 
pyridinyl carbon atoms of the heme group (Figure 4.14c) were located. 
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Figure 4.14  Energetically favorable binding site for the NH2 probe with 
a)CcP, b)APX, c)HRPC, d)B. pseudomallei CP, and e)M. tuberculosis CP.  
Contour levels are set at -10, -9, –9, -10, and -8 kcal/mol, respectively.  INH 







 The class I peroxidase, CcP was analyzed with the carbonyl probe to 
locate favorable sites for sp2 carbonyl oxygen binding.  Residues R48, W51, and 
H52, as well as the iron and pyridinyl nitrogen atoms of the heme moiety were 
determined to interact with the carbonyl probe (Figure 4.15a).  Energetically 
favorable interactions between APX and carbonyl probe were found to be similar 
to CcP, R38, W41, and H42, as well as the iron and pyridinyl nitrogen atoms of 
the heme moiety (Figure 4.15b).  The HRPC structure was analyzed with the.  
Near the heme active site, the carbonyl probe located favorable interactions with 
R38, F41, H42, and the iron and pyridinyl nitrogen atoms of the heme group in 
HRPC (Figure 4.16c).  In B. pseudomallei CP, the carbonyl probe identified 
favorable interactions with H112, W111, H279, R108, and the iron and pyridinyl 
nitrogens of the heme group (Figure 4.16d).  Analysis of M. tuberculosis CP with 
the carbonyl probe located energetically favorable interactions with residues 
H108, W107, R104, and the iron and pyridinyl nitrogen atoms of the heme moiety 
(Figure 4.16e).  
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Figure 4.15  Energetically favorable binding site for the carbonyl probe with 
a)CcP, b)APX, c)HRPC, d)B. pseudomallei CP, and e)M. tuberculosis CP.  







 Analysis of CcP, APX, HRPC, B. pseudomallei, and M. tuberculosis with 
the carboxy probe located energetically favorable regions for anionic carboxy 
oxygen atom binding near the heme moiety.  In the two class I peroxidases, 
energetically favorable interactions with the carboxy probe were with the 
arginine, tryptophan, and histidine residues nearest the heme, R48, W51, and H52 
for CcP (Figure 4.16a) and R38, W41, and H42 for APX (Figure 4.16b).  In 
HRPC, the strongest interactions were found to be with R38, F41, H42, P139, and 
the iron and pyridinyl nitrogen atoms of the heme group (Figure 4.16c).  Analysis 
of B. pseudomallei CP located energetically favorable residues H112, W111, 
H279, R108, as well as the iron atom and pyridinyl nitrogen atoms of the heme 
moiety (Figure 4.16d).  M. tuberculosis CP was evaluated with the carboxy probe 
and residues H108, W107, and R104, as well as the iron atom of the heme group 




Figure 4.16  Energetically favorable binding site for the carboxy probe with 
a)CcP, b)APX, c)HRPC, d)B. pseudomallei CP, and e)M. tuberculosis CP.  
Contour levels are set at -20, -20, -14, -20, and -16 kcal/mol, respectively.  





Aromatic Neutral Amide Probe 
The multi-atom probe, ar.conhr, was employed to locate energetically favorable 
binding positions for aromatic neutral amide functional groups.  The probe was 
set in a trans orientation, where the NH moiety was trans with respect to the 
carbonyl oxygen.  Energetically favorable interactions with residues R48, W51, 
H52, and P145 were located in CcP (Figure 4.17a).  Similar interactions were 
found in APX, R38, W41, H42, and P132 (Figure 4.17b).  The aromatic neutral 
amide probe found a pocket of favorable interactions with residues G69, H42, 
N70, R38, as well as the iron and pyridinyl nitrogen atoms of the heme moiety of 
HRPC (Figure 4.17c).  In B. pseudomallei CP residues H112, W111, H279, R108, 
as well as the iron and pyridinyl nitrogen atoms of the heme moiety were found to 
interact favorably (Figure 4.17d).  Analysis of M. tuberculosis CP with the 
aromatic neutral amide probe indicated energetically favorable interactions with 
residues H108, W107, R104, N137, as well as the pyridinyl nitrogen atoms of the 
heme moiety (Figure 4.17e). 
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Figure 4.17  Energetically favorable binding site for the aromatic neutral 
amide probe with a)CcP, b)APX, c)HRPC, d)B. pseudomallei CP, and e)M. 
tuberculosis CP.  Contour levels are set at -8, -8, –7, -8.5, and –8.5 kcal/mol, 






Aliphatic Neutral Amide Probe 
The multi-atom probe, conhr, was employed to locate energetically 
favorable binding positions for aliphatic neutral amide functional groups in CcP, 
APX, HRPC, B. pseduomallei CP, and M. tuberculosis CP.  The probe was set so 
that the NH moiety was in a trans orientation with respect to the carbonyl oxygen.  
A pocket of energetically favorable interactions was located in CcP involving 
residues R48, W51, H52, and P145 (Figure 4.18a).  Analysis of APX with the 
aliphatic neutral amide probe indicated the residues R38, W41, H42, and P132 
interacted favorably (Figure 4.18b).  In HRPC, the aromatic neutral amide probe 
found a pocket of favorable interactions with residues G69, H42, N70, R38, as 
well as the pyridinyl carbon atoms of the heme moiety (Figure 4.18c).  Residues 
H112, W111, H279, R108, as well as the iron and pyridinyl nitrogen atoms of the 
heme moiety in B. pseduomallei CP showed energetically favorable interactions 
with the aromatic neutral amide probe (Figure 4.18d).  Analysis of M. 
tuberculosis CP indicated energetically favorable interactions with residues H108, 





Figure 4.18  Energetically favorable binding site for the aliphatic neutral 
amide probe with a)CcP, b)APX, c)HRPC, d)B. pseudomallei CP, and e)M. 
tuberculosis CP.  Contour levels set at -8, -8.5, –7, -8.5, and –9 kcal/mol, 





Zinc Dication Probe for M. tuberculosis CP 
The Zn2+ probe was employed to locate energetically favorable binding 
positions for Zn2+ interactions.  The Zn2+ probe found a pocket of favorable 
interactions with residues Y95, D94, P100, K274, and H276, as well as the heme 
moiety (Figure 4.19). 
 
Figure 4.19  Energetically favorable binding site for the zinc dication probe 
with M. tuberculosis CP.  Contour level set at -50 kcal/mol. 
 
Crystallization of M. tuberculosis CP 
 Crystals of M. tuberculosis CP were obtained under a variety of conditions 
and have been shown to be reproducible (Figure 4.20).  Crystallization conditions 
included conditions similar to those described for B. pseduomallei CP.  Crystals 
chosen for X-ray diffraction study were obtained from 4% Polyethylene glycol 
(PEG) 3,350 and 0.1 M sodium acetate (pH 4.6) after one day at 20 °C.  The 
crystals were red-brown plates typically 0.2 x 0.2 x 0.05 mm in size. 
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Figure 4.20  Crystals of M. tuberculosis CP grown in 4% Polyethylene glycol 
(PEG) 3,350 and 0.1 M sodium acetate (pH 4.6) after one day at 20 °C. 
 
Data Processing 
Diffraction data were collected on beamLine 9.6 at the Synchrotron 
Radiation Source (SRS), Daresbury, UK using a CCD detector and 0.877 Å 
radiation.  The data set was processed with the HKL suite of programs.[75]  A 
summary of data processing parameters is shown in Table 4.3.  The data sets were 
processed as P42212 based on observed systematic absences, (00l:  l = 2n and h00:  
h = 2n).   
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M. tuberculosis CP 
Crystal M. tuberculosis CP 
Radiation Source BeamLine 9.6 (SRS, Daresbury, UK) 
λ (Å) 1.488 
Temperature (K) 100 
Space Group P42212 
Unit cell parameters 
a = 150.33   α = 90.000 
b = 150.33   β = 90.000 
c = 154.28   γ = 90.000 
No. of molecules in 
asymmetric unit 2 
Resolution range (Å) 30 – 2.4 
Total observations 1,932,986 
Unique reflections 62,065 
Completeness (%) 90.4 (89.1)* 
Rsym (%) 15.9 (39.1)* 
(I/σ(I)) 11.2 (4.2)* 
Table 4.3  Data collection and processing parameters for M. tuberculosis CP 
crystals.  * values in parentheses are for the high-resolution shell. 
 
Sequence Analysis and Molecular Replacement 
Sequence alignment of B. pseudomallei CP amino acid sequence was 
performed against that of M. tuberculosis CP using the program Genedoc.  A 64% 
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sequence identity was determined for the two amino acid sequences (Figure 4.21).  
Active site residues, H112 (H108), W111 (W107), H279 (H270), and R108 
(R104), are conserved between the two CP sequences (M. tuberculosis CP 
numbers are shown in parentheses), further confirming the similarity between the 
two enzymes.  Due to the significant sequence identity between B. pseudomallei 
and M. tuberculosis CP, the B. pseudomallei CP structure[67] was used as a search 
model. 
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B. pseudomallei CP 1 MPGSDAGPRR RGVHEQRRNR MSNEAKCP-F --HQAAGNGT SNRDWWPNQL DLSILH
M. tuberculosis CP 1 ------MPEQ HPPITETTTG AASNG-CPVV GHMKYPVEGG GNQDWWPNRL NLKVLH
B. pseudomallei CP 58 LSDPMGKDFN YAQAFEKLDL AAVKRDLHAL MTTSQDWWPA DFGHYGGLFI RMAWHS
M. tuberculosis CP 54 VADPMGAAFD YAAEVATIDV DALTRDIEEV MTTSQPWWPA DYGHYGPLFI RMAWHA
B. pseudomallei CP 118 RTADGRGGAG EGQQRFAPLN SWPDNANLDK ARRLLWPIKQ KYGRAISWAD LLILTG
M. tuberculosis CP 114 RIHDGRGGAG GGMQRFAPLN SWPDNASLDK ARRLLWPVKK KYGKKLSWAD LIVFAG
B. pseudomallei CP 178 ESMGFKTFGF AGGRADTWEP EDVYWGSEKI WLELSGGPNS RYSGDRQLEN PLAAVQ
M. tuberculosis CP 174 ESMGFKTFGF GFGRVDQWEP DEVYWGKEAT W--L---GDE RYSGKRDLEN PLAAVQ
B. pseudomallei CP 238 YVNPEGPDGN PDPVAAARDI RDTFARMAMN DEETVALIAG GHTFGKTHGA GPASNV
M. tuberculosis CP 229 YVNPEGPNGN PDPMAAAVDI RETFRRMAMN DVETAALIVG GHTFGKTHGA GPADLV
B. pseudomallei CP 298 EAAGIEAQGL GWKSAYRTGK GADAITSGLE VTWTTTPTQW SHNFFENLFG YEWELT
M. tuberculosis CP 289 EAAPLEQMGL GWKSSYGTGT GKDAITSGIE VVWTNTPTKW DNSFLEILYG YEWELT
B. pseudomallei CP 358 GAHQWVAK-- GADAVIPDAF DPSKKHRPTM LTTDLSLRFD PAYEKISRRF HENPEQ
M. tuberculosis CP 349 GAWQYTAKDG AGAGTIPDPF GGPGR-SPTM LATDLSLRVD PIYERITRRW LEHPEE
B. pseudomallei CP 416 FARAWFKLTH RDMGPRARYL GPEVPAEVLL WQDPIPAVDH PLIDAADAAE LKAKVL
M. tuberculosis CP 408 FAKAWYKLIH RDMGPVARYL GPLVPKQTLL WQDPVPAVSH DLVGEAEIAS LKSQIR
B. pseudomallei CP 476 TVSQLVSTAW AAASTFRGSD KRGGANGARI RLAPQKDWEA NQPE-QLAAV LETLEA
M. tuberculosis CP 468 TVSQLVSTAW AAASSFRGSD KRGGANGGRI RLQPQVGWEV NDPDGDLRKV IRTLEE
B. pseudomallei CP 535 FNGAQRGGKQ VSLADLIVLA GCAGVEQAAK NAGHAVTVPF APGRADASQE QTDVES
M. tuberculosis CP 528 FNSAAPGNIK VSFADLVVLG GCAAIEKAAK AAGHNITVPF TPGRTDASQE QTDVES
B. pseudomallei CP 595 EPVADGFRNY LKGKYRVPAE VLLVDKAQLL TLSAPEMTVL LGGLRVLGAN VGQSRH
M. tuberculosis CP 588 EPKADGFRNY LGKGNPLPAE YMLLDKANLL TLSAPEMTVL VGGLRVLGAN YKRLPL
B. pseudomallei CP 655 AREQALTNDF FVNLLDMGTE WKPTAADADV FEGRDRATGE LKWTGTRVDL VFGSHS
M. tuberculosis CP 648 EASESLTNDF FVNLLDMGIT WEPSPADDGT YQGKD-GSGK VKWTGSRVDL VFGSNS
B. pseudomallei CP 715 LAEVYGSADA QEKFVRDFVA VWNKVMNLDR FDLA 748
M. tuberculosis CP 707 LVEVYGADDA QPKFVQDFVA AWDKVMNLDR FDVR 740  
Figure 4.21 Sequence alignment of B. pseudomallei and M. tuberculosis CP.  
Identical residues are highlighted in blue and similar residues are 
highlighted in yellow.  Sequence was aligned and figure created in BioEdit.[76] 
 
Refined X-ray Crystal Structure of M. tuberculosis CP 
The X-ray crystal structure of M. tuberculosis CP was successfully refined 
to 2.4 Å resolution and is shown in Figure 4.22.  The structure consists of 716 
residues, 703 water molecules, and 3 glycerol molecules.  One well-defined heme 
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moiety is buried in the N-terminal domain.  The dimeric structure is generated by 
crystallographic symmetry (Figure 4.22).   
 
Figure 4.22  Structure of M. tuberculosis CP with the heme moieties indicated 
in red.  Figure was produced in PyMOL (DeLano Scientific, San Carlos, 
California).  
 
  The overall fold is similar to that of B. pseudomallei CP[67] and H. 
marismortui CP;[66] with two identical subunits related by non-cyrstallographic 
two-fold symmetry.  The first 431 residues compose the N-terminal domain, 
while the remaining 285 compose the C-terminal domain.  Structurally, M. 
tuberculosis CP contains mostly α-helices with few β-sheets, which is similar to 
both B. pseudomallei CP and H. marismortui CP (Figure 4.22).   
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The active site of M. tuberculosis CP is shown in (Figure 4.23).  The 
organization around the active site is similar in all three CP structures available, 
as indicated by the number of conserved residues, H108, H270, W107, and R104.  
Electron density around the heme moiety is well defined (Figure 4.24).  The heme 
moiety in the B. pseudomallei CP structure contained a two atom substituent 
attached to a vinyl group.[67]  This modification was not found in the M. 
tuberculosis CP structure.  The location of water molecules in the active sites does 
vary between the catalase-peroxidases, with M. tuberculosis CP having only two 
water molecules present on the distal side of the heme moiety (Figure 4.23).  B. 
pseudomallei CP has three water molecules on the distal side of the heme moiety 
with one molecule directly above the iron atom,[67] while H. marismortui CP has 
both a molecule with two water molecules and a molecule with three water 
molecules.[66]   
263 
 
Figure 4.23  Active site of M. tuberculosis CP with the water molecules shown 
in green.  Figure was created in DS Viewer Pro 5.0 (Accelrys, Cambridge, 
UK). 
 
Figure 4.24  2Fo-2Fc electron density map (blue) calculated to 2.4 Å 
resolution contoured at 1 σ.  The carbon atoms are shown in green, the 
nitrogen atoms in blue, the oxygen atoms in red and the Fe3+ in orange.  
Figure was produced in PyMOL (DeLano Scientific, San Carlos, California).  
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 When compared to the other structurally characterized catalase-
peroxidases, five additional residues were determined at the N-terminal of M. 
tuberculosis CP.  Residues G24, H25, M26, K27, and Y28 are indicated in Figure 
4.25 in red.  The N-terminal residues appear to interact with residues Y197, K200, 
and G208 of the C-terminal domain. 
 
Figure 4.25  Additional residues located at the N-terminal of M. tuberculosis 
CP are indicated in red, while glycerol molecules are shown in green.  Figure 
created in PyMOL (DeLano Scientific, San Carlos, California) 
  
 Although the identity is unknown, a potential metal cation was located 
near the γ-edge of the heme moiety.  The region of electron density is coordinated 
to the oxygen atom of the water molecule 261, the O2α and O1δ atoms of the 
propionate groups of the heme moiety, and NH1 of R104 in a distorted-
265 
tetrahedral-type geometry.  Based on the coordination geometry, the cation is 
unlikely to be Na+ or K+, but could be a dication such as Zn2+ or Ca2+. 
 
Figure 4.26  Unknown metal cation site in M. tuberculosis CP.  Figure created 
in PyMOL (DeLano Scientific, San Carlos, California) and edited in Adobe 
Illustrator CS (Adobe Systems, San Jose, California). 
 
 Three glycerol molecules, which were incorporated into the enzyme from 
the cyroprotectant solution, were located in the structure (Figure 4.25).  One 
molecule is located near residues G607, R693, N701, and L43, which is 
approaching the region close to the N-terminal.  The second molecule is near 
residues W191, K157, and K158, while the third molecule is located near residues 
L587 and K613.  
A region of continuous electron density was observed between Cε1 of 
Y229 and Cη2 of W107 and between C2ε of Y229 and Sδ of M255 (Figure 4.27).  
The existence of the covalent bonds between these side chains was confirmed in 





covalent bond places a positive charge on the side chain.  The guanidine group of 
R418 forms hydrogen bonds with Oη of Y229 and the amide nitrogen atom of 
M255, which stabilize the covalent bond between Y229 and M255 by fixing the 
relative position of the residues.  The covalent modification does not disturb the 
orientation of Y229 and the heme, which has been shown to be important for the 
reaction of the second peroxide with Compound I.[12] 
 
Figure 4.27  Electron density map showing covalent bond modification 
around W107-Y229-M255.  The figure was created in PyMOL (DeLano 
Scientific, San Carlos, California). 
 
The most obvious access route to the active site of M. tuberculosis CP is 
via a channel positioned similarly to other peroxidases.  The narrow channel 
prevents large substrates access to the heme moiety.  S315, a residue which has 
been shown to be important for INH activation,[43] is situated along the access 
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channel.  The funnel-shaped cavity was found to contain a continuum of water 
molecules in the X-ray crystal structure (Figure 4.28).   
 
Figure 4.28  Electron density map showing the continuum of water molecules 
(magenta) located in the access channel.  The S315 residue is indicated in 
yellow and the unidentified metal cation is green.  Figure created in PyMOL 
(DeLano Scientific, San Carlos, California). 
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 DISCUSSION 
 Improving treatment methods for tuberculosis is hindered by the lack of 
information regarding the binding/activation site of INH in M. tuberculosis CP.  
In order to aid in understanding where INH might bind, as well as what residues 
may play a critical role in the activation of the pro-drug, GRID analysis of M. 
tuberculosis CP and two other class III peroxidases, B. pseudomallei CP and 
HRPC, was undertaken.  The possibility of a second active site in B. pseudomallei 
CP, as reported by Carpena et al.,[67] was scrutinized using GRID analysis. 
 As previously discussed, M. tuberculosis CP is a dual-function enzyme, 
which is both catalase and peroxidase active.  In an attempt to identify any 
differences between the peroxidases and the catalase-peroxidases, GRID analysis 
was performed on the crystal structures of APX and CcP.  The absence of a loop 
located on the γ-edge of the heme in the catalase-peroxidase, was determined to 
be a potential difference between the peroxidases and catalase-peroxidases. 
 The presence of metal cations in the crystal structures of B. pseudomallei 
CP, HRPC, APX, and CcP, led to the hypothesis that M. tuberculosis CP would 
also contain a metal cation.  ICP-AES analysis indicated a significant quanity of 
Zn2+ present in the enzyme.  To elucidate the potential binding location of the 
Zn2+, GRID analysis was performed on the M. tuberculosis CP model.  The 
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information gained from the two studies was then applied to the crystal structure 
of M. tuberculosis CP, once acquired. 
 Although a model of M. tuberculosis CP was readily available, the X-ray 
crystal structure of the enzyme was desirable.  Crystallization and structural 
analysis of M. tuberculosis CP, has provided information regarding the 
environment around the heme moiety, the size and shape of the access channel 
and the presence of extra residues at the N-terminal of the enzyme.  The covalent 
bonding system between W-Y-M, found in B. pseudomallei CP and H. 
marismortui CP, was determined to be present in M. tuberculosis CP as well.  
GRID calculations for the binding of INH in M. tuberculosis CP, B. 
pseudomallei CP, and HRPC closely follow the HRPC-INH model presented by 
Banci et al.[51]  Residues will be presented corresponding to the number assigned 
to M. tuberculosis CP with the residue numbers for B. pseudomallei CP and 
HRPC presented in parentheses.  The NH and NH2 probes determined that 
residues H108 (H112, H42), the W107 (W111, F41), and R104 (R108, R38), as 
well as the iron and pyridinyl nitrogen atoms of the heme moiety are energetically 
favorable for interaction with the hydrazide moiety of INH (Figure 4.29).  The 
residues are similar to those reported by Banci et al.[51] for hydrazide interaction 
of INH in HRPC.  The carbonyl moiety, modeled by both the carboxy and 
carbonyl probes, shows clear interactions with heme iron as well as residues H108 
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(H112, H42), W107 (W111, F41), and R104 (R108, R28). In addition to 
coordination by the iron, the nitrogen atoms of the heme appear to be involved in 
interaction with the carbonyl moiety of INH (Figure 4.29)  Two multi-atom 
probes, conhr and ar.conhr, represent a larger portion of the INH structure than 
their single-atom counterparts.  Although the conhr should only locate the 
hydrazinocarbonyl of INH the two probes gave similar results.  Residues H108 
(H112, H42), W107 (W111, F41), R104 (R108, R28), as well as the pyridinyl 
nitrogen atoms of the heme moiety are predicted by GRID to create an 
energetically favorable binding pocket for the pyridine functional group of INH.  
The “aromatic binding pocket” is not identical to that predicted in the HRCP 
model, heme-18 methyl, G69, A140, P141, and F176.  Despite the differences in 




Figure 4.29  GRID maps depicting energetically favorable binding sites for 
the NH (green), NH2 (blue), carbonyl oxygen (red) and aromatic neutral 
amide (purple) probes on (A) M. tuberculosis CP (B) B. pseudomallei CP, and 
(C) HRPC.  GRID map contour levels are set at -8, -9, -12, and -8.5 kcal/mol 
for the NH, NH2, carbonyl, and aromatic neutral amide probes, respectively. 
In all panels the heme is in gray and protein mainchains and side chains are 
depicted in yellow.  Interacting amino acid residues are indicated as stick 




Data from the GRID calculations suggests that the INH binding site in B. 
pseudomallei CP is similar to that modeled in HRPC[51] and crystallographically 
determined for BHA in HRPC,[77] not the secondary active site previously 




INH are H112, W111, R108, and D141, as well as the heme moiety.  
Interestingly, the putative secondary active site suggested by Carpena et al. 
(Figure 4.7d)[67] did not show any energetically favorable interactions with the 
probes studied.  The idea of INH binding at this position was not supported by 
GRID calculations. 
GRID calculations to determine the most energetically favorable binding 
site for a pyridinyl substrate, such as INH, were performed on APX and CcP.  All 
residues numbers will be indicated for APX with CcP in parentheses.  The NH, 
NH2, and carbonyl probes all indicated interactions with Nε of R38 (48), Nε1 of 
W41 (51), Nε2 of H42 (52), and the iron and pyridinyl nitrogen atoms of the 
heme moiety (Figure 4.30).  In addition to the R, W, and H residues indicated to 
be energetically favorable toward the NH, NH2, and carbonyl probes, the aromatic 
neutral amide probe located interactions with the O atom of P132 (145) (Figure 
4.30).  The energetically favorable interactions determined for APX and CcP were 
similar to those found for the catalase-peroxidases, M. tuberculosis CP and B. 
pseudomallei CP (Figure 4.29). 
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Figure 4.30  GRID maps depicting energetically favorable binding sites for 
the NH (green), NH2 (blue), carbonyl oxygen (red) and aromatic neutral 
amide (purple) probes on (A) APX and (B) CcP.  GRID map contour levels 
are set at -8, -9, -12, and -8.5 kcal/mol for the NH, NH2, carbonyl, and 
aromatic neutral amide probes, respectively. In all panels the heme is in gray 
and protein mainchains and side chains are depicted in yellow.  Interacting 
amino acid residues are indicated as stick figures.  This figure was produced 
using DS ViewerPro 5.0 (Accelrys, Cambridge, UK). 
    
GRID calculations indicated no obvious differences between the active 
sites of the classical peroxidases, APX and CcP, and the catalase-peroxidases, M. 
tuberculosis CP and B. pseudomallei CP for the probes investigated.  The 
similarity in the active site as determined by GRID indicates the catalase function 
is most likely due to differences other then the active site.  The presence of 
covalently modified tryptophan, methionine, and tyrosine residues in the catalase-
peroxidases, but not the classical peroxidases, is one hypothesis for the difference 
in activity.  A second notable difference is the absence of a loop located at the γ-
edge of the heme in APX and CcP that is present in all of the catalase-peroxidases 
A B 
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which have been structurally characterized (Figure 4.31).  Sequence alignment 
indicates a clear absence of the 32 (29 for HRPC) residues that constitute the loop 
present in M. tubercuolosis CP, B. pseudomallei CP, and H. marisortui CP 
(Figure 4.32).    
 
Figure 4.31  Structure of (A) APX and (B) B. pseudomallei CP with the 
“missing” loop indicated in red.  Figure was produced in PyMol (DeLano 
Scientific, San Carlos, California). 
A B 
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B. pseduomallei CP 1 MPGSDAGPRRRGVHEQRRNRMSNEAKCPFHQAAGN-GTSNRDWWPNQLDLSILHRH
M. tuberculosis CP 1 -----MPEQHPPITETTTGAASNGCPVVGHMKYPVEGGGNQDWWPNRLNLKVLHQN




B. pseduomallei CP 60 DPMGKDFNYAQAFEKLDLAAVKRDLHALMTTSQDWWPADFGHYGGLFIRMAWHSAG
M. tuberculosis CP 56 DPMGAAFDYAAEVATIDVDALTRDIEEVMTTSQPWWPADYGHYGPLFIRMAWHAAG




B. pseduomallei CP 120 ADGRGGAGEGQQRFAPLNSWPDNAN--LDKARRLLWPIKQKYGRAISWADLLILTG
M. tuberculosis CP 116 HDGRGGAGGGMQRFAPLNSWPDNAS--LDKARRLLWPVKKKYGKKLSWADLIVFAG




B. pseduomallei CP 178 ESMGFKTFGFAGGRADTWEPE-DVYWGSEKIWLELSGGPNSRYSGDRQLENPLAAV
M. tuberculosis CP 174 ESMGFKTFGFGFGRVDQWEPD-EVYWGKEATWLGDE-----RYSGKRDLENPLAAV




B. pseduomallei CP 237 IYVNPEGPDGNPDPVAAARDIRDTFARMAMNDEETVALIAGGHTFGKTHGAG-PAS
M. tuberculosis CP 228 IYVNPEGPNGNPDPMAAAVDIRETFRRMAMNDVETAALIVGGHTFGKTHGAG-PAD




B. pseduomallei CP 296 EPEAAGIEAQGLGWKSAYRTGKGADAITSGLEVTWTTTPTQWSHNFFENLFGYEWE
M. tuberculosis CP 287 EPEAAPLEQMGLGWKSSYGTGTGKDAITSGIEVVWTNTPTKWDNSFLEILYGYEWE




B. pseduomallei CP 356 PAGAHQWVAKG--ADAVIPDAFDPSKKHRPTMLTTDLSLRFDP---AYEKISRRFH
M. tuberculosis CP 347 PAGAWQYTAKDG-AGAGTIPDPFGGPGRSPTMLATDLSLRVDP---IYERITRRWL




B. pseduomallei CP 411 QFADAFARAWFKLTHRDMGPRARYLGPEVPAEVLLWQDPIPAVDHPLIDAADAAEL
M. tuberculosis CP 403 ELADEFAKAWYKLIHRDMGPVARYLGPLVPKQTLLWQDPVPAVSHDLVGEAEIASL
H. marismortui CP 394 EFGMNFAKAWYKLTHRDMGPPERFLGPEVPDEEMIWQDPLPDADYDLIGDEEIAEL
APX 229 VFFADYAEAHLKLSELGFAEA-----------------------------------
CcP 259 KFFKDFSKAFEKLLENGITFPKDAPSPFIFKTLEEQGL------------------
1ATJ 272 TFFNAFVEAMDRMGNITPLTGTQGQIRLNCRVVNS--------------------- 
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B. pseduomallei CP 471 LASGLTVSQLVSTAWAAASTFRGSDKRGGANGARIRLAPQKDWEANQPE-QLAAVL
M. tuberculosis CP 463 RASGLTVSQLVSTAWAAASSFRGSDKRGGANGGRIRLQPQVGWEVNDPDGDLRKVI




B. pseduomallei CP 530 AIRTAFNGAQRGGKQVSLADLIVLAGCAGVEQAAKNAGHAVTVPFAPGRADASQEQ
M. tuberculosis CP 523 EIQESFNSAAPGNIKVSFADLVVLGGCAAIEKAAKAAGHNITVPFTPGRTDASQEQ




B. pseduomallei CP 590 SMAVLEPVADGFRNYLKGKYRVPAEVLLVDKAQLLTLSAPEMTVLLGGLRVLGANV
M. tuberculosis CP 583 SFAVLEPKADGFRNYLGKGNPLPAEYMLLDKANLLTLSAPEMTVLVGGLRVLGANY




B. pseduomallei CP 650 HGVFTAREQALTNDFFVNLLDMGTEWKPTAADADVFEGRDRATGELKWTGTRVDLV
M. tuberculosis CP 643 LGVFTEASESLTNDFFVNLLDMGITWEPSPADDGTYQGKD-GSGKVKWTGSRVDLV




B. pseduomallei CP 710 SQLRALAEVYGSADAQEKFVRDFVAVWNKVMNLDRFDLA 748
M. tuberculosis CP 702 SELRALVEVYGADDAQPKFVQDFVAAWDKVMNLDRFDVR 740
H. marismortui CP 693 DRLRAISEVYGSADAEKKLVHDFVDTWSKVMKLDRFDLE 731
APX 249 --------------------------------------- 249
CcP 296 --------------------------------------- 296
1ATJ 306 --------------------------------------- 306
 
Figure 4.32  Sequence alignment of B. pseudomallei CP, M. tuberculosis CP, 
H. marismortui CP, APX, CcP, and HRPC.  Identical residues are shown in 
blue, while similar residues are shown in yellow.  The loop missing found in 
the CPs that is not present in APX, CcP, and HRPC is highlighted in red. 
 
ICP-AES indicated the presence of Zn2+ in M. tuberculosis CP and the 
zinc dication GRID probe predicted an energetically favorable binding site near 
residues D94, Y95, P100, H274, and H276 (Figure 4.19).  The identified potential 
binding pocket for Zn2+ was adjacent to the propionate functional group of the 
heme moiety (Figure 4.8).  Once the crystal structure of M. tuberculosis CP was 
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solved, a potential metal cation site was located in the region predicted by GRID.  
The distorted tetrahedral geometry of the site suggests that the metal cation might 
be Zn2+; however other dications such as Ca2+ are not precluded.  Based on the 
proximity of the energetically favorable binding site to the heme moiety, the 
metal cation has the potential to play a structurally important role in maintaining 
the integrity of the active site.  
The three-dimensional X-ray crystal structure of M. tuberculosis CP has 
characterized an additional five residues at the N-terminal of the structure (Figure 
4.25).  The “hooked” structure of the additional residues interacts with a loop of 
the N-terminal domain of the other monomer.   Interestingly, a hydrophobic 
pocket is created by the π-stacking of two tyrosine residues, Y28 and Y197.  
These contacts may play a vital role in the dimerization of the enzyme. 
Presence of the continuous electron density between Y229, W107, and 
M255 in M. tuberculosis CP indicates that this may be a common feature of all 
catalase peroxidases and may contribute to their catalase activity.  The catalase 
activity of the catalase peroxidases is lost upon mutation of the tryptophan 
residue.[12, 68]  The exact function of the covalent modification is unknown; 
however, one hypothesis is that it stabilizes the enzyme by reducing the likelihood 
of damaging oxidations.[67]  
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The electrostatic environment of the active site in the vicinity of the 
proximal H276, D381, and W328 has a greater similarity to CcP than to APX.  
Formation of a tryptophan radical as the second oxidizing species of compound I 
is known for CcP.[78]  The electrostatic similarity in the active site may imply that 
the compound I intermediate of catalase peroxidases are formed via a mechanism 
similar to that in CcP, rather than APX.     
The X-ray crystal structure of M. tuberculosis CP indicates an access 
channel to the active site which extends from the γ-edge of the heme moiety to the 
exterior of the enzyme.  A continuum of water molecules is located in the funnel-
shaped channel (Figure 4.28).  The mutation S315T, which is located along the 
access channel, results in the loss of the activation of INH with no loss of 
peroxidase or catalase activity.[43]  It seems likely that INH accesses the heme 
moiety via the channel, which is small enough to prevent entry of larger, 




CONCLUSIONS AND FUTURE WORK 
Based on GRID calculations, the INH binding site in HRPC, B. 
pseduomalle CP, and M. tuberculosis CP is predicted in a similar location above 
the δ-edge of the heme moiety.  In Class I peroxidases, APX and CcP, GRID 
analysis of INH-like probes yielded results similar to those found for HRPC and 
the catalase peroxidases.   
The successful crystallization and structural characterization of M. 
tuberculosis CP has provided a plethora of useful information.  The presence of a 
loop, which partially blocks entrance into the substrate access channel, is present 
in the catalase peroxidase, but absent in the classical peroxidases suggesting a 
possible correlation between the loop and catalase activity.  A metal cation 
binding site was located near the γ-edge of the heme and may play a role in 
maintaining the structural integrity of the active site.  Five additional residues at 
the N-terminal may play a role in the dimerization of the enzyme.  Finally, the 
region of covalent modification between residues W107, Y229, and M255 
appears to be a common feature of all catalase peroxidases and potentially 
impacts the catalase activity.   
  A focus for future work involving M. tuberculosis CP, should include 
crystallization studies to trap isoniazid or an isoniazid analogue, such as 
benzhydroxamic acid, in the active site of the enzyme.  Structurally 
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characterization of such a system will provide valuable information for the design 
of more potent anti-tuberculosis treatment.  Additionally, kinetic studies to 
evaluate the impact of a metal chelator, such as ethylenediamminetetraacetate 
(EDTA), on catalase and peroxidase activities should be performed to determine 
the likelihood of a metal cation binding site near the γ-edge of the heme.
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EXPERIMENTAL SECTION 
General Synthetic Procedures 
Chemicals were purchased from Sigma-Aldrich (Poole, UK).  Protein 
molecular weight standards and Coomassie Brilliant Blue were from Amersham 
Pharmacia Biotech (Little Chalfont, UK).  Media reagents were purchased from 
Merck (Lutterworth, UK) and were made according to published protocols [79].  
Media were sterilized by autoclaving and stored at room temperature.  Luria broth 
(LB) contained 1% (w/v) tryptone, 0.5% (w/v) yeast extract, and 0.5% (w/v) NaCl 
in distilled water.  Luria agar (L-agar) consisted of LB with the addition of 1.5% 
(w/v) agar.  2xYT containted 1.6% (w/v) tryptone, 1.0% (w/v) yeast extract, and 
0.5% (w/v) NaCl in distilled water.  Antibiotics were added as required at 
concentrations of 100 µg/mL ampicillin and 10 µg/mL tetracycline. 
Several groups have used Escherichia coli to express the katG gene of M. 
tuberculosis including Zhang et al.,[5] Johnsson et al.,[37] Wengenack et al.,[43] 
Hillar and Loewen,[42] Nagy et al.,[80] and, most recently, Saint-Joanis et al.[81]  
Using similar methods, E. coli UM255 was grown in either LB or 2xYT.  Since E. 
coli UM255 contains the tetracycline resistant Tn10 transposon in its katE gene, 
as well as a mutated katG gene it lacks endogenous catalase and peroxidase 
activity.  This E. coli strain was used for expression of the enzyme with catalase 
and peroxidase activity. 
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 pTBCP[80] (Figure 4.33), a gift from Dr. J. M. Nagy, Imperial College 
London, was constructed by ligation of a PCR-generated fragment from pYZ56[5], 
a pUC19 derivative containing the M. tuberculosis katG, encoding catalase-
peroxidase, into the EcoRI and HindIII sites of pTrc99A.  The translated gene 
product, M. tuberculosis, utilizes the ATG start codon contained within the NcoI 
restriction site resulting in three additional amino acid residues at the N-terminus 
upstream of the mycobacterial start codon (GTG) translated as valine.  The 
resulting N-terminal sequence is M-E-F-V.   
 
Figure 4.33  Plasmid diagram for pTBCP. 
Crude Cell Extract 
 An L-agar plate containing 100 µg/mL ampicillin and 10 µg/mL 
tetracycline streaked from a glycerol stock solution of E. coli UM255[pTBCP].  
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20 mL of LB containing 100 µg/mL ampicillin and 10 µg/mL tetracycline were 
inoculated with one colony of E. coli UM255.  The cultures were grown overnight 
at 37 ˚C with shaking; each LB culture was inoculated into 1 L of 2xYT 
containing 100 µg/mL ampicillin and 10 µg/mL tetracycline.  Cells were grown at 
37 ˚C with shaking until a cell density corresponding to an OD550 of 0.4-0.6 was 
reached at which point they were induced with IPTG to a final concentration of 
0.2 mg/mL.  Growth was continued for an additional 12 h.  Cells were harvested 
by centrifugation at 7500 g, at 4 ˚C for 50 min.  Cells were resuspended in 10 mL 
of KH2PO4/K2HPO4 phosphate buffer (pH 6.5).   
Heme Addition 
The level of heme incorporation into CP enzymes has been shown to vary 
from sub-stoichiometric to stoichiometric.  The Reinheitzahl value (Rz : ASôret 
band/A280 nm), which is typically between 0.2 and 0.7, is used as a measure of 
purity.  The inconsistent incorporation of heme into the CP enzyme is believed to 
be due to overproduction of the enzyme in E. coli resulting in normal levels of 
heme biosynthesis being insufficient.[23] 
 Alteration of a previously reported method was used for heme addition [82].  
A 24.5 mM solution of hemin chloride solution was prepared using Milli-Q water.  
In order to completely dissolve the hemin chloride, the pH was raised to around 
12 by the addition of 1-2 µL of 1 M NaOH.  The final pH of the solution was 
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approximately 6.0.  A 1 to 25 v/v ratio of heme solution was added to the 
resuspended cells at 4 °C and mixed well by vortexing to increase the 
stoichiometric amount of holoenzymes present.  Cells were lysed by sonication 
with 3 x 30 sec bursts on power level 8, using a microtip and an XL2020 
sonicator (Labcaire Systems, Clevedon, UK).  Insoluble material was removed by 
centrifugation at 10000 g at 4 ˚C for 50 min.  The supernatant was treated with 
100 µg/mL DNAse and 10 µg/mL RNAse for 1 h at 4 ˚C and then recentrifuged 
as just described.  Free hemin was removed from the solution by subsequent 
centrifugation and chromatography. 
DEAE-Sepharose Anion-Exchange Chromatography 
 A Pharmacia XK-16/40 column containing 25 mL of DEAE-Sepharose 
(Fast Flow) attached to a Pharmacia Gradifrac system was equilibrated with 100 
mM KH2PO4/K2HPO4 pH 6.6 buffer at a flow rate of 2.0 mL/min.  The 
supernatant obtained from the cell extraction was passed through a Millipore 
0.45-µm filter and loaded onto the column at a flow rate of 2.0 mL/min.  The 
column was washed with 30 mL of 100 mM KH2PO4/K2HPO4 (pH 6.5) and M. 
tuberculosis CP was eluted with a 150-mL linear gradient of 0.0-0.6 M NaCl in 
100 mM KH2PO4/K2HPO4, pH 6.5 at a flow rate of 3 mL/min.  2.0-mL fractions 
were collected between 0.25 and 0.40 M NaCl elution and pooled.  The samples 
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were analyzed by SDS polyacrylamide gel electrophoresis for the presence of the 
enzyme and pooled.   
Gel Filtration 
 Fractions obtained from the DEAE-Sepharose anion-exchange column 
were further purified using a Pharmacia XK-16/70 column containing 100 mL 
Superose 6 Prep Grade.  The column was equilibrated with phosphate buffered 
saline [PBS:  0.01 M KH2PO4/K2HPO4 buffer, 0.0027 M KCl, 0.137 M NaCl (pH 
7.5)] overnight at a flow rate of 0.5 mL/min.  The fractions were passed through a 
Millipore 0.45-µm filter and loaded onto the column with a flow rate of 0.5 
mL/min.  1.0-mL fractions were collected and fractions from the absorbance 
maximum region were pooled. 
Resource Q Anion-Exchange Chromatography 
 For further purification, the fractions were loaded onto a Pharmacia 
Resource Q column (6 mL) at a flow rate of 2.0 mL/min, which had first been 
equilibrated with 30 mL of 100 mM KH2PO4/K2HPO4 (pH 6.5).  The enzyme, M. 
tuberculosis CP, was eluted with a 30-mL linear gradient of 0-1.0 M NaCl in 100 
mM KH2PO4/K2HPO4 (pH 6.5) at a flow rate of 2.0 mL/min.  1.0-mL fractions 
were collected and pooled. 
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Protein Concentration Determination 
 Concentration of M. tuberculosis CP was determined using a Shimadzu 
UV-1601 UV-visible spectrophotometer and the extinction coefficient values for 
wild-type heme-added M. tuberculosis CP:  ε280 = 1.5 * 105 M-1cm-1 and ε405 = 3.4 
* 105 M-1cm-1 [82]. 
HiTrap Desalt Column 
 To replace the NaCl containg buffer with KH2PO4/K2HPO4 buffer, a 
HiTrap Desalt column was used (Amersham Pharmacia Biotech, Little Chalfont, 
UK).  The column was equilibrated with 25 mL of KH2PO4/K2HPO4 (pH 6.5) at a 
flow rate of approximately 5 mL/min.  The 3.3 mg/mL sample of M. tuberculosis 
CP was loaded onto the column in 1.5 mL aliquots at a flow rate of 5 mL/min.  
Elution of the protein with the desired buffer yielded 2 mL of 2.0*10-4 mM (0.016 
mg/mL) sample.   
SDS Polyacrylamide Gel Electrophoresis 
 Analysis of the protein was performed using hand-poured  
80 mm x 80 mm x 1mm gels consisting of 6 mL resolving gel layered by 2 mL 
stacking gel.  The resolving gel was prepared by 0.1% sodium dodecyl sulphate 
(SDS) and 12% polyacrylamide,[83] which polymerized in the presence of 0.04% 
(v/v) tetraethylmethyldiamine and 0.1% (w/v) ammonium persulphate.  The 
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stacking gel was prepared by the polymerisation of 0.1% sodium dodcyl sulphate 
(SDS) and 5% polyacrylamide in the presence of 0.1% (v/v) 
tetraethylmethyldiamine and 0.1% (w/v) ammonium persulphate).[83]  The gels 
were ran on a Novex minigel system (Invitrogen, Groningen, Netherlands).  
Protein samples were mixed in a 1 in 6 ratio with 5x concentrated protein sample 
buffer [250 mM Tris-HCl (pH 6.8), 10% (w/v) SDS, 500 mM Dithiothreitol 
(DTT), 0.5% (w/v) bromophenol blue, 50% (v/v) glycerol].  Before loading the 
proteins on the gels, samples were boiled for 5 min.  The gels were stained in 
0.08% (w/v) Coomassie Brilliant Blue, 10% (v/v) acetic acid, and 30% (v/v) 
methanol for 1 h to aid visualization.  Destaining solution, 30% (v/v) ethanol in 
10% acetic acid, was used to remove stain not bound to the protein. 
Induced Coupled Plasma Atomic Emission Spectroscopy 
 Purified M. tuberculosis CP was analyzed by induced coupled plasma 
atomic emission spectroscopy (ICP-AES) using a Fisons ARL 3580B to 
determine Li, Na, K, Be, Mg, Ca, Sr, Ba, Al, La, Ti, V, Cr, Mo, Mn, Fe, Co, Ni, 
Cu, Ag, Zn, Cd, Pb, P, As, and S content by Dr. G. Fowler (Imperial College, 
London, UK).  For each measurement, two samples were analyzed, one 
containing only the acid matrix and the second containing both protein and acid 
matrix.  Samples were prepared in 25 mL round bottom flasks fitted with rubber 
septa and vented using 2 stainless steal 20 gauge needles.  1-mL 2.5 mg/mL 
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protein (KH2PO4/K2HPO4, pH 6.5) in 2 mL concentrated nitric acid and 0.5 mL 
perchloric acid was heated until a heating mantle for 3 h at 50 ˚C while stiring.  
The temperature was increased to 150 ˚C and the samples heated for an additional 
3 h.  Both samples were heated to dryness at 190 ˚C.  The remaining solid residue 
was dissolved in 2 mL of 5 M hydrochloric acid and heated for 1 h at 60 ˚C.  The 
sample was diluted to 10 mL with Mili-Q water followed by filtration through a 
0.45-µm filter. 
GRID Calculations 
 All calculations were performed using the Linux operating system and the 
GREAT, GRIN, and GRID software package [84] version 21.  Structure files were 
obtained from the PDB [85], with the exception of the M. tuberculosis model, 
which was provided by N. A. J. Eady.[74]  All remarks and water molecules were 
removed from the protein database file before processing.   
The HRPC PDB file and the INH-docked NMR model of HRPC, obtained 
from Dr. L. Banci,[51] were superpositioned by Alwyn Jones’ O software[86] to 
according to their Cα position.  This superpositioning aided in visually comparing 
the calculated position of INH by GRID to that determined in the NMR model.  
Protein residues missing from the protein database file were modeled in idealized 
positions according to the location of the side chain using Swiss PDBViewer.[72] 
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The files were prepared for use in GRID using program GRIN.  The 
charge of the protein was calculated in GRIN and counterions of Na+ or Cl- were 
added appropriately to create a charge balanced structure.  To determine the best 
placement positions for the counterions, a GRID calculation was performed using 
the Na+ or Cl- probe to locate the most energetically favorable binding site for the 
counterions.  The counterions were then manually entered in suggested positions 
away from the active site and set to move in response to the probe.  When the 
probe is moving around the GRID and moves into the vicinity of the counterion, 
the counterion reacts and shifts slightly to avoid being “seen” by the probe.  
Moving counterions prevent a large charged area from being present during the 
experiment.   
All GRID calculations were performed on the charge balanced protein 
coordinate files with the following directives: NPLA (Number of Planes) equal to 
2 thus the GRID points were 0.5 Å apart to improve the accuracy of the contour 
surfaces and MOVE equal to -1 to allow the counterions to be flexible with 
respect to the probe.   
Probes used in the course of the experiment included both single-atom 
multi-atom types.  The carbonyl probe was designed to locate regions of favorable 
binding energy toward sp2 carbonyl oxygens, while the carboxy probe was 
modeled as an sp2 carboxy oxygen atom.  The N1 and N2 probes were used to 
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model NH and NH2 functional groups.  Two multi-atom probes, AR.CONHR and 
CONHR, modeled a larger portion of the INH structure.  The aromatic neutral 
amide probe was set so that the NH group was trans with respect to the carbonyl 
oxygen and was used to locate energetically favorable binding sites for aromatic 
amides.  The aliphatic neutral amide probe, CONHR, was also set in a trans 
orientation and searched for sites which would be energetically favorable for 
aliphatic amide binding.  The zinc and calcium probes were used to model the 
zinc and calcium dication, respectively.   
Visualization of Data 
The output data generated by GRID were read into MSI Insight II[87] 
software version 2000 for visualization of the energy maps.  The data map files 
were output from Insight II as ascii files and reopened in DS Viewer Pro v. 5.0 for 
generation of the graphics.   
Crystallization of M. tuberculosis CP 
All buffers were filtered through a 0.45-µl filter prior to use in 
crystallization trials.  M. tuberculosis CP sample fractions from the Resource Q 
purification step were pooled.  The protein was buffer exchanged into 
KH2PO4/K2HPO4 (pH 6.5) using a HiTrap Desalt Column.  Using a Centricon-30 
protein concentrator, the protein sample was concentrated to 22 mg/mL.  The 
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protein concentration was determined according to the Beer-Lambert law using 
the extinction coefficient ε405 = 3.4 * 105 M-1cm-1 [82].  The concentrated protein 
was used to set up hanging-drop[88] crystallization trays with Hampton Research 
Crystal Screen Kits 1 and 2.  Multi-well crystallization plates were used with each 
well containing 500 µl of reservoir solution.  2-µl protein droplets were placed on 
siliconized glass cover slips and were mixed with 2 µl reservoir solution.  Each 
cover slip was inverted onto the reservoir solution-filled wells of the multi-well 
plate, the opening of which had been encircled with vacuum grease to provide a 
seal.  The trays were placed in the dark at 20 °C. 
Data Collection and Processing 
Diffraction data were collected at the Synchrotron Radiation Source, 
Daresbury, UK using an Area Detector System Corporation Quantum-4 CCD 
detector and 0.877 Å radiation.  Crystals were prepared for cryocooling by 
soaking in a cryoprotection buffer containing the components of the reservoir 
solution for the crystal being tested and 20% glycerol.  A single crystal was 
mounted in a nylon cryoloop and maintained at 100 K using a nitrogen 
cryostream.   
Data sets were processed using the HKL package version 1.97.2,[75] 
specifically Denzo and XdisplayF.  The peak search option in XdisplayF was used 
to identify and select desired peaks from the oscillation image.  The peaks were 
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autoindexed using Denzo[89] and ideal cells for all 14 Bravais lattices were 
calculated.   
The crystal and detector parameters were refined for the displayed 
oscillation image using a least-squares method, which allows each parameter to be 
refined in turn.  During the refinement process, mosaicity (the smallest angle 
through which the crystal can rotate, about any axis or combination of axes, while 
a reflection is still observed),[90] and the spot size and shape are estimated by the 
user.  These refined parameters are then applied to all images of the data set.  
During this process, Denzo[89] looks for spots on all images of the data set and 
uses the profile-fitting method to estimate the intensities of spots and 
subsequently calculates the reflection intensities.  To calculate the diffraction 
intensity, the background must be estimated and then subtracted from the 
reflection profile.  The profile-fitting method within Denzo[89] is a two-step 
process.  First a profile is predicted based on the profiles of other reflections.  
Secondly, the diffraction intensity of each spot is calculated by estimating and 
then subtracting the background from the reflection profile. 
Data Scaling and Merging 
Scaling and merging of data sets was performed using Scalepack from the HKL 
software package.[75]  The program calculates single, isotropic scale and B factors 
for each of the images of the processed data.  All images are put on a common 
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scale, thereby taking into account changes in beam intensity.  Scalepack also 
performs postrefinement, the implementation of which enables improved unit cell 
parameters, mosaicity and crystal orientation of each image, but with the same 
unit cell value for the whole data set.  Postrefinement was run two times, first to 
write a list of outlying observations and on following rounds these observations 
were rejected in the refinement of the orientation parameters.  Following 
postrefinement, Scalepack merges the data.  All related spots, for example, partial 
reflections, symmetry related spots and Friedel pairs, are merged together and an 
Rmerge value is calculated.  The quality of the diffraction data can by analyzed by 
the agreement between symmetry related reflections, the Rmerge, or the ratio of the 
intensity to the error of the intensity, I/σ(I). 
Generation of FreeR Flag 
The output reflection file was converted to MTZ format using the f2mtz 
program from the Collaborative Computational Project, Number 4 (CCP4 
Program Suite v. 4.1).  The resulting MTZ file was processed using truncate 
which calculates a Wilson plot, uses the resulting scale factor to place all 
reflections on an absolute scale and deal with weak reflections by ensuring no 
reflection is negative.  A best estimate of |F(hkl)| from I, the standard deviation of 
I and the distribution of intensities in resolution shells are calculated.  All negative 
reflections are forced to be positive and the weakest reflections (less than three 
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standard deviations) are inflated.  The program freerflag from the CCP4 Program 
Suite then designated 5% of the data as a test set for subsequent generation of the 
R-free value.[91] 
Molecular Replacement 
Molecular replacement was performed using the automated program 
molrep[92] from the CCP4 Program Suite.  The program is based upon the fast 
rotation function[93] and uses the translation function defined as the overlap of the 
observed and calculated Patterson functions for a given orientation of the 
model.[92] 
M. tuberculosis CP was found to have 66% sequence identity to B. 
pseudomallei CP and was expected to be similar in structure.  The crystal 
structure of B. pseudomallei CP[67] was used as a search model for the molecular 
replacement process.   
Refinement 
Following molecular replacement, the model was underwent several 
cycles of refinement in order to obtain closer agreement between the calculated 
and observed structure factors.  The agreement index between calculated and 
observed structure factors is represented by R, where k represents a weighting 













Equation 4. 1  Formula for determining the reliability index of a structure. 
 The macromolecular structure determination software, Crystallography 
and NMR System (CNS),[91] was used for structure refinement.  Refinement 
within CNS utilizes maximum likelihood with cross-validation, in order to reduce 
over-fitting, which in turn is combined with simulated annealing.[91]  Between 
each refinement step the model was inspected and manually rebuilt where 
necessary in the molecular graphics program O.[86]  Observation of the 3Fo-2Fc 
Fourier maps indicated when the selection of alternative side chain rotamers and 
adjustment of torsion angles was required.  
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Appendix.  Compound Numbers 
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